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2 ABBREVIATIONS 
BM basement membrane 
BMP bone morphogenetic protein 
BP180 bullous pemphigoid protein 180 
BSA bovine serum albumin 
ChIP chromatin immunoprecipitation 
Ck cytokeratin 
DIG digoxigenin 
ECM extracellular matrix 
EGF epidermal growth factor 
EGFP enhanced green fluorescent protein 
ELISA enzyme-linked immunosorbent assay 
EMT epithelial-mesenchymal transition 
FAK focal adhesion kinase 
FCS fetal calf serum 
FESEM field emission scanning electron microscopy 
FRAP fluorescence recovery after photobleaching 
GAPDH glyceraldehyde-3-phosphate dehydrogenase 
GFP green fluorescent protein 
GSK3 glycogen synthase kinase 3 
GST glutathione S-transferase 
HD1 hemidesmosomal protein 1/ plectin 
HRP horseradish peroxidase 
IgG immunoglobulin G 
ILK integrin-linked kinase 
KGM-1 keratinocyte growth medium 1 
MAb monoclonal antibody 
MET mesenchymal-epithelial transition 
MMP matrix metalloproteinase 
Mr relative molecular mass 
MT1-MMP membrane-type 1 matrix metalloproteinase 
NA numerical aperture 
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PBS phosphate-buffered saline 
PCR polymerase chain reaction 
PMSF phenylmethylsulfonyl fluoride 
RPMI Roswell Park Memorial Institute 
RT room temperature 
RT-PCR reverse transcriptase polymerase chain reaction 
SCC squamous cell carcinoma 
SD standard deviation 
SDS sodium dodecyl sulphate 
SDS-PAGE sodium dodecyl sulphate polyacrylamide gel electrophoresis 
SEM standard error of the mean 
SPARC secreted protein, acidic and rich in cysteine 
TGF- transforming growth factor  
TIRF total internal reflection fluorescence  
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3 ABSTRACT 
In epithelial-mesenchymal transition (EMT), epithelial cells acquire traits typical for 
mesenchymal cells, dissociate their cell-cell junctions and gain the ability to migrate. EMT 
is essential during embryogenesis, but may also mediate cancer progression. Basement 
membranes are sheets of extracellular matrix that support epithelial cells. They have a 
major role in maintaining the epithelial phenotype and, in cancer, preventing cell 
migration, invasion and metastasis. Laminins are the main components of basement 
membranes and may actively contribute to malignancy.  
 
We first evaluated the differences between cell lines obtained from oral squamous cell 
carcinoma and its recurrence. As the results indicated a change from epithelial to 
fibroblastoid morphology, E-cadherin to N-cadherin switch, and change in expression of 
cytokeratins to vimentin intermediate filaments, we concluded that these cells had 
undergone EMT. We further induced EMT in primary tumour cells to gain knowledge of 
the effects of transcription factor Snail in this cell model. The E-cadherin repressors 
responsible for the EMT in these cells were ZEB-1, ZEB-2 and Snail, and ectopic 
expression of Snail was able to augment the levels of ZEB-1 and ZEB-2.  
 
We produced and characterized two monoclonal antibodies that specifically recognized 
Snail in cell lines and patient samples. By immunohistochemistry, Snail protein was found 
in mesenchymal tissues during mouse embryonal development, in fibroblastoid cells of 
healing skin wounds and in fibromatosis and sarcoma specimens. Furthermore, Snail 
localized to the stroma and borders of tumour cell islands in colon adenocarcinoma, and in 
laryngeal and cervical squamous cell carcinomas.  
 
Immunofluorescence labellings, immunoprecipitations and Northern and Western blots 
showed that EMT induced a progressive downregulation of laminin-332 and laminin-511 
and, on the other hand, an induction of mesenchymal laminin-411. Chromatin 
immunoprecipitation revealed that Snail could directly bind upstream to the transcription 
start sites of both laminin 5 and 4 chain genes, thus regulating their expression. The 
levels of integrin 64, a receptor for laminin-332, as well as the hemidesmosomal 
complex proteins HD1/plectin and BP180 were downregulated in EMT-experienced cells. 
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The expression of Lutheran glycoprotein, a specific receptor for laminin-511, was 
diminished, whereas the levels of integrins 61 and 11 and integrin-linked kinase were 
increased. In quantitative cell adhesion assays, the cells adhered potently to laminin-511 
and fibronectin, but only marginally to laminin-411. Western blots and 
immunoprecipitations indicated that laminin-411 bound to fibronectin and could 
compromise cell adhesion to fibronectin in a dose-dependent manner.  
 
EMT induced a highly migratory and invasive tendency in oral squamous carcinoma cells. 
Actin-based adhesion and invasion structures, podosomes and invadopodia, were detected 
in the basal cell membranes of primary tumour and spontaneously transformed cancer 
cells, respectively. Immunofluorescence labellings showed marked differences in their 
morphology, as podosomes organized a ring structure with HD1/plectin, II-spectrin, 
talin, focal adhesion kinase and pacsin 2 around the core filled with actin, cortactin, 
vinculin and filamin A. Invadopodia had no division between ring and core and failed to 
organize the ring proteins, but instead assembled tail-like, narrow actin cables that showed 
a talin-tensin switch. Time-lapse live-cell imaging indicated that both podosomes and 
invadopodia were long-lived entities, but the tails of invadopodia vigorously propelled in 
the cytoplasm and were occasionally released from the cell membrane. Invadopodia could 
also be externalized outside the cytoplasm, where they still retained the ability to degrade 
matrix. In 3D confocal imaging combined with in situ gelatin zymography, the podosomes 
of primary tumour cells were large, cylindrical structures that increased in time, whereas 
the invadopodia in EMT-driven cells were smaller, but more numerous and degraded the 
underlying matrix in significantly larger amounts. Fluorescence recovery after 
photobleaching revealed that the substructures of podosomes were replenished more 
rapidly with new molecules than those of invadopodia. Overall, our results indicate that 
EMT has a major effect on the transcription and synthesis of both intra- and extracellular 
proteins, including laminins and their receptors, and on the structure and dynamics of oral 
squamous carcinoma cells.  
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4 REVIEW OF THE LITERATURE 
4.1. Progression of carcinomas 
The development of cancer in humans is a complex event that may proceed over a period 
of decades. Through a process termed cancer progression, normal cells evolve into cells 
with increasingly neoplastic phenotypes (Greer 2006; Weinberg 2007). Cancer 
progression is driven by accumulation of multiple genetic mutations and epigenetic 
alterations of DNA that affect the genes controlling traits such as cell motility, 
proliferation, survival and angiogenesis. Genetic abnormalities in cancer typically have an 
effect on two general classes of genes. First, oncogenes are cancer-promoting genes that 
may be activated in cancer cells, resulting in novel properties, e.g., excess growth and 
division, sustained angiogenesis, protection against cell death, escape from normal tissue 
boundaries and acquisition of invasive and metastatic abilities (Hanahan and Weinberg 
2000). Second, tumour suppressor genes may become inactivated in cancer cells, causing 
abnormal DNA replication, cell cycle control and cell orientation and adhesion within 
tissues. The order and mechanistic means to achieve these properties can vary between 
different tumours (Hanahan and Weinberg 2000).  
 
Over 90% of tumours arise from epithelia and are called carcinomas (Weinberg 2007). 
Carcinomas are considered benign (carcinoma in situ) if they remain in the same tissue 
compartment, and malignant if individual carcinoma cells or groups of cells invade the 
surrounding stroma (Fidler 2003; Weinberg 2007). As a consequence of malignant 
transformation, invasive cancer cells penetrate through epithelial basement membranes 
(BM) and proliferate in the surrounding mesenchymal stroma. After local invasion, they 
penetrate lymph or blood vessel walls (intravasation), move via circulation and become 
lodged in microvessels of distant tissues. Then, they again pass through endothelial BMs 
(extravasation), invade the parenchyma and establish secondary colonies (Bosman et al. 
1992; Liotta and Kohn 2001; Fidler 2003). Epithelial-mesenchymal transition (EMT) may 
represent one of the mechanisms by which carcinoma cells acquire migratory and cell 
survival abilities to escape from their primary locations (Section 4.3). Each step of 
tumourigenesis is essential and requires interactions between tumour cells and their 
microenvironment. In fact, the network of extracellular matrix (ECM) molecules 
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surrounding a tumour can facilitate or hinder tumour progression and is gaining a role as 
an important participant in tumourigenesis (Ingber 2002; Tlsty and Coussens 2006). 
Moreover, non-malignant mesenchymal stromal cells, such as fibroblasts, may alter the 
microenvironment of normal epithelial cells to predispose them to malignant 
transformation (Liotta 1984; Liotta and Kohn 2001; Kalluri and Neilson 2003). 
Furthermore, fibroblasts residing near tumours, called carcinoma-associated fibroblasts, 
seem to promote the growth of their parent tumours and have been suggested to originate 
from EMT (Petersen et al. 2003; Orimo et al. 2005).  
4.2. Oral squamous cell carcinoma (SCC) 
Head and neck squamous cell carcinoma (SCC) represents a major worldwide health 
problem. It includes cancers of the oral and nasal cavity, paranasal sinuses, pharynx and 
larynx. Oral cancer is the sixth most prevalent cancer in the world, ranking third in 
developing countries and eighth in developed countries. Over 80% of these lesions are 
SCCs. Approximately 500 new cases of oral cancer are diagnosed each year in Finland 
and 274 000 cases globally. The number of yearly deaths related to oral cancer is 150 in 
Finland and 127 000 worldwide (Parkin et al. 2005; Finnish Cancer Registry 2007).  
 
Oral mucous membranes and the surrounding structures are composed of stratified 
squamous epithelium supported by a fibrous connective tissue lamina propria and a 
submucosa of fibroadipose tissue. Minor salivary glands, nerves and capillaries course 
throughout the submucosa (Greer 2006). Most oral SCCs arising from these mucous 
membranes show a very aggressive phenotype. They rapidly invade the surrounding 
tissues and metastasize early. Sometimes oral SCC lesions are preceded by mucosal 
alterations with dysplastic changes, but highly malignant tumours may also occur directly 
without any pre-existing clinically detectable mucosal change. The current management 
for oral SCC includes radiation therapy and surgery, either alone or in combination with 
chemotherapy. However, less than 50% of oral SCC patients survive for over five years, 
and this survival rate has not improved in the last 30 years. The most important causes of 
treatment failure are cancer recurrence and local invasion (Kramer et al. 2005; Greer 2006; 
Ziober et al. 2006; Pitiyage et al. 2009).  
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The main risk factors for oral cancer include tobacco smoking or chewing, alcohol 
consumption and viral infections such as human papilloma virus (Greer 2006; Mehrotra 
and Yadav 2006). Other predisposing agents are previous family history of oral cancer, 
poor nutrition and such immune deficiencies as human immunodeficiency virus (HIV). 
Genetic alterations related to malignant transformation of oral cancer include alterations in 
tumour suppressor genes, loss- or gain-of-function mutations and chromosomal 
amplifications. More specifically, changes in genes and proteins controlling the cell cycle, 
apoptosis, angiogenesis, cytoskeleton and cell adhesion have been revealed (Mehrotra and 
Yadav 2006; Ziober et al. 2006; Pitiyage et al. 2009). Because little is known about the 
molecular basis underlying the progression of oral SCC to an invasive phenotype, it is 
very difficult to predict individual tumour aggressiveness and to design effective treatment 
plans. Therefore, identification of molecular markers that help in the prediction of disease 
progression is needed to improve the management of oral cancer.  
4.3. Epithelial-mesenchymal transition (EMT) 
Epithelial cells are adherent cells that form continuous layers due to their cell-cell 
adhesion complexes, namely, tight junctions, adherens junctions and desmosomes. 
Epithelial cells display a polarized, apico-basal morphology and organize 
hemidesmosomal complexes at their basal sides, which enable tight and stable attachment 
to the BM. Mesenchymal cells, in contrast, are spindle-shaped, end-to-end polarized cells 
that lack most of the intercellular junctions. Mesenchymal cells, e.g., fibroblasts and 
smooth muscle cells, are able to migrate as individual cells through the ECM. Epithelial-
mesenchymal transition (EMT) is considered a fundamental process in which epithelial 
cells acquire mesenchymal traits (Figure 1). EMT has its origins in development, 
occurring during implantation, gastrulation, neural crest formation and embryo- and 
organogenesis (Nieto 2002; Thiery 2002; Hay 2005). During implantation extravillous 
cytotrophoblast cells undergo EMT to infiltrate the endometrium (Vicovac and Aplin 
1996). In gastrulation, epiblast cells migrate and produce three distinct germ layers, the 
ectoderm, mesoderm (primary mesenchyme) and endoderm. In nervous system 
development, the epithelial cells in the primary neural tube undergo EMT to become 
migratory neural crest cells. During further development the neural crest cells differentiate 
into, for instance, peripheral neural ganglia, bone and cartilage of the jaws, melanocytes 
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and glial cells. Tertiary EMT occurs, e.g., in the development of heart valves, in which 
three cycles of EMTs and METs (mesenchymal-epithelial transitions) take place 
(Savagner 2001; Pérez-Pomares and Muñoz-Chápuli 2002).  
 
 
Figure 1. A schematic illustration of epithelial-mesenchymal transition and mesenchymal-
epithelial transition (modified from Peinado et al. 2007; Weinberg 2007).  
In the adult organism, EMT plays a role mainly in wound-healing, tissue regeneration and 
inflammation, but abnormal EMT activation leads to pathogenic situations such as fibrosis 
and carcinogenesis (Kalluri and Weinberg 2009). In renal fibrosis, renal tubular epithelial 
cells are turned into myofibroblasts by EMT, which consequently deposit high levels of 
ECM (Iwano et al. 2002; Zeisberg and Kalluri 2004). The end result is tubulointerstitial 
fibrosis, which obstructs filtering functions of the kidney glomeruli. In the lung, the 
myofibroblasts responsible for the fibrotic cascade may be derived from alveolar 
epithelium via EMT (Willis et al. 2006). A similar, TGF--mediated EMT has been 
recognized in lens epithelial cells, leading to cataract (de Iongh et al. 2005). In 
carcinogenesis, EMT has been suggested to initiate invasive and metastatic behaviour in 
carcinoma cells (Thiery 2002; Thiery 2003). Progression of solid tumours may involve 
spatial and temporal events of EMT, which enable cell migration and invasion (Figure 1). 
Subsequently, at the site of metastasis, the disseminated mesenchymal tumour cells must 
undergo a reverse transition, MET, resulting usually in the recapitulation of the phenotype 
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of their primary tumours. This suggests that cellular plasticity, the ability to undergo both 
EMT and MET, is a key feature of a malignant cell (Thiery 2002; Thiery 2003; Kalluri 
and Weinberg 2009).  
 
4.3.1. Molecular definition of EMT 
EMT is a culmination of transcriptional and protein modification events that leads to a 
long-term, although occasionally reversible, cellular change. In EMT, cell-cell adhesion 
junctions are reduced, usually via transcriptional repression and delocalization of proteins 
situated in the tight and adherens junctions as well as in the desmosomes (Nieto 2002; 
Thiery 2002; De Craene et al. 2005a). E-cadherin is downregulated and N-cadherin 
expression may emerge. -catenin is frequently lost from the cell membrane and 
translocated to the nucleus, where it may participate in EMT signalling events. Apart from 
E-cadherin, other epithelial genes, including desmoplakin, Muc-1, cytokeratin-18, 
occludin, claudin-1 and claudin-7, are downregulated (Cano et al. 2000; Guaita et al. 
2002; Ikenouchi et al. 2003; Ohkubo and Ozawa 2004; Vandewalle et al. 2005). On the 
other hand, mesenchymal markers, such as vimentin and fibronectin, are upregulated 
(Cano et al. 2000; Yokoyama et al. 2003). Also some controversies of the importance of 
EMT in carcinomas have risen (Tarin et al. 2005; Thompson et al. 2005; Christiansen and 
Rajasekaran 2006). As different carcinomas represent different patterns of EMT proteins, 
it may be difficult to predict whether the cells of a certain tumour have undergone EMT or 
not. In addition, many transcription factors controlling EMT are short-lived, their 
detection is complicated (Zhou et al. 2004) and EMT may continue without their constant 
presence. Moreover, EMT could be a transient state of the cell, which again sets 
challenges for its detection (Christiansen and Rajasekaran 2006; Weinberg 2007). 
Therefore, further investigations on the specific markers of EMT are required.  
4.3.2. E- and N-cadherin 
In the adherens junction, cadherins mediate cell-cell adhesion through their extracellular 
domains and connect to the actin cytoskeleton through their cytoplasmic domains by 
association with -, -, - and p120- catenins (Semb and Christofori 1998; Behrens 1999) 
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(Figure 2). Cadherin anchorage to the actin cytoskeleton stabilizes the junctional structure 
and contributes to maintenance of cell morphology and control of cell motility. Through 
homophilic interactions, cadherins contribute to sorting cells of different lineages during 
embryogenesis, establishing cell polarity, and maintaining tissue morphology and cell 
differentiation (Semb and Christofori 1998; Van Aken et al. 2001). Most epithelial cells 
express E-cadherin, whereas mesenchymal cells express various cadherins, including N-
cadherin, R-cadherin and cadherin-11 (Cavallaro and Christofori 2004).  
 
Actin
Arp 2/3
-actinin
-catenin
-catenin
-catenin vinc-act



E-cadherin
p120-catenin
Vinculin
p120
p120
p120
 
 
vin
c

-a
ct 

vin
c

-a
ct
 
Figure 2. The adherens junction (modified from Van Aken et al. 2001; Cavallaro and Christofori 
2004). 
E-cadherin (also known as epithelial cadherin, cadherin-1, type 1 or uvomorulin) is 
considered the main gatekeeper of epithelial tissue integrity. It has been proposed that the 
loss of E-cadherin-mediated cell adhesion is a prerequisite for tumour cell invasion and 
formation of metastases (Christofori 2003). E-cadherin-deficient mice present with 
dissociated, unpolarized cells and defective formation of the trophectoderm, and die in 
utero before implantation (Larue et al. 1994; Riethmacher et al. 1995). Decreased 
expression of E-cadherin has been shown to correlate with increased cell migration and 
invasion in vitro, and vice versa, forced expression of E-cadherin in invasive mammary 
carcinoma cells results in a restoration of a non-invasive phenotype, suggesting that E-
cadherin is a tumour- and invasion-suppressor gene (Vleminckx et al. 1991). Loss of E-
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cadherin has been connected to cell dedifferentiation and metastasis in several carcinomas, 
e.g., breast, colorectal, gastric, and head and neck carcinomas, where it may predict an 
infiltrative growth pattern, lymph node metastasis and poor patient prognosis (Schipper et 
al. 1991; Gabbert et al. 1996; De Leeuw et al. 1997; Chow et al. 2001; Kanazawa et al. 
2002; Lim et al. 2004). Fragments consisting of the E-cadherin extracellular domain have 
been detected in the circulation of carcinoma patients (Katayama et al. 1994) and were 
suggested to implicate dissociation of cell-cell adhesion leading to invasion. Importantly, 
in a mouse pancreatic -cell tumour model, maintenance of E-cadherin caused arrest of 
tumour development at the adenoma stage, whereas expression of dominant-negative E-
cadherin induced early invasion and metastasis, supporting the hypothesis that loss of E-
cadherin is a rate-limiting step in progression from adenoma to carcinoma (Perl et al. 
1998).  
 
One of the first recognized signs of EMT is the downregulation of E-cadherin in the 
adherens junction. This phenomenon has been suggested to occur mainly through 
transcriptional downregulation of the E-cadherin gene CDH1, but may result from 
mutations or deletions of the gene, hypermethylation of the promoter, post-translational 
modifications of the protein or cleavage of E-cadherin by matrix metalloproteinases 
(MMPs) (Hirohashi 1998; Van Aken et al. 2001; Kanazawa et al. 2002). Downregulation 
of the CDH1 gene occurs through binding of transcription factors to a CANNTG 
sequence, called the E-box motif, within the promoter site of the E-cadherin gene 
(Bussemakers et al. 1994).  
 
In carcinomas, e.g., oral SCC, E-cadherin may be replaced by N-cadherin (neuronal 
cadherin, cadherin 2, type 1) in a process called cadherin switching, resulting in a change 
from tight cell-cell adhesion to a more loosely connected and possibly more dynamic type 
of adhesion (Islam et al. 1996; Cavallaro et al. 2002; Cavallaro and Christofori 2004; 
Maeda et al. 2005b). Occasionally, the E-cadherin levels may persist, but additional 
neoexpression of N-cadherin, cadherin-11, P-cadherin or T-cadherin is found (Shimoyama 
and Hirohashi 1991; Nieman et al. 1999; Tomita et al. 2000; Riou et al. 2006; Vered et al. 
2010). Overexpression of N-cadherin in oral SCC and breast carcinoma cells 
downregulates the levels of endogenous E-cadherin by accelerating its degradation (Islam 
et al. 1996; Nieman et al. 1999). Furthermore, cells that express significant amounts of E-
  18
cadherin but only small amounts of N-cadherin still have increased motility, suggesting 
that N-cadherin participates in cell migration independently of E-cadherin (Nieman et al. 
1999; Hazan et al. 2000; Hazan et al. 2004; Rosivatz et al. 2004). It is possible that loss of 
E-cadherin prevents adhesion to other epithelial cells, whereas upregulation of N-cadherin 
may enable interaction with stromal cells, and, subsequently, cell motility (Cavallaro and 
Christofori 2004). Taken together, loss of E-cadherin has been detected in several 
carcinomas and is considered a major hallmark of EMT. However, the presence of N-
cadherin in carcinomas, as well as the role of cadherin switching in EMT, remains largely 
unsolved.  
4.3.3. Transcription factors Snail and Slug  
The first member of the Snail superfamily of zinc-finger transcription factors, Snail, was 
identified in Drosophila melanogaster, where it was shown to be indispensable for 
mesoderm formation (Simpson 1983; Grau et al. 1984; Boulay et al. 1987; Alberga et al. 
1991). Subsequently, over 50 family members have been described in many species, 
including humans, other vertebrates and invertebrates. Vertebrates express three isoforms 
of Snail, namely Snail (also called Snail1), Slug (Snail2) and Smuc (Snail3), which seem 
to have developed through evolutionary gene duplications (Nieto et al. 1994; Barrallo-
Gimeno and Nieto 2005). The Snail transcription factors share common structural features 
including a highly conserved DNA-binding carboxyterminal region with four to six C2H2-
type zinc finger repeats, whereas the aminoterminal region is more divergent (Nieto 2002) 
(Figure 3). Snail family members act as transcriptional repressors through binding to 
CAGGTG E-box sequences, motifs targeted also by basic helix-loop-helix (bHLH) and 
ZEB transcription factors (Mauhin et al. 1993). Furthermore, a Snail/ Gfi-1 (SNAG) 
domain located in the aminoterminal region enhances the repressor activity (Grimes et al. 
1996), and a nuclear export sequence (NES) regulates Snail’s cytoplasmic location and 
activity (Domínguez et al. 2003).  
 
 19
SNAG NES Zinc Fingers
Snail
Slug
Slug
ZEB-1/ZEB-2 
Zinc Fingers Zinc Fingers
Zinc FingersSNAG
 
Figure 3. Main structural domains of transcription factors Snail, Slug, ZEB-1 and ZEB-1 (modified 
from Domínguez et al. 2003; Peinado et al. 2007).  
The genes encoding for Snail and Slug are highly homologous and in certain stages of 
development have overlapping expression (Sefton et al. 1998). They seem, however, to 
have separate roles. Snail-deficient mouse embryos exhibit abnormal mesoderm 
morphology and fail to gastrulate, which leads to an accumulation of epithelial, E-
cadherin-positive cells that are unable to migrate, and, eventually, to death of the embryo 
(Carver et al. 2001). By contrast, Slug-deficient mice are viable, despite slower growth, 
malformations of the craniofacial area and discoloration (Jiang et al. 1998). Snail 
mutations have not been described in humans. Patients with Slug mutations show similar 
phenotypes to mice, which are related to defective functions of the neural crest. In 
piebaldism, Slug deletion results in congenital white forelock and depigmented skin 
(Sánchez-Martín et al. 2003). In Waardenburg syndrome type 2, the patients suffer from 
deafness and impaired melanocyte function and migration (Sánchez-Martín et al. 2002).  
 
During embryonic development Snail genes function in the EMTs of, for instance, 
formation of the neural crest (Nieto et al. 1992; Sefton et al. 1998). More generally, they 
seem to induce cell migration. They also act as survival factors, as they confer resistance 
to DNA damage and direct apoptotic stimuli (Vega et al. 2004). Snail may have an 
additional role in determination of left-right asymmetry (Sefton et al. 1998). Many 
signalling cascades, such as TGF-, FGF, Wnt, MEK/ERK and Notch signalling, may 
control the levels of Snail or Slug (De Craene et al. 2005b; Peinado et al. 2007). Snail 
protein is also under post-transcriptional regulation. For instance, glycogen synthase 
kinase 3 (GSK3) phosphorylates Snail, promoting its nuclear export and degradation in 
the proteasome (Zhou et al. 2004). Inhibition of GSK3, in turn, increases the amount of 
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Snail and lengthens the time it can affect gene expression in the nucleus (Zhou et al. 
2004). Importantly, Snail has been shown to be a repressor of E-cadherin transcription 
during both embryonic development and tumour progression (Thiery 2002; Thiery 2003). 
Snail overexpression is related to the acquisition of invasive properties in different human 
carcinoma cell lines (Yokoyama et al. 2001; Yokoyama et al. 2003). A reverse correlation 
between Snail and E-cadherin mRNAs has been reported in carcinoma cell lines (Batlle et 
al. 2000; Cano et al. 2000; Yokoyama et al. 2001). Snail mRNA is expressed in invasive 
cells of mouse skin tumours and in biopsies from patients with ductal breast, gastric and 
hepatocellular carcinomas (Cano et al. 2000; Blanco et al. 2002; Rosivatz et al. 2002; 
Sugimachi et al. 2003). It has been suggested to be an early marker of a malignant 
phenotype in breast cancer (Blanco et al. 2002). However, the studies of Snail in 
malignancies have been hindered by the lack of specific antibodies that could corroborate 
the presence of Snail protein in patient samples. Furthermore, the functions of Snail may 
extend beyond repression of E-cadherin, i.e., the array of Snail target genes is far from 
complete.  
4.3.4. Transcription factors ZEB-1 and ZEB-2 
Other transcription factors connected to EMT are ZEB-1 (zinc finger E-box binding 
protein 1, also known as delta E-box factor 1, EF1, or TCF8) and ZEB-2 (also known as 
Smad interacting protein 1, SIP1), which belong to the ZEB family of transcription factors 
(Postigo and Dean 1997; Postigo et al. 1997; Grooteclaes and Frisch 2000; Postigo and 
Dean 2000; Comijn et al. 2001). ZEB-1 and ZEB-2 are characterized by two separate 
clusters of C2H2-type zinc finger domains and a centrally located, less conserved and non-
DNA-binding homeodomain (Verschueren et al. 1999). They regulate TGF-/ bone 
morphogenetic protein (BMP) signalling through differential recruitment of coactivators 
p300 and P/CAF and co-repressor CtBP to the Smad complex (Postigo 2003). 
Furthermore, ZEB-1 and ZEB-2 downregulate E-cadherin expression and may induce 
EMT in different cell lines in vitro (Verschueren et al. 1999; Grooteclaes and Frisch 2000; 
Comijn et al. 2001; Eger et al. 2005). For instance, ZEB-2 overexpression induces loss of 
cell aggregation, enhances invasion and downregulates certain tight junction and 
desmosomal proteins in colon carcinoma cell lines (Vandewalle et al. 2005).  
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Mice deficient for the gene encoding for ZEB-1, zfhx1a, develop to term, but die shortly 
after birth (Takagi et al. 1998). They have short limbs and trunk, craniofacial defects and 
T cell deficiency. Homozygous mutant embryos lacking the gene encoding for ZEB-2, 
zfhx1b, display early arrest in neural crest migration and fail to survive (Van de Putte et al. 
2003). These embryos have elevated E-cadherin mRNA levels in their neural ectoderm 
and visceral endoderm. In humans, ZEB-1 mutations have been detected in posterior 
polymorphous corneal dystrophy, which includes abnormal corneal BMs and impaired 
endothelial cell migration (Krafchak et al. 2005). ZEB-2 mutations cause Mowat-Wilson 
syndrome, a form of Hirschsprung’s disease associated with microcephaly, mental 
retardation and dysmorphic facial features (Zweier et al. 2002).  
 
In cancer, ZEB-1 expression has been implicated as a poor prognostic factor in colorectal 
carcinoma, and ZEB-2 is correlated with lack of E-cadherin expression in oral SCC and 
intestinal type gastric carcinoma (Rosivatz et al. 2002; Maeda et al. 2005a; Peña et al. 
2005; Spaderna et al. 2006). Similar to the Snail family, the specific roles of ZEB-1 and 
ZEB-2 in tumourigenesis are not fully understood.  
4.4. Extracellular matrix (ECM) 
The extracellular matrix (ECM) provides the physical environment in which the cells 
reside. It provides a substrate for cell anchorage, tissue form and function and guides cell 
migration. The ECM also transmits signals to cells that modify their functions such as 
growth, proliferation and differentiation. The cells, on the other hand, actively modulate 
the consistency of their surrounding ECM by degrading and secreting new molecules. The 
interactions between cells and ECM molecules are mediated through cell-specific 
receptors, for instance, integrins (Gustafsson and Fässler 2000; Geiger et al. 2001; Aszódi 
et al. 2006).  
 
The ECM of connective tissues is predominantly composed of fibrillar polymers, 
including collagens and elastins, which are embedded within a mixture of non-fibrillar 
components, such as fibronectins and tenascins, and ground substance. The relative 
proportions and arrangements of fibrillar and non-fibrillar components dictate the overall 
physical properties of a particular ECM (Aszódi et al. 2006). In addition, specialized 
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sheets of the ECM called basement membranes contain molecules such as collagen type 
IV, laminins and nidogen (Miner and Yurchenco 2004).  
 
Many ECM proteins are large multifunctional molecules containing multiple domains that 
may bind several other molecules simultaneously. The ground substance consists of 
glycosaminoglycans and proteoglycans. Glycosaminoglycans, such as hyaluronan and 
heparan sulphate, consist of repeated sulphated oligosaccharide units. 
Glycosaminoglycans bind to a proteoglycan core protein and form large macromolecules 
such as versican and aggrecan. The glycosaminoglycan side-chains contain negatively 
charged residues, attracting water molecules and forming a hydrated gel that resists 
compressive forces. Growth factors and signalling molecules are trapped into this gel 
(Gustafsson and Fässler 2000; Aszódi et al. 2006). Collagens, the most ubiquitous proteins 
in human tissues, are glycoproteins that share a structural homology of three  chains 
intertwined into a triple helix (Myllyharju and Kivirikko 2004). Collagen fibres provide 
mechanical strength, organize the matrix and enable cell adhesion and migration. Elastic 
fibres, consisting of elastin and microfibrils, are arranged into a branching pattern among 
the collagen fibres. They limit the distensibility of the tissues and prevent tearing from 
excessive stretching (Ramirez 2000). Fibronectins are large glycoproteins that function in 
blood in a soluble form, but in tissues as insoluble fibrils composed of fibronectin 
multimers. They mediate cell adhesion and are especially prominent in loose connective 
tissues, granulation tissue, embryonic BMs and stroma (Bosman et al. 1992). Matricellular 
proteins, including tenascins, thrombospondins, osteopontin and SPARC (secreted protein, 
acidic and rich in cysteine), are a structurally unrelated protein family that functions as 
adaptors and modulators of cell-matrix interactions. They have a strictly regulated 
expression, being especially abundant during embryogenesis, tissue repair and 
regeneration, and are suggested to confer anti-adhesive properties to cells (Murphy-Ullrich 
2001; Bornstein and Sage 2002).  
4.5. Basement membrane 
Basement membranes (BMs), present in multicellular organisms, are the first extracellular 
matrices produced during embryogenesis. The BM is an amorphous, dense, sheet-like 
structure of 50-100 nm in thickness. BMs are usually found beneath epithelial and 
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endothelial cells and surrounding muscle, adipose and Schwann cells (Bosman et al. 1992; 
Kalluri 2003). The BM acts as a regulator of cell attachment, differentiation and growth, 
as well as a passive barrier that segregates tissue compartments. The BM provides 
structural support and regulates cell behaviour and polarization. It also mediates signals 
from the ECM to the cytoplasm and binds growth factors, hormones and ions. During 
embryogenesis, tissue repair and regeneration BMs guide cell migration (Merker 1994; 
Flug and Köpf-Maier 1995).  
 
Ultrastructural analysis has indicated that BMs consist of three layers. Adjacent to the 
plasma membrane of the adherent cell is an electron-lucent layer, called the lamina rara or 
lamina lucida (Merker 1994). The lamina lucida, however, may be an artefact derived 
from tissue dehydration. The lamina densa, an electron-dense layer, consists of a large 
network of filaments and is considered the main BM zone. Lamina fibroreticularis, 
restricted to only certain epithelia, lies at the stromal side of the BM and consists of type 
VII collagen anchoring fibrils (Merker 1994). Epithelial BMs were long assumed to be 
produced exclusively by adjacent epithelial cells. However, it has become clear that the 
BM arises through an interaction between epithelial and stromal cells (Bosman et al. 
1992).  
 
The main components of BMs are laminins, type IV collagen, heparan sulphate 
proteoglycans and nidogen/ entactin. Minor components include agrin, SPARC, 
osteopontin, fibulins and type XV and XVIII collagens. Altogether, 50 different proteins 
have been identified in the BM. Currently, 15 laminins and three isoforms of type IV 
collagen have been recognized (Erickson and Couchman 2000; Borza et al. 2001; 
Yurchenco et al. 2004; Khoshnoodi et al. 2008). Each BM may contain highly variable 
components, and may perform significantly different functions in regulating organ-
specific behaviour. Distinct from all other BM components, only laminin and type IV 
collagen molecules are able to initiate the self-assembly of BM into sheet-like structures. 
Previously, most models of BM organization assumed that type IV collagen would serve 
as the major scaffold upon which the laminin network would be deposited. However, it 
has been established that the laminin polymers function as the initial template (Timpl and 
Brown 1996; Yurchenco et al. 1997; Li et al. 2002). After the laminin molecules are 
formed and secreted, they concentrate at the plasma membrane via binding to cellular 
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receptors, e.g., integrins and -dystroglycan. Adjacent laminin molecules bind each other 
via stable interactions between the short-arm globular LN domains. Type IV collagen 
polymers organize their own network, which is stabilized by covalent crosslinks and 
bridged to laminins through nidogen/ entactin. The covalent bonding of type IV collagen 
provides a great deal of the mechanical stability to the BM. Type IV collagen with the 
triple-helical chain composition 112(IV) is the most ubiquitous BM collagen, whereas 
collagens 345(IV) and 556(IV) have more restricted expressions (Borza et al. 
2001; Myllyharju and Kivirikko 2004; Khoshnoodi et al. 2008). Nidogen provides binding 
sites for heparin sulphate proteoglycans, especially perlecan. Perlecan and other 
proteoglycans, such as collagens XV and XVIII and agrin, potentially confer selective 
filtration properties and serve as reservoirs for growth factors (Timpl and Brown 1996; 
Yurchenco et al. 2004). This multimolecular scaffold then provides specific interaction 
sites for yet other BM constituents.  
 
Discontinuous or thin BMs have been found in many carcinomas, including oral SCC 
(Kannan et al. 1994; Flug and Köpf-Maier 1995; Hagedorn et al. 1998; Kosmehl et al. 
1999; Määttä et al. 2001). In laryngeal SCC, loss of BM components, especially type IV 
collagen, is inversely correlated with the degree of tumour differentiation (Hagedorn et al. 
1998). Cancer cells, which themselves present marked heterogeneity, appear to produce 
different patterns of BM components, resulting in imbalances in the composition and 
assembly of BMs (Flug and Köpf-Maier 1995; Ingber 2002; Tlsty and Coussens 2006). 
The loss of BM may also be due to increased matrix turnover caused by active degrading 
proteases or by remodelling by the tumour cells. Furthermore, the tumour BM may be 
significantly less crosslinked and therefore more susceptible to proteolysis, remodelling 
and turnover (Kalluri 2003).  
4.6. Laminins 
Laminins are a family of extracellular matrix proteins that are located primarily in BMs. 
The first laminin was isolated in intact form from the Engelbreth-Holm-Swarm (EHS) 
tumour (Timpl et al. 1979). Through interactions with specific cell surface receptors, 
laminins regulate various cellular functions such as adhesion, motility, proliferation, 
differentiation and apoptosis. The three subunits of laminins, designated ,  and  chains, 
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assemble to form a cross- or T-shaped structure. Five , four  and three  chains have 
been identified. To date, 15 different laminin heterotrimers have been found, although 
many more combinations are theoretically possible (Miner and Yurchenco 2004). The 
laminin isoforms are expressed in a cell-, tissue- and developmental stage-specific 
manner. Laminins are present in all BMs, and reciprocal differences in their structure and 
receptor interactions enable variation in their functions (Patarroyo et al. 2002). 
 
Laminins are large glycoproteins with a relative molecular mass (Mr) ranging from ca. 
400 000 to 900 000. All laminins share some degree of structural homology. The laminin 
molecule consists of one long chain and two to three short chains linked together by 
disulphide bridges (Figure 4). The long chain is formed from intertwined - chains, 
whereas the short chains consist of single - chains (for a thorough review of laminin 
structure, see Colognato and Yurchenco 2000; Aumailley et al. 2005). The N-terminus of 
each chain has a LN domain, used in polymerization of laminins, followed by epidermal 
growth factor (EGF)-like (LE) domains, laminin four (L4 or LF) domain and laminin  
knob (L) domain. The C-terminus of the coiled-coil long arm harbours five globular 
domains LG1-LG5, which contain binding sites for, e.g., integrins, heparin, -
dystroglycan and Lutheran blood group glycoproteins. The short arms of laminin isoforms 
show the greatest variability in domain number and arm length. For instance, laminin-111 
has full-length arms, whereas laminin-332 has truncations in every short arm and 
laminins-411/ -421 have truncations in the 4 chain short arm. By contrast, laminins-511/ 
-521 have additional domains that lengthen their 5 chains. Many laminins further 
undergo post-translational proteolytic cleavage, producing small laminin fragments that 
may themselves have some functionality (Yurchenco et al. 1997; Colognato and 
Yurchenco 2000; Aumailley et al. 2005). The assembly of BMs is dependent on the 
primary polymerization of laminins, which, in turn, is controlled by the secretion of the  
chain (Matsui et al. 1995b; Yurchenco et al. 1997).  
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Figure 4. Structure of laminins -111, -332, -411 and -511 (modified from Aumailley et al. 2003; 
Aumailley et al. 2005).  
Several different names have been given to laminin trimers since the first laminin, such as 
merosin, kalinin and nicein. To obtain a more consistent nomenclature, the laminin 
heterotrimers were named in the order of their discovery (laminins 1-15) (Burgeson et al. 
1994). As it eventually became problematic to remember and recognize the different 
isoforms by these numbers only, a second nomenclature was adopted in 2005 (Aumailley 
et al. 2005). This nomenclature, which designates the chain composition of different 
laminins, is used in this thesis. For example, laminin-1, composed of 1, 1 and 1 chains, 
is now called laminin-111, and laminin-5 (332) is called laminin-332 (Table 1). The 
corresponding genes for each chain are called LAMA, LAMB and LAMC, respectively 
(Aumailley et al. 2005).  
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Table 1. Nomenclature of laminins. 
Chain composition Current abbreviation Previous abbreviation Previous names 
111 Laminin-111 Laminin-1  EHS-laminin 
211 Laminin-211 Laminin-2 merosin 
121 Laminin-121 Laminin-3 s-laminin 
221 Laminin-221 Laminin-4 s-merosin 
3A32 Laminin-332 (-3A32) Laminin-5 (-5A) BM-600, epiligrin, kalinin, ladsin, nicein 
3B32 Laminin-3B32 Laminin-5B  
311 Laminin-311 (-3A11) Laminin-6 (-6A) k-laminin 
321 Laminin-321 (-3A21) Laminin-7 (-7A) ks-laminin 
411 Laminin-411 Laminin-8  
421 Laminin-421 Laminin-9  
511 Laminin-511 Laminin-10  
521 Laminin-521 Laminin-11  
213 Laminin-213 Laminin-12  
423 Laminin-423 Laminin-14  
523 Laminin-523 Laminin-15  
 
Laminin 1 and 3, together with 3 and 2 chains, are mainly expressed in epithelial 
cells (Patarroyo et al. 2002). Laminin 1 chain has a limited distribution and is present, 
e.g., in the endometrium, kidney, mammary gland, ovary, placenta and prostate (Virtanen 
et al. 2000), and laminin 2 chain is expressed in skeletal and cardiac muscle, peripheral 
nerves and capillaries (Colognato and Yurchenco 2000). Laminin 2 and 4 chains are 
mainly expressed by mesenchymal cells. Typically, both epithelial and mesenchymal cells 
participate in the synthesis of laminin isoforms of a single BM. The BM of fetal oral 
squamous epithelium contains laminin chains 2, 3, 5, 1, 2, 3, 1 and 2, and the 
adult oral epithelium contains laminin chains 3, 5, 1, 2, 3, 1 and 2 (Kosmehl et al. 
1999; Pakkala et al. 2002). 
4.6.1. Laminin-332 
The gene encoding for laminin 3 chain, LAMA3, consists of 76 exons on chromosome 
18q11.2 and was first found in human foreskin keratinocytes (Ryan et al. 1994; McLean et 
al. 2003). Laminin 3 chain protein has since been identified as a constituent of laminins-
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332 (332), -311 (311) and -321 (321). Laminin-332, formerly known as BM-
600, epiligrin, kalinin, ladsin, nicein or laminin-5, was described as a cell adhesion and 
scattering factor and a component of the anchoring filaments in BMs (Verrando et al. 
1987; Carter et al. 1991; Rousselle et al. 1991; Marinkovich et al. 1992; Watt and Hotchin 
1992; Miyazaki et al. 1993). Rotary shadowing electron microscopy has demonstrated that 
it is a truncated, even, rod-like molecule (Rousselle et al. 1991). The 3 chain mRNA 
exists in two alternatively spliced transcript variants, producing a shorter Mr 200 000 3A 
and a longer Mr 325 000 3B chain. Laminin 3A chain is especially enriched in epithelia, 
being present in simple, squamous, compound and stratified epithelia, whereas 3B chain 
expression is weak in the epidermis, but readily found in the lung and central nervous 
system (Galliano et al. 1995). Also the laminin 2 chain has two mRNA variants, of which 
the longer form is epithelium-specific and the shorter form is restricted to the cerebral 
cortex, lung and kidney tubules (Airenne et al. 1996). According to the new laminin 
nomenclature, laminin-332 is considered to include the 3A chain, and the term laminin-
3B32 is used otherwise (Aumailley et al. 2005). Laminin-332 is initially synthesized in a 
Mr 460 000 precursor form and is composed of three polypeptides, the ca. Mr 200 000 3 
chain, Mr 145 000 3 chain and Mr 155 000 2 chain (Marinkovich et al. 1992; Matsui et 
al. 1995b). The 3 and 2 chains seem to be linked together in the cytoplasm first, after 
which the  chain is introduced to the dimer. Laminin-332 chains are further post-
translationally N-glycosylated. Extracellularly, the chains are processed to gain the 
165 000 3' chain and 105 000 2' chain forms, which assemble into 440 000 (3'32) 
and 400 000 (332') laminin trimers, respectively. Several proteases, such as BMP-1, 
MMP-2, MMP-3, MMP-20, membrane-type 1-MMP (MT1-MMP) and plasmin, may 
cleave the 2 chain short arm and release the following fragment to the ECM (Aumailley 
et al. 2003; Pirilä et al. 2003; Katayama and Sekiguchi 2004; Miner and Yurchenco 2004; 
Ziober et al. 2006).  
 
In the epidermal BM, laminin-332 is a component of the anchoring filaments and plays an 
essential role in the stable anchorage of basal keratinocytes to the underlying dermis. 
Laminin-332 is highly adhesive, as it binds integrin 64 in hemidesmosomes. However, 
laminin-332 may also have a pro-migratory function, as it is expressed in epithelial wound 
margins and migrating keratinocytes in culture (Ryan et al. 1994; Goldfinger et al. 1999; 
Patarroyo et al. 2002). The switch in functional states may be caused by the different 
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processing of the  and  chains, but this remains largely unsolved. It is possible that 
cleavage of the 3 chain induces a change towards a form that actively binds integrin 64 
and enables stable adhesion, whereas cleavage of the 2 chain changes the static form to a 
motile one (Goldfinger et al. 1999; Miyazaki 2006).  
 
Mice exhibiting laminin 3, 3 or 2 chain knock-out die at the neonatal stage and suffer 
from blisters and erosions of the skin and oral cavity, indicating that laminin-332 is an 
important regulator of epidermal cell-BM interaction (Ryan et al. 1994; Meng et al. 2003; 
Mühle et al. 2006). This is consistent with the phenotype of patients with mutations in any 
of the laminin-332 chains. Junctional epidermolysis bullosa is a severe, often lethal, 
disease that causes generalized blistering of the skin and gastrointestinal mucosae 
(Pulkkinen and Uitto 1999). Similar symptoms arise in anti-laminin cicatrical pemphigoid, 
which is caused by autoantibodies against the laminin 3 chain (Kirtschig et al. 1995). An 
N-terminal deletion in the 3A chain leads to laryngo-onycho-cutaneous syndrome, 
characterized by defective healing of skin erosions, nail dystrophy and development of 
granulation tissue in the eye and larynx (McLean et al. 2003).  
 
The amounts of laminins vary in different cancers. The presence of laminin-332 has been 
reported in several carcinomas, for instance, in colorectal, pancreatic and some renal cell 
carcinomas (Lohi et al. 1996; Tani et al. 1997; Lohi et al. 2000). On the other hand, 
reduced amounts of laminin-332 have been reported in, for example, breast, lung and 
prostate cancers in vivo and in vitro (Martin et al. 1998; Akashi et al. 2001; Brar et al. 
2003; Katayama and Sekiguchi 2004). Laminin 32 chains are synthesized as a dimer 
and retained in the cytoplasm in colorectal carcinoma (Sordat et al. 1998). The 2 chain 
may have additional roles in tumour invasion, as cytoplasmic and extracellular 
overexpression of 2 monomer has been detected in invasive fronts of, e.g., colorectal 
carcinoma and oral SCC (Koshikawa et al. 1999; Ono et al. 1999; Yamamoto et al. 2001). 
However, most of the studies have been conducted with monoclonal antibodies (MAbs) 
against only laminin 2 chain and have been erroneously interpreted to report the 
expression of the whole laminin-332 trimer (Ziober et al. 2006). Therefore, the roles of 
laminin-332 in carcinomas and especially in EMT remain to be established.  
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4.6.2. Laminin-511 
The laminin 5 chain gene, LAMA5, consists of 80 exons and is located in chromosome 
20q13.2-q13.3. First identified in mice and then in humans, the laminin 5 chain is 
considered to be evolutionarily most related to the laminin 3 chain (Miner et al. 1995; 
Durkin et al. 1997; Miner et al. 1997; Doi et al. 2002). The laminin 5 chain is a 
component of laminins-511 (511), -521 (521) and -523 (523) heterotrimers 
(Miner et al. 1997; Libby et al. 2000). Rotary shadowing has shown that laminin-511 
(formerly called laminin-10) is a cruciform molecule with an elongated N-terminal 5 
chain (Doi et al. 2002). Similarly to the processing of the laminin 3 chain, the laminin 5 
chain undergoes tissue-specific glycosylation and post-translational cleavage, resulting in 
the secretion of Mr 350 000-400 000 forms. Together with Mr 200 000 1 and 1 chains, it 
comprises a Mr 800 000 laminin-511 trimer (Champliaud et al. 2000; Doi et al. 2002).  
 
Discrepancies regarding the distribution and functions of laminins have existed due to 
misinterpretations in the use of laminin preparations and antibodies. In cell adhesion and 
migration studies, many previous investigations have used commercial laminin 
preparations from human placenta, assumed to contain laminin-111. However, this 
placental laminin preparation has since been shown to include mainly laminins-511 and -
521 (Ferletta and Ekblom 1999). Furthermore, MAb 4C7, widely used in laminin 
distribution studies, was initially thought to detect the laminin 1 chain (Engvall et al. 
1986). Based on reports using different antibodies and in situ hybridization, MAb 4C7 was 
established to recognize the laminin 5 chain (Tiger et al. 1997). Currently, the laminin 5 
chain is acknowledged to be widely expressed in embryonic and adult BMs (Miner et al. 
1997). Laminin-511 is present in practically all BMs, including epithelia and endothelia. 
Laminin-521 (formerly called laminin-11), on the other hand, is limited to certain BMs, 
such as those of neuromuscular synapses in skeletal muscle, the perineurium of peripheral 
nerves, and BMs of smooth muscle arterioles and kidney glomeruli (Miner et al. 1995; 
Gullberg et al. 1999; Miner and Patton 1999). Laminin-523 has been detected in the retina 
(Libby et al. 2000). Laminin-511 is a potent cell adhesive agent, and it also has a role in 
cell migration and proliferation (Kikkawa et al. 2000; Doi et al. 2002). Laminin-511 may 
also have a barrier function, as it seems to hinder the migration of T lymphocytes through 
endothelia (Sixt et al. 2001).  
 
 31
The importance of the laminin 5 chain is highlighted by the phenotype of knock-out 
mice. The mice suffer from various developmental defects, including defects in neural 
tube closure, digit separation, placental labyrinth, kidney and lung development, and die 
by day E16.5 during late embryogenesis (Miner et al. 1998; Miner and Li 2000). The 
absence of the laminin 5 chain evokes accumulation of laminin 1, 2 and 4 chains, 
which can be detected at the weakened, discontinuous BMs (Miner et al. 1998). 
Furthermore, laminin 5 chain-deficient skin grafts transplanted into nude mice do not 
develop any hair, suggesting that laminin-511 is essential also in hair morphogenesis (Li 
et al. 2003). MET is impaired in the kidneys of laminin 5 chain-deficient mice, observed 
as a breakdown of BM, disorganized glomerular cells and defective vascularization, 
suggesting that the laminin 5 chain could participate in mediating the epithelial 
transformation (Miner and Li 2000).  
 
As the laminin 5 chain and laminin-511 are widely distributed in BMs, their presence has 
also been detected in malignancies. For instance, expression of laminin-511 has been 
shown to be well-preserved in renal cell and prostate carcinoma (Lohi et al. 1996; Brar et 
al. 2003). However, the laminin 5 chain or laminin-511 expression is reduced in invasive, 
budding areas of oral SCC, colorectal carcinoma and lung adenocarcinoma, in which it is 
associated with lymph node metastasis (Kosmehl et al. 1999; Lohi et al. 2000; Akashi et 
al. 2001). The role of laminin-511 in progression of carcinomas is incompletely 
understood.  
4.6.3. Laminin-411 
The gene encoding for the laminin 4 chain, LAMA4, contains 39 exons spanning over 
122 kb and is located in chromosome 6q21 (Richards et al. 1994; Iivanainen et al. 1995; 
Richards et al. 1996; Iivanainen et al. 1997; Richards et al. 1997). The laminin 4 chain 
has been identified in laminins-411 (411), -421 (421) and -423 (423) (Frieser et 
al. 1997; Miner et al. 1997; Libby et al. 2000). In rotary shadowing microscopy, laminins-
411 and -421 have a truncated, T-shaped ultrastructure (Frieser et al. 1997; Kortesmaa et 
al. 2000). The laminin 4 chain resembles the laminin 3A chain, as the short arm mainly 
consists of LE domains, but also shares similarity with the laminin 2 chain, which is 
located in close proximity, on chromosome 6q22-23 (Richards et al. 1996; Richards et al. 
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1997). The N- or C-terminal parts of the laminin 4 chain may be post-translationally 
modified by glycosylation, addition of glycosaminoglycans or chondroitin sulphate, or by 
proteolytic cleavage, resulting in size variations of Mr ca. 180 000-230 000 (Kortesmaa et 
al. 2000; Talts et al. 2000; Fujiwara et al. 2001; Sasaki et al. 2001; Kortesmaa et al. 2002). 
The laminin 4 chain has two identified transcript variants, which differ by 21 nucleotides 
(Hayashi et al. 2002).  
 
Laminin-411, a Mr 570 000-650 000 trimer, operates in cell migration, invasion and 
endothelial transmigration (Sixt et al. 2001; Khazenzon et al. 2003). It seems to participate 
also in wound-healing and angiogenesis (Fujiwara et al. 2001). Laminin-411 containing 
the longer 4B transcript may be more potent in promoting cell spreading than the one 
containing the 4A transcript (Hayashi et al. 2002). Many blood cells, such as monocytes, 
B and T lymphocytes, NK cells and thrombocytes, synthesize, secrete, adhere and migrate 
on laminin-411 (Geberhiwot et al. 1999; Pedraza et al. 2000; Geberhiwot et al. 2001). It is, 
however, considered a relatively poor adhesion substrate (Fujiwara et al. 2001; Sixt et al. 
2001). The laminin 4 chain is widely distributed in tissues of mesenchymal origin, such 
as smooth, cardiac and skeletal muscle, adipose tissue and peripheral nerves. It is also 
found in stroma, salivary glands, epidermis and the gastrointestinal tract and is especially 
detected in vascular BMs (Iivanainen et al. 1995; Richards et al. 1996; Frieser et al. 1997; 
Miner et al. 1997; Lefebvre et al. 1999; Petäjäniemi et al. 2002). Laminin-411 is the most 
ubiquitous form, secreted by, e.g., adipocytes and endothelial cells (Niimi et al. 1997; 
Kortesmaa et al. 2000). Other 4 chain laminins have more restricted distributions; 
laminin-421 localizes to arterial BMs and the neuromuscular junction, whereas laminin-
423 has been detected in the retina (Libby et al. 2000; Patton et al. 2001; Ljubimova et al. 
2004). 
 
Laminin 4 chain-deficient mice are viable and fertile. However, they show haemorrhages 
and anaemia from E11.5 to the neonatal period, reflecting impaired microvessel 
maturation (Thyboll et al. 2002). In addition, the adult mice represent abnormal 
development of neuromuscular synapses, defective Schwann cell myelinization, mild 
ataxia and features of cardiomyopathy (Patton et al. 2001; Wallquist et al. 2005; Wang et 
al. 2006). Neutrophils, activated by an inflammatory response, fail to extravasate 
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(Wondimu et al. 2004). In humans, laminin 4 chain mutations may have a role in the 
development of dilated cardiomyopathy (Knöll et al. 2007).  
 
The laminin 4 chain has been detected in several mesenchymal cancer cell lines, 
including leiomyosarcoma, glioma, neuroblastoma and fibrosarcoma cells (Iivanainen et 
al. 1997; Fujiwara et al. 2001; Hayashi et al. 2002). Laminin-411 may promote glioma cell 
invasiveness in vitro (Khazenzon et al. 2003). In glioma, upregulation of the laminin 4 
chain and laminin-411 in the endothelial BMs is correlated with higher tumour grade and 
poor prognosis (Ljubimova et al. 2001; Ljubimova et al. 2004). However, the role of the 
laminin 4 chain and laminin-411 in malignancies, especially carcinomas, remains 
elusive.  
4.7. Laminin receptors 
4.7.1. Integrins 
Integrins are cell surface receptors that are considered to be the prime mediators of cell-
matrix adhesions (Hynes 2002). Integrins modulate a variety of cell functions, including 
cell survival, proliferation, morphogenesis, differentiation, migration, invasion and 
metastasis. The first integrins, later named integrins 51 and v3, were found to bind the 
minimal recognition sequence consisting of arginine, glycine and aspartic acid (RGD) that 
was present in fibronectin and vitronectin (Pytela et al. 1985a; Pytela et al. 1985b). 
Integrins are non-covalently linked heterodimeric transmembrane proteins, which act as 
receptors for ECM components, e.g., laminins, collagens, fibronectin and vitronectin. Also 
other ECM molecules, such as nidogen/ entactin, perlecan and SPARC, possess integrin 
binding sites. Some integrins bind counter-receptors of other cells. Several pathogens, 
such as HIV and papilloma viruses, use integrins to gain access into cells (van der Flier 
and Sonnenberg 2001a). Currently, 18  and 8  integrin subunits have been characterized 
in mammals. Different combinations of single  and  subunits dimerize to form at least 
24 receptors with distinct but also often overlapping specificities for ECM proteins. 
Different integrin isoforms arise through alternative mRNA splicing and post-translational 
modifications (van der Flier and Sonnenberg 2001a; Watt 2002). Furthermore, genes 
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encoding for six novel  subunits and one  subunit have been detected in genome-wide 
surveys, although their existence remains to be confirmed. Expression of integrins is 
dependent on cell and tissue type, as well as on the stage of cell differentiation. Many 
integrin heterodimers recognize more than one ligand, and some ligands are recognized by 
more than one integrin (van der Flier and Sonnenberg 2001a). The  and  subunits that 
together dictate the ligand-binding specificity have large extracellular domains and are 
connected to the cytoplasm by single membrane-spanning domains. The non-catalytic 
cytoplasmic portions are generally small, ca. 30-50 amino acids, except for the 1000 
amino-acid-long tail of the integrin 4 subunit. Perhaps due to the unique characteristic of 
the integrin 4 tail, it mediates linkage to cytokeratins (Cks) instead of actin filaments. The 
cytoplasmic tails of several  subunits contain NPxY domains, which are used for 
interaction with adaptor proteins like talin and tensin (Hynes 2002; Legate and Fässler 
2009). Recruitment of adaptor proteins to the cytoplasmic domains leads to 
conformational changes and cytoskeletal reorganization (inside-out signalling). The 
binding of a ligand to the integrin heterodimer changes the conformation and activates the 
integrin and the subsequent signalling cascades (outside-in signalling). The strength of 
ligand binding is modulated by integrin clustering, mechanical tension, association with 
accessory molecules and cations such as Mn2+, Mg2+ and Ca2+ (Watt 2002; Mould and 
Humphries 2004). Mn2+ stabilizes a high-affinity conformation, whereas Ca2+ is inhibitory 
and promotes a low-affinity conformation. Phosphorylation of the cytoplasmic domains or 
proteolytic cleavage may also have a role in ligand binding.  
 
A multitude of integrin-binding proteins reside at the cytoplasmic side of cell membrane. 
These include such proteins as -actinin, talin, tensin and filamins, which mediate the link 
to the cytoskeleton and may serve as additional docking sites for other molecules (Otey 
and Carpén 2004; Le Clainche and Carlier 2008). Signalling molecules, e.g., focal 
adhesion kinase (FAK) and integrin-linked kinase (ILK), may operate in integrin 
activation (Giancotti and Ruoslahti 1999; van der Flier and Sonnenberg 2001a). Integrin 
binding to ECM ligands activates FAK and mediates ERK signalling to promote cell 
survival and migration (Hood and Cheresh 2002). ILK, on the other hand, binds the 
cytoplasmic tails of integrin 1, 2 and 3 subunits, stabilizes integrin-actin interactions, 
mediates integrin signalling and regulates actin polymerization (Hannigan et al. 1996; Li 
et al. 1999; Mulrooney et al. 2000). Furthermore, growth factors, such as EGF, interact 
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with integrins and potentially enhance integrin signalling through clustering of growth 
factor receptors. Integrins seem to influence the expression of other integrin complexes as 
well as other cell-cell adhesion molecules (Giancotti and Ruoslahti 1999; van der Flier and 
Sonnenberg 2001a; Guo and Giancotti 2004). 
 
Many integrins, including 11, 21, 31, 61, 64, 71, 91, v3, v5 and v8 
heterodimers, may serve as laminin receptors (Belkin and Stepp 2000; Hynes 2002). 
Integrins 31 and 64, among others, bind to the LG domains of laminin  chains, 
whereas 21 can interact with LN domains of laminin - chains (Belkin and Stepp 
2000). Integrins 11 and 21 are considered mainly collagen receptors, whereas 31 and 
61 recognize primarily laminins. Integrins IIb3, 31, 41, 47, 51, 81, v1, v3, 
v6 and v8 bind fibronectin (van der Flier and Sonnenberg 2001; Hynes 2002). 
Stratified squamous epithelia express a range of integrins, including 21, 31 and 64. In 
the epidermis, integrin expression is largely confined to the basal layer, whereas the oral 
epithelium expresses integrins also in suprabasal layers (Jones et al. 1993). 
 
The main receptors for laminin-332 are integrins 31, 61 and 64. Also integrin 21 
may have some cell-specific binding capacity (Carter et al. 1991; Rousselle and Aumailley 
1994; Orian-Rousseau et al. 1998). In addition to integrins, the LG4-5 domains potentially 
bind -dystroglycan and syndecan, and the 2 chain interacts with type VII collagen, 
fibulins and nidogens (Aumailley et al. 2003). Integrins 31 and 61 are regarded as the 
principal mediators of adhesion to laminin-411 (Kortesmaa et al. 2000; Pedraza et al. 
2000; Fujiwara et al. 2001; Geberhiwot et al. 2001). Depending on the cell type, integrins 
21, 64, 71, M2, v3, -dystroglycan, fibulins, heparin and sulphatides may also 
have adhesive interactions with laminin 4 chain or its LG domain fragments (Geberhiwot 
et al. 1999; Kortesmaa et al. 2000; Pedraza et al. 2000; Talts et al. 2000; Gonzalez et al. 
2002; Patarroyo et al. 2002; Wondimu et al. 2004). The interactions between laminin-511 
and the ECM are mainly mediated through integrins 31 and 61. Laminin-511 is also 
bound by several other receptors, including integrins 21, 64, v3, -dystroglycan and 
Lutheran (Tani et al. 1999; Kikkawa et al. 2000; Pouliot et al. 2000; Pouliot et al. 2001; 
Sasaki and Timpl 2001; Kikkawa et al. 2002). The receptors utilized depend on the cell 
type, the functional state of the cell, e.g., migration or adhesion, and the presence of 
cytokines or growth factors.  
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In humans, several genetic diseases stem from mutations in integrin subunits. For instance, 
the severe skin blistering disease junctional epidermolysis bullosa is due to mutations in 
genes encoding either the 6 or 4 subunit (van der Flier and Sonnenberg 2001a). Integrins 
are also gaining a role as important mediators of malignant conversion (Guo and Giancotti 
2004). Cells that have become neoplastic are much less dependent on ECM adhesion for 
survival and proliferation (Ruoslahti and Giancotti 1989; Giancotti and Ruoslahti 1999). 
Cancer cells enhance the expression of those integrins that favour their proliferation, 
survival and migration, whereas they downregulate the expression of integrins that 
mediate their adhesion to the ECM (Hood and Cheresh 2002; Guo and Giancotti 2004). 
The switches in integrin expression are complex and depend on the origin of tissue, 
histological type of tumour and stage of progression. The major integrin receptors of oral 
epithelial cells as well as oral SCC include 2 31, 61 and 64 (Kramer et al. 2005; 
Ziober et al. 2006).  
4.7.2. Lutheran 
Cells can bind laminins and other ECM components also via non-integrin receptors, such 
as - and -dystroglycans, lectins, syndecans and Lutheran blood group glycoproteins 
(Belkin and Stepp 2000; Patarroyo et al. 2002; Kikkawa and Miner 2005). Lutheran is a 
transmembrane glycoprotein that belongs to the immunoglobulin family (Kikkawa and 
Miner 2005). Two different isoforms arise from the Lutheran gene, Mr 85 000 Lutheran 
and Mr 78 000 basal cell adhesion molecule, B-CAM. The B-CAM molecule lacks a 40 
amino-acid-long cytoplasmic tail, including the SH3 domain required for intracellular 
signalling (Rahuel et al. 1996). Lutheran mediates binding of erythrocytes to endothelia 
and is overexpressed in erythrocytes of sickle-cell anaemia patients (El Nemer et al. 1998; 
Udani et al. 1998). These erythrocytes adhere to laminin more strongly than normal 
erythrocytes. Lutheran reacts specifically with the LG3 domain of 5 chain laminins 
(Parsons et al. 2001; Kikkawa et al. 2002). The binding site of Lutheran resides close to 
that of integrins, implying that they may compete for the binding to laminin the 5 chain. 
Lutheran expression has been found in various tissues, including the lung, liver, prostate, 
kidney and arterial walls (Parsons et al. 1995; Rahuel et al. 1996). It occurs on the basal 
surfaces of many epithelial cells and on muscle cells adjacent to laminin 5 chain-
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containing BMs (Moulson et al. 2001). Only limited information is available on the role of 
Lutheran in cancer. B-CAM has been detected in colon and ovarian carcinoma cell lines 
and is overexpressed in ovarian carcinomas (Campbell et al. 1994; Määttä et al. 2005). In 
ovarian cancer progression, Lutheran/ B-CAM expression is non-polarized, which was 
suggested to indicate loss of stabilizing interactions with the BM (Määttä et al. 2005).  
4.8. Cell adhesions 
Adhesion of cells to each other and to the surrounding ECM is fundamental for the 
maintenance of tissue architecture, function, cell migration and induction of cell adhesion-
mediated signalling. Epithelial cells are connected through several intercellular junctions 
(Figure 5).  
 
Hemidesmosome Podosome Focal adhesion Invadopodium
Tight junction
Adherens junction
Desmosome
Gap junction
 
Figure 5. Different types of cell adhesions.  
Epithelial cell adhesion to the underlying BM is mediated by, e.g., focal complexes, focal 
adhesions, hemidesmosomes and podosomes (see Section 4.10.1 for podosomes). In some 
epithelial cells, the early stages of cell attachment to BM or ECM are mediated by 
hyaluronan molecules residing at the pericellular coat. After attachment, the cells spread 
out and form narrow cell extensions, called filopodia, or broad lamellipodia (Faix and 
Rottner 2006; Yamaguchi and Condeelis 2007). Punctate focal complexes appear next 
under the protrusive lamellipodia. They contain, for instance, integrin v3, talin, 
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phosphotyrosine and paxillin, which gather to the immediate cell membrane and are 
involved in binding of the actin cytoskeleton to the cell membrane. Next, vinculin, -
actinin, FAK and Arp 2/3 sequentially enter the maturing focal complex (Zaidel-Bar et al. 
2004). Focal complexes assemble and disassemble quickly in response to Rho GTPase 
signalling. Through recruitment of zyxin and integrin 51, a subset of these adhesions 
may grow and transform into larger, streak- or spearhead-shaped focal adhesions. The 
transition depends on actomyosin contractility, which applies force at cell-ECM adhesions 
(Geiger et al. 2001; Zamir and Geiger 2001; Zaidel-Bar et al. 2004). The hitherto 
unorganized actin mesh is arranged into densely packed straight bundles of filaments, i.e., 
actin stress fibres. Focal adhesions are multimolecular structures that consist of over 50 
adaptor proteins, e.g., cytoskeletal proteins, serine/ threonine kinases, GTPase modulators, 
several actin-binding, -capping or -bundling molecules and proteoglycans (Figure 6). 
Focal adhesions are considered to enable stable and firm adhesion, and they operate as 
mechanosensors transmitting tensile signals from the ECM to the actin cytoskeleton 
(Geiger et al. 2001; Zamir and Geiger 2001; Geiger and Bershadsky 2002; Wehrle-Haller 
and Imhof 2002). In addition, they seem to act as signalling centres from which various 
intracellular pathways emanate to regulate cell growth, survival and gene expression. 
Focal adhesions may further evolve into fibrillar adhesions that consist of elongated, 
tensin-rich fibrils. Mechanical tension appears to be involved also in this turnover. 
Characteristics of fibrillar adhesions are the substitution of integrin v3 by integrin 51, 
low levels of phosphotyrosine and their more central location near the nucleus. These 
molecules participate in the formation of fibronectin fibrils (Zaidel-Bar et al. 2004).  
 
Hemidesmosomes are cell-ECM adhesion sites that directly connect the epithelial 
intermediate filaments, Cks, to the underlying BM (Figure 6). Hemidesmosomes are 
specific structures of different epithelia, including stratified squamous, transitional and 
pseudostratified epithelia (Nievers et al. 1999). They mediate firm adhesion and provide 
resistance to mechanical stress. In skin, hemidesmosomes reside between the epidermis 
and dermis, where they maintain skin integrity. The assembly of hemidesmosomes begins 
by the gathering of integrin 64 to the cell membrane. The binding of integrin 64 to 
hemidesmosomal protein-1 (HD1)/ plectin is considered to be central in the assembly of a 
hemidesmosome. In some simple epithelia, e.g., in the intestine, type II hemidesmosomes 
comprise only these molecules attached to Ck filaments (Hieda et al. 1992; Litjens et al. 
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2006). In type I hemidesmosomes, bullous pemphigoid (BP) antigens BP180 (collagen 
XVII) and BP230 are further recruited to the complex. Through its extracellular domain, 
integrin 64 binds to laminin-332 in the BM and transducts signals to the cytoplasm 
(Owaribe et al. 1991; Niessen et al. 1997; Nievers et al. 1999).  
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Figure 6. Focal adhesion (A) and the hemidesmosome (B) (modified from Zamir and Geiger 
2002; Littjens et al. 2006).  
4.9. Cell migration and invasion 
Cell migration is essential in physiological tissue development and homeostasis, including 
embryonic morphogenesis, immune surveillance, inflammation and wound-healing. 
Furthermore, it is a key event in neoplastic dissemination and metastasis. Extracellular 
stimuli, including growth factors, chemoattractants or structural proteins provided by the 
ECM induce changes in intracellular signalling cascades and in cell polarization 
(Lauffenburger and Horwitz 1996). The migratory cells produce a pericellular matrix on 
which they migrate. For instance, during wound-healing, keratinocytes secrete a 
provisional matrix containing, e.g., fibronectin and laminin-332. The ECM receptor 
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pattern of the migrating cells also changes (Gailit et al. 1994; Larjava et al. 1996). During 
cell migration on planar surfaces the forward cell protrusion of the filopodia or 
lamellipodia is driven by actin polymerization (Lauffenburger and Horwitz 1996; Pollard 
et al. 2000; Ridley et al. 2003). In lamellipodia, actin filaments form a branched network 
mediated by Arp 2/3, whereas in filopodia they are organized into parallel bundles (Faix 
and Rottner 2006). New globular actin monomers (G-actin) are added to the barbed end of 
the growing filamentous actin (F-actin). At the pointed end of these filaments, monomeric 
actin is liberated by depolymerization. This process is referred to as actin treadmilling 
(Wehrle-Haller and Imhof 2002; Wehrle-Haller and Imhof 2003). Several GTPases, for 
instance, Rac, Cdc42 and RhoA, activate WASP proteins, which induce the formation of 
actin branches mediated by the Arp 2/3 complex. Actin polymerization, in turn, is 
regulated by numerous proteins that control the availability of actin monomers (profilin), 
branching (-actinin, cortactin, filamins), debranching and depolymerizing proteins 
(cofilin), as well as capping and severing proteins (gelsolin) (Pollard et al. 2000; Pollard 
and Borisy 2003; Ridley et al. 2003; Otey and Carpén 2004; Kramer et al. 2005). In order 
to transform the treadmilling to cell movement, the growing actin filaments that push the 
cell membrane are anchored in place through focal complexes and focal adhesions. In 
some cells, such as macrophages, cell migration is mediated through another type of actin-
based adhesion structure, namely, the podosome (Section 4.10.1). The maturing focal 
adhesions, enriched in integrins and other adhesion proteins, pull the cell forward against 
the resistance of focal adhesions at the rear of the cell. Myosin II motor proteins provide 
the force of traction. In addition, the microtubule system may be involved, as the 
orientation of the microtubule-organizing centre changes in migrating cells, and 
microtubules are frequently found to target the focal adhesion sites (Ridley et al. 2003; 
Wehrle-Haller and Imhof 2003). At the retractive side of the cell, the focal contacts 
disassemble. The integrin affinity for the ECM is reduced, the integrin complexes are 
internalized and recycled to the cell front, addition of new cytoskeletal linker proteins is 
inhibited and the actin filaments are depolymerized (Bretscher and Aguado-Velasco 1998; 
Hood and Cheresh 2002; Wehrle-Haller and Imhof 2002; Friedl and Wolf 2003).  
 
Cell invasion through the BM has been described to constitute three steps, namely, cell 
attachment to BM, focal BM proteolysis and cell migration through the BM (Liotta 1984; 
Liotta and Kohn 2001). Cell invasion occurs in several physiological events, such as 
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embryonic implantation, inflammation and wound-healing, and in various diseases, 
including atherosclerosis and cancer. The invasion of individual cells in 3D substrata 
corresponds to the migration of single cells after loss of cell adhesion. After detachment, 
individual cells invade the adjacent stroma and maintain the cell-ECM contacts rather than 
the cell-cell contacts (Friedl and Bröcker 2000). The cells may follow an adhesive, 
fibroblast-like type of migration described above or a more rapid amoeboid crawling. In 
the former type, used by single carcinoma cells or cells of mesenchymal cancers, such as 
fibrosarcoma, the cells assemble focal adhesion-like contacts. The formation of 
pseudopodia, a 3D equivalent of lamellipodia, or invadopodia in malignant cells (Section 
4.10.2) is followed by secretion of proteolytic enzymes. This is gained through integrin-
mediated recruitment of surface proteases, such as seprase, cathepsins and MMPs, to ECM 
contacts. Some MMPs activate each other, and thus, regulate the onset and extent of 
pericellular proteolysis (Condeelis and Segall 2003; Friedl and Wolf 2003; Wolf et al. 
2003; Yamaguchi et al. 2005b; Carragher et al. 2006).  
 
In the amoeboid type of migration, detected in lymphoma, and some carcinoma cells, such 
as small-cell lung carcinoma, the tumour cell undergoes a marked cytoskeletal 
reorganization and seems to pass the ECM filament networks without the need for 
substantial proteolysis (Wolf et al. 2003; Carragher et al. 2006). Furthermore, carcinoma 
cells, such as breast carcinomas, may migrate in tissues as chains of tumour cells, 
indicating preserved contact and communication. This type of invasion confers high 
metastatic capacity and poor prognosis. Some carcinoma cells migrate as coherent sheets 
that also maintain their cell-cell and cell-ECM contacts. These cells tend to invade through 
the paths of least resistance, e.g., along lymphatic and blood vessels or nerves. The cancer 
cells in migrating clusters may express different characteristics, for instance, the cells at 
the front may secrete increased amounts of MMPs, and the cells at the rear may express 
more adhesion receptors or deposit ECM proteins (Friedl and Bröcker 2000; Friedl and 
Wolf 2003).  
  42
4.10. Cell-ECM adhesion and invasion complexes 
4.10.1. Podosomes 
Podosomes are vertical accumulations of the actin cytoskeleton, first described at the 
ventral cell membranes of macrophages, osteoclasts and Rous sarcoma virus-transformed 
fibroblasts (Lehto et al. 1982; Marchisio et al. 1984; Tarone et al. 1985). Since then, 
podosomes have been reported in epithelial, endothelial and vascular smooth muscle cells 
and by recent definition, they appear in non-malignant cells (Hai et al. 2002; Moreau et al. 
2003; Spinardi et al. 2004; Linder 2007). However, the majority of studies thus far have 
addressed the podosomes of macrophages or osteoclasts, in which podosomes have a role 
in cell adhesion, migration and matrix degradation. For instance, prior to bone resorption, 
osteoclasts assemble podosomes to form a broad ring fused around an area targeted for 
resorption. Podosome formation enables close contacts and stabilizes the bone matrix-
osteoclast interface, producing an isolated compartment between the ruffled border and the 
bone surface (Marchisio et al. 1984; Lakkakorpi and Väänänen 1991). During monocyte 
maturation into macrophages the assembly of podosomes mediates extravasation through 
vessel walls into tissues (Lehto et al. 1982).  
 
Podosomes consist of an F-actin core and several cytoskeletal proteins, such as cortactin, 
N-WASP and Arp 2/3 complex, which are involved in actin network organization 
(Schuuring et al. 1993; Linder et al. 2000a; Pfaff and Jurdic 2001; Mizutani et al. 2002) 
(Figure 7). The core is surrounded by a ring of scaffolding and adhesion molecules, 
including paxillin, talin and vinculin (Lehto et al. 1982; Marchisio et al. 1988; Pfaff and 
Jurdic 2001). The core and ring are connected through linker proteins such as -actinin 
(Lehto et al. 1982; Marchisio et al. 1984). A cloud of F-actin and G-actin has been 
reported to surround the podosome structure (Destaing et al. 2003). Actin has been 
suggested to be continuously polymerized and depolymerized at podosomes, based on 
actin polymerization complex containing Cdc42, N-WASP and Arp 2/3 (Linder et al. 
1999; Linder et al. 2000b) and actin-severing protein gelsolin localizing to podosomes 
(Gavazzi et al. 1989). Furthermore, photobleaching experiments show rapid turnover of 
actin molecules in osteoclast podosomes (Destaing et al. 2003). Degradation of ECM, 
considered one of the functions defining podosomes, is suggested to occur through 
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regulated expression of MMPs such as MT1-MMP and MMP-9 (Sato et al. 1997; Delaissé 
et al. 2000). However, the depth and extent of degradation, depicting whether or not 
podosomes are invasive structures, remain undetermined.  
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Figure 7. A: Podosome structure (scheme modified from Linder and Aepfelbacher 2003). B-D: 
Podosomes of human osteoclasts assemble into clusters or belts. B: F-actin localizes 
to podosome cores. C: Red, F-actin; green, cortactin; yellow, overlay of figures. D: -
actinin in podosome rings. Scale bars, 10 and 5 m, respectively. Osteoclasts were 
obtained by inducing human blood monocyte/ macrophages to differentiate for 7 days 
with 25 ng/ml macrophage-colony stimulating factor and 40 ng/ml soluble Receptor 
activator of the nuclear factor  B ligand (RANKL).  
Interference reflection microscopy has shown that podosomes lie in close proximity to the 
ECM, suggesting that they mediate adhesion (Lehto et al. 1982; Marchisio et al. 1984). In 
agreement with this observation, several integrins are enriched at podosomes. Depending 
on the cell type, integrin 1 subunit localizes at the podosome core, and integrin 3, v, X, 
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2 and 3 subunits localize at the ring structure (Marchisio et al. 1988; Zambonin-Zallone 
et al. 1989; Gaidano et al. 1990; Pfaff and Jurdic 2001; Spinardi et al. 2004). Furthermore, 
transmission electron microscopy studies have early suggested that podosomes form 
cylindrical protrusions to the ECM, from which their name, depicting cellular feet, 
originates (Tarone et al. 1985).  
 
In microscopic images, individual podosomes are dot-like accumulations, but they can 
assemble, e.g., in endothelial cells or transformed fibroblasts into circular or crescent-
shaped arrangements called rosettes (Tarone et al. 1985). In osteoclasts, podosomes form 
several superstructures, i.e., clusters, rings or belts, depending on the state of 
differentiation, ECM composition and resorption cycle (Akisaka et al. 2001; Destaing et 
al. 2003). The podosome cores of osteoclasts have a height of ca. 0.5 m and a diameter of 
0.3-0.5 m (Gavazzi et al. 1989; Destaing et al. 2003). The average life-span of osteoclast 
podosomes is approximately 2-12 minutes, thus implying a dynamic structure (Kanehisa 
et al. 1990; Akisaka et al. 2001; Destaing et al. 2003). Furthermore, osteoclasts may use 
cyclic assembly and disassembly of the actin core in podosomes to generate high rates of 
cell motility (Kanehisa et al. 1990).  
 
Podosomes have previously been interpreted as modified focal adhesions, as they share 
some morphological similarities as well as similar protein composition, including paxillin, 
talin and vinculin. Focal adhesions, however, are elongated structures that have a 
tangential orientation with respect to the ECM (Geiger et al. 2001). They do not protrude 
the plasma membrane, nor do they possess significant ECM degradation ability (Chen et 
al. 1984; Tarone et al. 1985; Gavazzi et al. 1989; Linder et al. 2000a; Pfaff and Jurdic 
2001). Furthermore, it has been suggested that an intact microtubule system is needed in 
podosome formation in macrophages and osteoclasts, although the situation is unclear in 
epithelial cell podosomes (Linder et al. 2000b; Destaing et al. 2003; Spinardi et al. 2004). 
Microtubules target focal adhesions, providing crosstalk to the actin cytoskeleton (Palazzo 
and Gundersen 2002). However, they may not be essential in focal adhesion assembly; in 
fact, disruption of the microtubules by nocodazole in fibroblasts leads to enhanced focal 
adhesion formation (Bershadsky et al. 1996; Linder et al. 2000b; Destaing et al. 2003). As 
for focal adhesions, the in vivo existence of podosomes is still controversial. However, 
when osteoclasts are cultured on digestible bone or dentine matrices, podosomes develop, 
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which supports a role for podosomes also in living organisms (Teti et al. 1999; Chellaiah 
et al. 2000; Destaing et al. 2003).  
 
Absence of podosomes have been reported in osteopetrosis, in which osteoclasts are 
unable to resorb bone properly, resulting in calcified, brittle bone structure and recurrent 
fractures (Teti et al. 1999). In Wiskott-Aldrich syndrome (WAS), WAS protein mutations 
prevent podosome organization in macrophages and dendritic cells, causing defective cell 
orientation and impaired movement towards the antigen and subsequently to the lymphatic 
organs (Linder et al. 1999). These may be the culprits for WAS patients’ feeble 
inflammatory cell chemotaxis, leading to immune defects and even increased 
susceptibility to lymphomas (Stewart et al. 2001). In atherosclerosis, vascular smooth 
muscle cells respond to vascular injury or inflammation by proliferating and migrating 
from the tunica media to the tunica intima. The surplus of smooth muscle cells results in 
constriction of the vessel walls, impairing blood circulation, for instance, to the heart 
muscle (Newby and Zaltsman 2000). In this process, activated smooth muscle cells are 
suggested to acquire podosomes that may accumulate MMPs, for instance MMP-9, to 
surpass the BMs and to enable cell migration (Raines 2000; Gimona and Buccione 2006). 
Also macrophages and T lymphocytes that cluster to the region harbour podosomes and 
may gather MMPs to produce tissue destruction and further inflammation (Newby and 
Zaltsman 2000; Raines 2000). Apart from cell trafficking and immune surveillance, 
podosomes may have a role in malignancies arising from the haematopoietic cell lineage. 
Podosomes have been detected in B lymphocytes of patients suffering from chronic 
lymphocytic and hairy cell leukaemia, whereas they are not found in normal B 
lymphocytes (Caligaris-Cappio et al. 1986). On the other hand, in chronic myeloid 
leukaemia, characterized by erroneously constitutive tyrosine kinase signalling, dendritic 
cells are devoid of podosomes, which impairs their adhesion, spreading and migration 
(Dong et al. 2003).  
 
Taken together, podosomes have been detected in cells that reside at tissue interfaces. 
These cells can adhere firmly when needed, for instance, in the turbulence of the blood 
stream, and can degrade ECM to cross anatomical boundaries, to gain information about 
the surrounding environment or to generate passages for other cells such as osteoblasts in 
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bone. Podosomes may also operate in cancer, although reports of podosomes in carcinoma 
cells are largely missing.  
4.10.2. Invadopodia 
Invadopodia are actin-rich membrane protrusions in invasive cancer cells such as 
melanoma, breast adenocarcinoma and fibrosarcoma (Chen et al. 1994; Mueller et al. 
1999). Resembling podosomes, they contain a well-established actin-regulatory 
machinery, containing cortactin, N-WASP, Arp 2/3 complex, paxillin, gelsolin and 
phosphotyrosine (Bowden et al. 1999; Yamaguchi and Condeelis 2007) (Figure 8). In 
contrast to podosomes, the structure of invadopodia is less organized around the F-actin 
core, and no ring structure is detected (Weaver 2006). Other reported and largely cell type-
dependent differences between podosomes and invadopodia are in their size, number, 
persistence and localization. Invadopodia have a more diverse diameter of 1-8 m, and 
may appear in fewer numbers than podosomes (1-10/ cell vs. 20-100/ cell) (Linder 2007). 
Whereas osteoclast podosomes have short, minute-scale lifetimes, those of invadopodia in 
mammary carcinoma cells may vary from minutes to several hours (Yamaguchi et al. 
2005a). Furthermore, invadopodia have been reported to reside close to the Golgi 
apparatus, and thus, near the protein synthesis and secretion systems (Baldassarre et al. 
2003). Especially, localization of actin and cortactin and a direct association with ECM 
degradation sites have been used to define the presence of invadopodia (Bowden et al. 
1999; Gimona and Buccione 2006; Weaver 2006).  
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Figure 8. The invadopodium (modified from Stylli et al. 2008; Yilmaz and Christofori 2009).  
Some integrin subunits, i.e., 3, 5, v, 1 and 3, have been found in invadopodia of 
melanoma or breast carcinoma cells (Mueller et al. 1999; Deryugina et al. 2001; Artym et 
al. 2002). It is not certain that the integrins per se elicit adhesive strength; they may 
instead have a more vital role in signalling or cytoskeletal organization, for instance, in 
gathering other proteins to the cell membrane (Weaver 2006). In fact, integrin 31 
recruits proteolytic enzyme seprase to invadopodia, and integrin 51 is needed for the 
initial contact between the cell membrane and ECM preceding invadopodia formation in 
melanoma cells (Mueller et al. 1999; Deryugina et al. 2001).  
 
Functions of invadopodia in matrix degradation and cell invasion are emphasized by the 
finding that invasion potential of breast carcinoma cells is directly correlated with ECM 
degradation activity and ECM phagocytosis occurring through their invadopodia 
(Coopman et al. 1998; Kelly et al. 1998). In line with the assumption that invasive cells 
encounter and degrade various ECM components, a wide array of proteolytic enzymes 
have been detected in invadopodia. MMP-2 and MMP-9 localize to invadopodia of 
melanoma, breast carcinoma or head and neck SCC cells, and docking of MT1-MMP to 
invadopodia is required for invasion of melanoma cells (Chen et al. 1994; Nakahara et al. 
1997; Sato et al. 1997; Deryugina et al. 2001; Clark et al. 2007). In general, MT1-MMP 
has been shown to activate MMP-2 and MMP-9 in a complex including also a tissue 
inhibitor of MMPs, TIMP-2 (Hernandez-Barrantes et al. 2000; Toth et al. 2003). Apart 
from MMPs, different membrane-bound serine proteases, such as seprase and dipeptidyl 
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peptidase IV, accumulate in invadopodia of melanoma cells (Monsky et al. 1994; Artym et 
al. 2002; Ghersi et al. 2002). In contrast to MMPs, which are activated from proenzymes 
by cleavage of inhibitory fragments, serine proteases must oligomerize before they are 
active (Chen and Kelly 2003). In this event, integrins may operate in invadopodia 
(Mueller et al. 1999; Deryugina et al. 2001).  
 
In conclusion, invadopodia are found in invasive carcinoma cells and potentially have 
large proteolytic capacities, but may also have possible roles in traits such as cell 
migration, invasion and metastasis. The majority of studies thus far are limited to a narrow 
selection of breast carcinoma and melanoma cell lines. These previous reports need to be 
interpreted with caution since they may describe functions of podosomes, invadopodia, or 
even other actin-based structures such as filopodia, lamellipodia or microspikes. Recently, 
the denomination of podosomes and invadopodia has been under additional debate, and it 
has been proposed that the definition for podosomes should be restricted to include 
podosomes only in non-cancerous cells and invadopodia in malignant cells (Linder 2007). 
The molecular and functional mechanisms underlying podosomes and invadopodia are 
still largely unsolved.  
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5 AIMS OF THE STUDY 
EMT is suggested to enable neoplastic cells to become migratory and invasive and break 
through epithelial BMs. However, a molecular signature and specific markers to identify 
EMT in different carcinomas are lacking. Furthermore, the ECM deposited via epithelial-
mesenchymal interactions may itself participate in carcinogenesis.  
 
Specific aims of this study were: 
1. To characterize the changes related to spontaneous EMT detected in recurrent, 
invasive oral SCC cells compared with primary oral tumour cells. The effects of 
transcription factor Snail overexpression in primary SCC cells were also assessed.  
2. To produce a MAb against Snail.  
3. To analyse the expression of Snail protein in normal and malignant cell lines and 
tissues.  
4. To investigate the effects of EMT on the synthesis and secretion of laminins-332, -
511 and -411 and on their ECM receptors such as integrins and Lutheran. To 
determine whether Snail can bind to promoter sites of laminin 5 and 4 chain genes.  
5. To examine the differences between the structure and dynamics of cell adhesion and 
invasion complexes, podosomes and invadopodia in primary tumour and EMT-
experienced oral SCC cells.  
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6 MATERIALS AND METHODS 
The study protocols were approved by the Animal Experimentation Committee of the 
University of Helsinki (Helsinki, Finland) and the Ethics Committee or the Animal 
Experimentation Ethics Committee of Institut Municipal d’Investigació Mèdica 
(Barcelona, Spain). The Joint Ethics Committee of University of Turku and Turku 
University Central Hospital (Turku, Finland) approved the use of patient samples to 
produce cell lines. All patients signed an informed consent.  
6.1. Cell lines and cell culture (I-IV) 
Oral squamous cell carcinoma cell line UT-SCC-43A (43A) is derived from a primary 
gingival tumour of a 75-year-old Finnish female. The tumour was staged as T4N1M0, and 
was histologically a moderately to well-differentiated grade 2 SCC (Haikonen et al. 2003). 
UT-SCC-43B (43B) is derived from a recurrent tumour from the same patient after 
radiation therapy and surgery. The cell lines were established by methods described earlier 
(Takebayashi et al. 2000). To obtain cell line 43A-SNA, 43A cells were stably transfected 
with full-length, haemagglutinin-tagged cDNA of murine Snail (Batlle et al. 2000), 
manually cloned and selected with 200 g/ml G418 (Sigma-Aldrich, St. Louis, MO, 
USA).  
 
Pancreatic carcinoma cells AsPC-1, BxPC-3, HPAC, PANC-1 and RWP-1, colon 
carcinoma cells HT-29 and SW-620, and murine fibroblasts NIH-3T3 were obtained from 
the American Type Culture Collection (Manassas, VA, USA). HT-29 M6 cells contained a 
tetracycline-controlled transactivator, which induced expression of haemagglutinin-tagged 
murine Snail when tetracycline (4 g/ml) was withdrawn from the culture medium as 
described (Batlle et al. 2000). Human embryonal fibroblasts and human gingival 
fibroblasts were obtained from a local source.  
 
The cells were cultured in Roswell Park Memorial Institute (RPMI) 1640 medium (Sigma-
Aldrich; St. Louis, MO, USA) supplemented with 10% fetal calf serum (FCS) and 
antibiotics, or in a subset of studies, in defined serum-free keratinocyte growth medium 
(KGM-1; PromoCell, Heidelberg, Germany). CO2-Independent Medium (Gibco/ 
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Invitrogen, Paisley, UK), supplemented with 10% FCS, was used in live-cell imaging. In 
some experiments, the cells were exposed to proteasome inhibitor MG132 (10 M; 
Sigma-Aldrich) for 1-5 hours to inhibit destruction of labile transcription factor proteins, 
or monensin (5 M; Sigma-Aldrich) overnight, to inhibit secretion of newly synthesized 
proteins (Tartakoff 1983). Additionally, cycloheximide (10 g/ml; Sigma-Aldrich) was 
used to inhibit protein synthesis (Clark et al. 1986), cytochalasin B (10 g/ml; Sigma-
Aldrich) to disrupt the actin cytoskeleton, demecolcine (10 g/ml; Sigma-Aldrich) to 
disrupt the microtubule network and EGF (100 ng/ml; Sigma-Aldrich) to induce cell 
migration.  
6.2. Animals (I, II) 
Female Balb/c mice and nude, athymic Balb/cnu/nu mice were obtained from Harlan (Horst, 
the Netherlands) and housed at the Meilahti Experimental Animal Centre, University of 
Helsinki. Tissues from CD-1 mice and CD-1 mouse embryos (Harlan) were obtained from 
the Institut Municipal d’Investigació Mèdica (Barcelona, Spain). The animals had ad 
libitum access to standard diet and water and were housed at an ambient temperature of 
20-22°C throughout the studies.  
6.3. Tissues (II) 
Paraffin-embedded biopsies from colon adenocarcinoma, cervical SCC, laryngeal SCC, 
sarcoma, fibrosarcoma and fibromatosis were retrieved from the files of Servei 
d'Anatomia Patològica, Hospital del Mar (Barcelona, Spain), or the Departament de 
Patología, Hospital Virgen de la Salud (Toledo, Spain). Tissues from CD-1 mice and 
mouse embryos (Harlan) were formalin-fixed and embedded in paraffin. The 4-m 
sections were dewaxed, rehydrated and subjected to immunohistochemistry.  
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6.4. Immunocytochemistry, immunohistochemistry and 
microscopy (I-IV) 
The cells were grown on glass coverslips and fixed by immersion in prechilled methanol 
at -20°C or freshly prepared 4% paraformaldehyde at room temperature (RT) for 15 
minutes. Primary mouse MAbs (Table 2) were applied for 1 hour, followed by Alexa 
Fluor 488, 568 or 594 goat anti-mouse IgG conjugates (Molecular Probes/ Invitrogen, 
Eugene, OR, USA) for 30 minutes. For double-labelling, the specimens were exposed to 
secondary rat MAbs or polyclonal rabbit or goat antisera, followed by Alexa Fluor 488, 
568 or 594 goat anti-rat, goat anti-rabbit or donkey anti-goat IgG conjugates (Molecular 
Probes/ Invitrogen), respectively. The specimens were embedded in sodium veronal-
glycerol buffer (1:1, pH 8.4) or in Vectastain mounting medium (Vector Laboratories, 
Burlingame, CA, USA) and covered with cover slips. For negative controls, the primary 
antibody was omitted.  
 
Immunohistochemical labellings of human tissues were performed with the CSA II system 
(Dako, Glostrup, Denmark) based on the detection of horseradish peroxidase (HRP) –
conjugated anti-mouse immunoglobulins, fluorescyl-tyramide amplification, HRP-
conjugated anti-fluorescein detection and diaminobenzidine enhancement following the 
manufacturer’s instructions. Antigen retrieval was accomplished by boiling the samples in 
10 mM citrate buffer (pH 6.0) for 5 minutes. After blocking of non-specific binding with 
phosphate-buffered saline (PBS) supplemented with 1% skim milk, the sections were 
treated with the primary antibody at RT for 2 hours. In immunohistochemistry of mouse 
tissues, antigen retrieval was accomplished by boiling the samples in Tris-EDTA (pH 9.0) 
for 15 minutes. Endogenous peroxidase activity was quenched with 4% hydrogen 
peroxide in PBS, supplemented with 0.1 sodium azide, at RT for 15 minutes. After 
washing with PBS containing 1% bovine serum albumin (BSA) to block non-specific 
binding, the antibody was applied and the samples were incubated at 4°C overnight. After 
washing, the bound antibody was detected with the Envision system (Dako) based on the 
detection of HRP activity, and finally, the sections were counterstained with 
haematoxylin.  
 
The specimens were studied with a Leica Aristoplan microscope (Leica Microsystems, 
Wetzlar, Germany) or an Olympus AX70 Provis microscope (Olympus Corporation, 
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Hamburg, Germany) equipped with appropriate filters, UplanFl 10x/ 0.30 NA, 20x/ 0.50 
NA, 40x/ 0.75 NA, PlanAPO 60x/ 1.40 NA oil or 100x/ 1.30 oil objectives and AnalySiS 
Pro 3.0 software (Olympus Corporation). Laser scanning confocal microscopy was 
performed with a Leica TCS SP2 AOBS system (Leica Microsystems) with argon 
excitation line 488 nm, DPSS 561 nm or helium-neon 633 nm, HCX PL APO CS 40x/ 
1.25 NA or 63x/ 1.40 NA oil immersion objectives and Leica Confocal software. Image 
stacks were acquired through the specimen using a standardized 120 nm z-sampling 
density. Selected image stacks were deconvolved and restored using theoretical point 
spread function and iterative maximum likelihood estimation algorithm (Huygens 
Professional software, Scientific Volume Imaging BV, Hilversum, the Netherlands). In 
double-labelled specimens, each channel was imaged sequentially to prevent cross-
contamination between fluorochromes.  
 
 
Table 2. Antibodies, antisera, fluoroprobes and gene constructs used in this study.  
Specificity Monoclonal antibody Reference 
Laminin 2 chain 5H2 Leivo and Engvall 1988 
Laminin 3 chain BM2 Marinkovich et al. 1992 
Laminin 3 chain, 
unprocessed  12C4 Goldfinger et al. 1999 
Laminin 4 chain 168FC10 Petäjäniemi et al. 2002 
Laminin 4 chain 3H2 Wondimu et al. 2004 
Laminin 5 chain 4C7 Engvall et al. 1986 
Laminin 2 chain S5F11 Wewer et al. 1997b 
Laminin 3 chain 6F12 Marinkovich et al. 1992 
Laminin 1 chain 113BC7 Määttä et al. 2001 
Laminin 2 chain D4B5 Mizushima et al. 1998 
Laminin 2 chain when 
complexed in Lm-332 GB3 Matsui et al. 1995a 
Bullous pemphigoid protein 
BP180 233 Owaribe et al. 1991 
Cortactin 4F11 Upstate/ Millipore, Charlottesville, VA, USA 
Cytokeratins 5, 14 KA1 Nagle et al. 1986 
Cytokeratins 8, 18, 19 2A4 Virtanen et al. 1985 
E-cadherin Clone 36 BD Biosciences, San Jose, CA, USA 
E-cadherin HECD-1 Shimoyama et al. 1989 
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Filamin A  PM6/317 Chemicon/ Millipore, Temecula, CA, USA 
Focal adhesion kinase 2A7 Upstate/ Millipore 
Hemidesmosomal protein 1/ 
plectin  HD-121 Hieda et al. 1992 
Haemagglutinin  Clone 3F10 Roche, Mannheim, Germany 
Integrin 1 subunit TS2/7 Hemler et al. 1984 
Integrin 3 subunit J143 Fradet et al. 1984 
Integrin 6 subunit GoH3 Sonnenberg et al. 1987; Chemicon, Temecula, CA, USA 
Integrin v subunit LM142.69 Cheresh and Spiro 1987 
Integrin 1 subunit 102DF5 Ylänne and Virtanen 1989 
Integrin 4 subunit AA3 Tamura et al. 1990 
Integrin 5 subunit 1A9 Pasqualini et al. 1993 
Integrin-linked kinase ILK Upstate/ Millipore 
Lutheran BRIC221 
Parsons et al. 1997; AbD 
Serotec/ Morphosys, Oxford, 
UK 
MT1-MMP LEM-2/15 Gálvez et al. 2001 
N-cadherin 13A9 Johnson et al. 1993 
Phosphotyrosine PY20 Molecular Probes/ Invitrogen, Eugene, OR, USA 
Snail 173EC3, 173CE2 Studies I-II  
II-spectrin 101AA6 Ylikoski et al. 1990 
Talin MCA725S AbD Serotec/ MorphoSys 
Tensin Clone 5 BD Biosciences 
-tubulin DM3B3 Blose et al. 1984 
Vimentin 65EE3 Virtanen et al. 1985 
 
Antiserum Species Reference 
Laminin 4 chain rabbit  Iivanainen et al. 1997 
Laminin 2 chain rabbit  Sugiyama et al. 1995 
Laminin-332 rabbit  Filenius et al. 2001 
Annexin 2 rabbit  P.Navarro, IMIM, Barcelona, Spain 
Arp 2/3 rabbit  Upstate/Millipore 
Fibronectin rabbit  Dako 
Lutheran rabbit  Moulson et al. 2001 
MMP-2 goat  R&D Systems, Wiesbaden, Germany 
MMP-9 goat  R&D Systems 
Pacsin 2 rabbit  Abgent, San Diego, CA, USA 
Vinculin rabbit  Lehto et al. 1982 
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Specificity Fluoroprobe Reference 
Cytoplasm (thiol compounds) CellTracker Orange Molecular Probes/ Invitrogen 
F-actin Rhodamine phalloidin Molecular Probes/ Invitrogen 
Nucleus (DNA) Hoechst 33258 (DAPI) Riedel-de Haën AG, Seelze-Hanover, Germany 
Nucleus (DNA) TO-PRO-3 Molecular Probes/ Invitrogen 
 
Gene construct Accession number Reference 
EGFP-actin AY582799 BD Biosciences 
EGFP-cortactin NM_007803 Zhu et al. 2007 
EGFP-filamin A NM_001110556 Nakamura et al. 2006 
GFP-Slug NM_011415 Domínguez et al. 2003 
GST-Snail, haemagglutinin-
Snail NM_011427 Batlle et al. 2000 
 
6.5. Stable and transient transfections (I-IV) 
43A cells were manually cloned by picking single cells with suction from sparse cell 
cultures under microscopic control. The cells were transfected with a pIRES vector 
(Clontech, Mountain View, CA, USA) containing haemagglutinin epitope-tagged, full-
length cDNA of murine Snail (Batlle et al. 2000) or with empty plasmids as controls using 
JetPei reagent (Qbiogene, Carlsbad, CA, USA), based on polyethylenimine cationic 
transfection (Boussif et al. 1995). Efficiency of Snail transfections was monitored using 
immunofluorescence labellings with MAb to haemagglutinin (Roche). Individual 43A-
SNA cell clones were manually isolated after selection with 400 g/ml G418 (Sigma), and 
they were maintained in 200 g/ml G418. The experiments in Study I were performed 
with at least five different stable Snail-transfected clones in addition to uncloned 43A-
SNA cells. Furthermore, GFP-Slug (Domínguez et al. 2003) -transfected RWP-1 cells 
were used in Study II to verify that MAb to Snail did not crossreact with Slug. In Study 
IV, 43A and 43B cells were transiently transfected with EGFP-actin (BD Biosciences), 
EGFP-cortactin (Zhu et al. 2007) or EGFP-filamin A (Nakamura et al. 2006), using 
Fugene HD reagent (Roche) based on lipofection (Jacobsen et al. 2004). To gain maximal 
transfection efficiency and to ensure reorganization of the cytoskeletal structures, second 
passage cells after transfections were used in Study IV.  
  56
6.6. Production of monoclonal antibodies against Snail (I, II) 
Nine-week-old female Balb/c mice (Harlan) were immunized subcutaneously with 1-2 g 
of murine GST-Snail fusion protein (Batlle et al. 2000) in ImmunEasy adjuvant (Qiagen, 
Hilden, Germany). The adjuvant, containing bacterial cytosine-guanine dinucleotides that 
the mammalian immune system considers as a sign of infection, was used to enhance the 
immune reaction. Immunizations were repeated twice, after which the final, fourth 
immunizations were performed by injecting the tail veins with the antigen mixed in PBS. 
The spleens were harvested and minced, and polyethylene glycol was used in the fusion 
with P3X63Ag8.653 murine myeloma cells (American Type Culture Collection) by 
standard methods (Köhler and Milstein 1975). The cells were seeded on 96-well plates in 
Hypoxanthine Aminopterin Thymidine selection medium (HAT medium; Biological 
Industries, Kibbutz Beit Haemek, Israel) with 10% Ab-Max medium (ABCELL, Tampere, 
Finland) and 20% FCS in RPMI, which allowed only B cell-myeloma cell fusions to 
survive. Immunofluorescence labellings, Western blots and enzyme-linked 
immunosorbent assay (ELISA) were used in the characterization of the MAbs (Section 
7.2). In ELISA, 96-well plates were coated with GST-Snail fusion protein or GST alone 
overnight at 4°C. After blocking with 1% BSA in PBS, undiluted supernatant from 
hybridoma cell cultures was applied for 2 hours at 37°C. After five washes with 0.05% 
Tween 20 in PBS, the bound MAbs were incubated with alkaline phosphatase-coupled 
goat anti-mouse immunoglobulins (AbD Serotec/ Morphosys) for 2 hours at 37°C, and 
with 2 mg/ml phosphatase substrate (Sigma) in carbonate buffer, pH 9.5, for 1 h at 37°C. 
The enzyme activity was measured with a spectrophotometer at 405 nm. Two of the 
hybridomas, producing MAbs 173CE2 (IgG2a) and 173EC3 (IgG1), were manually cloned 
and subsequently cultured in RPMI medium supplemented with 10% or 20% FCS and 
antibiotics. The immunoglobulin isotype and light chain composition of the MAbs were 
determined with Mouse Isotyping Kit MMT1 (AbD Serotec/ Morphosys), and the MAbs 
were purified with GammaBind Plus Sepharose beads (Amersham Biosciences, Uppsala, 
Sweden).  
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6.7. Immunoprecipitation (I, III, IV) 
For immunoprecipitations, 43A, 43B and 43A-SNA cells were deprived of methionine for 
30 minutes to 1 hour, after which they were radioactively labelled with [35S]methionine 
(50 Ci/ml; Amersham Biosciences) at 37°C overnight. To detect the chains of laminin-
332 (Study I), laminins-411/ -421 and laminins-511/ -521 (Study III), the culture medium 
was collected, cleared by centrifugation and supplemented with normal mouse or rabbit 
serum and 0.5% Triton X-100. To detect laminin-332 from cell-free ECM material (Study 
I), the cells were treated thrice with 0.5% sodium deoxycholate (DOC; Sigma) in 10 mM 
Tris-HCl, 150 mM NaCl, 1 mM phenylmethylsulfonyl fluoride (PMSF), pH 8.0, on ice for 
10 minutes, and washed thrice in 2 mM Tris-HCl, 150 mM NaCl, 1 mM PMSF, pH 8.0, 
on ice. The ECM material was scraped off from culture plates with rubber policeman and 
solubilized in ice-cold radioimmunoprecipitation assay buffer (10 mM Tris-HCl, pH 7.2, 
150 mM NaCl, 0.1% sodium dodecyl sulphate [SDS], 1.0% Triton X-100, 1.0% DOC, 5 
mM EDTA, 1 mM PMSF). For immunoprecipitations of integrins and Lutheran (Study 
III), [35S]methionine-labelled cells were scraped off from culture plates and similarly 
solubilized in radioimmunoprecipitation assay buffer. For immunoprecipitations of 
laminin 1 chain (Study III), the cells were left unlabelled. For immunoprecipitations of 
integrins (Study IV), the cells were surface-labelled with 0.2 mg/ml NHS-SS-biotin 
(Pierce, Rockford, IL, USA) and solubilized in 100 mM Tris, 150 mM NaCl, 1 mM CaCl2, 
1 mM MgCl2, 1% Triton X-100, 0.1% SDS and 0.1% Nonidet P-40, pH 7.4. For 
immunoprecipitations of FAK (Study IV), the cells were treated with 60 mM KCl, 1 mM 
EDTA, 2 mM EGTA, 1 mM cysteine, 40 mM imidazole, pH 7.0, supplied with 0.5% 
Triton X-100, 1 mM PMSF and 1 mM Na3VO4, on ice for 30 minutes. The supernatant 
was collected and the treatment repeated.  
 
The samples were then preabsorbed with uncoupled GammaBind Plus Sepharose beads 
(Amersham Biosciences), followed by application to GammaBind Plus Sepharose beads 
prebound with antibodies (Table 1), and incubated in a rolling shaker at 4°C overnight. 
For negative controls, the primary antibody was omitted. The precipitated proteins were 
separated with SDS polyacrylamide gel electrophoresis (SDS-PAGE) following 
Laemmli’s procedure with reducing or non-reducing 5% to 10% gels. [14C]Methylated 
Molecular Weight Marker (Amersham Biosciences) was used as a size marker. 
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Radioactively labelled proteins were detected from dried gels using Hyperfilm MP 
(Amersham Biosciences). Other immunoreactive proteins were then subjected to Western 
blotting.  
6.8. Western blot analysis (I-IV) 
For Western blots, cells scraped from culture plates or previously immunoprecipitated 
samples were diluted in reducing Laemmli’s sample buffer. In Study I, laminin-332 was 
recovered from overnight cultures of serum-free RPMI medium with ammonium sulphate 
precipitation by treatment with 0.53 g/ml ammonium sulphate, 0.5 mg/ml gelatin, 0.02% 
sodium azide and 1 mM PMSF. The proteins were then separated with SDS-PAGE and 
transferred onto nitrocellulose filters, which were blocked with 5% skim milk (BD 
Biosciences) in PBS. After addition of the MAbs or antisera, the immunoreactive bands 
were detected either with Vectastain Elite ABC kit (Vector Laboratories), based on avidin-
biotin peroxidase complex, using goat anti-mouse or goat anti-rabbit immunoglobulins, 
nickel intensification and diaminobenzidine (Sigma) as a substrate, or with SuperSignal 
West Pico Chemiluminescent Substrate (Pierce, Rockford, IL, USA), using HRP-coupled 
anti-mouse or anti-rabbit immunoglobulins (Dako), or HRP-coupled MAb to 
phosphotyrosine (Table 2). Equal loading of proteins was verified with Amido Black 
(Sigma) labellings or with MAb to -tubulin (Table 2). Molecular Weight Marker (M.W. 
30 000-200 000; Sigma) was used as a size marker.  
 
For detection of Snail in Study II, cell extracts were incubated in a buffer containing 50 
mM Tris-HCl, pH 8.0, 150 mM NaCl, 1 mM EGTA, 1% DOC, 1% Triton X-100, 0.2% 
SDS and protease and phosphatase inhibitors (5 mM NaF, 1 mM Na3VO4, 2 mM -
glycerolphosphate, 10 mg/ml leupeptin, 10 mg/ml aprotinin, 10 mg/ml pepstatin, 2 mM 
Pefablock [Boehringer Mannheim, Germany]) on ice for 30 minutes. Cell lysates were 
centrifuged and the supernatant was used for Western blot analysis. The proteins were 
separated with SDS-PAGE using 15% gels, transferred onto nitrocellulose filters, and 
analysed as above. Equal loading of proteins was verified with rabbit antiserum to annexin 
2 (Table 2).  
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6.9. Northern blot analysis (I, III) 
Total RNA of 10 000 000 43A, 43B and 43A-SNA cells was extracted with Eurozol 
(EuroClone, Milan, Italy), or by acid phenol-guanidium thiocyanate-chloroform extraction 
method as described by Chomczynski and Sacchi (1987), and the mRNAs were enriched 
by capturing the poly-A-tails with Dynabeads Oligo (dT)25-beads (Dynal Biotech, Oslo, 
Norway). The mRNAs were separated in denaturing 1.2% agarose gels and transferred by 
upward capillary transfer onto Hybond membranes (Amersham Biosciences). The 
membranes were washed with 6 x SSC (0.9 M NaCl, 0.09 M sodium acetate, pH 7.0), air-
dried for 30 minutes, UV-crosslinked and hybridized with non-radioactive, digoxigenin-
labelled (DIG) probes (Roche).  
 
In Study I, the cDNA probes were produced with DIG High Prime DNA Labelling and 
Detection Starter Kit II by excising inserts with restriction enzymes and labelling them 
with DIG. The nucleotide sequences and restrictions sites were verified by DNA 
sequencing. The following cDNA probes were generated: 702 bp EcoRI fragment of 
laminin α3 chain (in pCRII plasmid, Invitrogen; Ryan et al. 1994), 534 bp EcoRI/ HindIII 
fragment of laminin γ2 chain (in pGEM 3Z plasmid, Promega; Airenne et al. 1996), full-
length, 800 bp EcoRV/ BamHI cDNA of human Slug (in pcDNA3 plasmid; Domínguez et 
al. 2003) and 500 bp NcoI/ NotI fragment of human Snail (in pGEM-T plasmid, Promega; 
Batlle et al. 2000). Full-length, 3.5 kb EcoRI cDNA of murine ZEB-1 (in pcDNA3 
plasmid; Invitrogen) was received from Tom Genetta (Children’s Hospital, Philadelphia, 
PA, USA), and full-length, 3.6 kb NcoI/ XbaI cDNA of human ZEB-2 (in pCs2Mt 
plasmid; Turner and Weintraub 1994) was from Antonio Postigo (Washington University 
School of Medicine, St. Louis, MO, USA; Postigo 2003). A PstI fragment of GAPDH was 
used as a control (in pBluescript plasmid, Stratagene; Fort et al. 1985). Prehybridization 
and hybridization in high SDS hybridization buffer (7% SDS, 50% deionized formamide, 
5 x SSC, 0.1% N-lauroylsarcosine, 2% Blocking Solution [Roche], 50 mM sodium 
phosphate, pH 7.0) were carried out at 50°C for 30 minutes and for 18 hours, respectively. 
The probes were detected with alkaline phosphatase-conjugated anti-DIG antibody and 
CSPD, and the blots were exposed to Hyperfilm MP (Amersham Biosciences). For re-use 
of the blots, the previously detected probes were erased with boiling in 0.1% SDS for 10 
minutes, after which the blots were rinsed in 0.1 M maleic acid, 0.15 M NaCl, pH 7.5, 
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0.2% Tween 20, and stored in 2 x SCC. A 0.24-9.5 kb RNA ladder was used as a size 
marker (Life Technologies, Gaithersburg, MD, USA).  
 
In Study III, the cRNA probes for the laminin 5 chain and the laminin 4 chain were 
generated from plasmid cDNA templates as follows: antisense cRNA probe for the 
laminin 5 chain was generated by linearizing pBluescript SK+ plasmid (Stratagene, La 
Jolla, CA, USA) covering nucleotides 9805-11 332 (Durkin et al. 1997), with NotI, and 
incorporating DIG label by in vitro transcription using DIG RNA Labelling kit (SP6/T7) 
and T7 RNA polymerase (Roche). Antisense cRNA probe for the laminin 4 chain was 
generated by linearizing pBluescript plasmid covering nucleotides 94-2808 (Kortesmaa et 
al. 2000), with EcoRI, using T7 RNA polymerase. Prehybridization and hybridization with 
DIG Easy Hyb (Roche) were carried out at 68°C for 30 minutes and for 18 hours, 
respectively. The probes were thereafter detected as above. For re-use of the blots, the 
membranes were washed twice in stripping solution (50% formamide, 5% SDS, 50 mM 
Tris-HCl, pH 7.2) at 80°C for 60 minutes and re-probed. Hybridizations with antisense 
GAPDH probes were used to confirm the equal loading of mRNA, and hybridizations 
with sense cRNA probes were used as negative controls. Digoxigenin-labelled RNA 
molecular weight marker I (Roche) was used as a size marker.  
6.10. Preparation of crude nuclear extracts (I) 
For evaluation of endogenous Snail in pancreatic adenocarcinoma cell line PANC-1, the 
cells were grown to confluency, trypsinized and treated with trypsin-neutralizing solution 
(PromoCell). The cells were collected by centrifugation, allowed to swell in ice-cold, 
hypotonic cell homogenization buffer (10 mM HEPES-KOH, pH 7.9, 1.5 mM MgCl2, 10 
mM KCl, 0.5 mM dithiothreitol, 0.5 mM PMSF) for 10 minutes on ice and centrifuged. 
To disrupt the cell membranes and release the nuclei, the pellet was resuspended in ice-
cold buffer (0.5% Triton X-100, 50 mM Tris-HCl, pH 7.9) and homogenized on ice with a 
Dounce homogenizer. Lysis of cells was followed under a microscope, after which the 
cells were washed in cell homogenization buffer, centrifuged and used in Western blotting 
(Sambrook and Russell 2001).  
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6.11. Quantitative reverse transcription polymerase chain 
reaction (II) 
To analyse whether expression of Snail was dependent on serum, NIH-3T3 cells were 
starved of serum for 24 hours, after which they were exposed to 10% FCS for 0-24 hours. 
Total RNA was extracted with GenElute Mammalian total RNA kit (Sigma). Analysis of 
Snail RNA levels was performed with QuantiTect SYBR Green RT–PCR (Qiagen). All 
quantifications were performed in triplicate and normalized to the endogenous control 
cyclophilin or hypoxanthine-guanine phosphoribosyltransferase. Relative quantification 
values for each target gene, compared with the calibrator for that target, were expressed as 
2-(Ct-Cc), in which Ct and Cc are mean threshold cycle differences after normalizing to 
controls. The following oligonucleotides were used to detect Snail: 5’-
TTCCAGCAGCCCTACGACCAG-3’ (forward) and 5’-CTTTCCCACTGTCCTCATC-3’ 
(reverse).  
6.12. Wound-healing assay in vivo (II) 
After induction of anaesthesia with isoflurane (Abbot Laboratories, Abbot Park, IL, USA), 
the dorsums of CD-1 mice (Harlan) were shaved free from hair, and the skins were 
cleaned with 70% ethanol. Four full-thickness wounds were aseptically made with a 2-mm 
biopsy punch lateral to the spine of each animal. Wound closure was monitored daily. The 
mice were sacrificed at 2, 3, 5 or 7 days post-wounding, and the wounded tissues were 
collected and subjected to immunohistochemistry.  
6.13. Cell morphology and cell invasion assays (III, IV) 
Cell morphology, cytoskeletal structures and cell invasion abilities were studied with 
modified Boyden chambers. Matrigel (5 mg/ml; BD Biosciences) was coated on Falcon 
FluoroBlok Individual Cell Culture Inserts (BD Biosciences) with 8 m pores at 37°C for 
1 hour. Altogether 50 000 cells in 350 l of cell culture medium were added to the upper 
chamber, and 900 l of culture medium was added to the lower chamber. The cells were 
grown at 37°C overnight, after which the filters were fixed in 4% paraformaldehyde and 
labelled with rhodamine phalloidin (Molecular Probes/ Invitrogen). The filters were 
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detached from the inserts with a scalpel, mounted in Vectashield mounting medium on 
objective slides and covered with cover slips. The cells on both sides of the filter were 
examined. The cells that had invaded through the ECM and the filter pores to the lower 
sides of the filters were photographed using an Olympus AX70 microscope with UPlanFl 
10x/ 0.30 NA, 20x/ 0.50 NA, or 40x/ 0.75 NA objectives or a Leica TCS SP2 AOBS 
confocal microscope with an HCX PL APO CS 63x/ 1.40 NA oil immersion objective. 
The experiments were performed at least in triplicate.  
6.14. Chromatin immunoprecipitation and polymerase chain 
reaction (III) 
Chromatin immunoprecipitations (ChIP) were performed on 43A-SNA cells with a ChIP-
IT Express Assay Kit (Active Motif, Carlsbad, CA, USA) to analyse whether Snail binds 
to gene promoter sites of laminin 5 and 4 chains. 43A-SNA cells were fixed with 1% 
formaldehyde at RT for 15 minutes to crosslink the DNA-binding proteins to DNA. After 
cell lysis on ice for 30 minutes, the DNA was sheared into fragments with a Dounce 
homogenizator and enzymatically digested at 37°C for 15 minutes. A portion of chromatin 
lysate was stored as an Input control. DNA-protein complexes were immunoprecipitated at 
4°C overnight using Protein G beads with 2-6 g of negative control mouse IgG antibody 
(Dako), positive control RNA polymerase II antibody provided by the kit, or MAb 
173EC3 against Snail (Studies I and II). The DNA was eluted, the crosslinks were 
reversed at 94°C for 15 minutes, the proteins were removed with Proteinase K at 37°C for 
1 hour and the DNA was used as a template for PCR.  
 
Promoter sequences for laminin 5 (NM_005560) and 4 (NM_002290) chain genes were 
extracted from human genome sequence with Genomatix Gene2Promoter software 
(Genomatix Software, Munich, Germany). Overlapping primers (Tables 2 and 3 in Study 
III) covering the genomic region 3000 bp upstream of laminin 5 and 4 transcription start 
sites were designed with Primer3 software (Rozen and Skaletsky 2000) and were produced 
by Oligomer (Helsinki, Finland). Primers were ca. 20 nucleotides long, and were designed 
to minimize primer dimers, to have a 45-55% GC concentration and to have a melting 
temperature (Tm) of ca. 60°C. Primers for GAPDH, used to detect the control Input DNA, 
were provided in the kit. PCR amplification was performed with AmpliTaq Gold DNA 
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polymerase (Applied Biosystems, Foster City, CA, USA) in a thermal cycler (RoboCycler 
Gradient 40; Stratagene) as follows: initial denaturation at 95°C for 10 minutes, 40 cycles 
with denaturation at 95°C for 1 minute, annealing at 60-64°C for 1 minute, extension at 
72°C for 1 minute and a final extension for 20 minutes. The samples were fractionated 
through 1% agarose gels with a 100 bp DNA ladder (Invitrogen). MatInspector software 
(Genomatix Software) was used to screen the laminin 5 and laminin 4 chain promoter 
sites for the E-box (5´-CA(C/G)(C/G)TG-3´) and Z-box (5´-CAGGT(G/A)-3´) motifs.  
6.15. Quantitative cell adhesion assay (III) 
Quantitative cell adhesion experiments were based on a method detecting intracellular 
acid phosphatase activity (Prater et al. 1991). The wells of 96-well cell culture plates were 
coated with 4 g/ml recombinant human laminin-411, 4 g/ml native human laminin -511 
or 5 g/ml human plasma fibronectin at RT for 1 hour. Recombinant laminin-411, 
comprising human laminin 4 and 1 chains and murine laminin 1 chain, was produced 
in a mammalian expression system (Kortesmaa et al. 2002). Native laminin-511 was 
purified from the culture medium of PANC-1 cells with immunoaffinity chromatography 
(Tani et al. 1999). Fibronectin was purified from outdated human plasma (Finnish Red 
Cross Blood Transfusion Service, Helsinki, Finland) with gelatin-Sepharose affinity 
chromatography (Amersham Biosciences) (Engvall and Ruoslahti 1977). After three 
washes with PBS, the wells were post-coated with 3% BSA (Sigma) at RT for 1 hour to 
inhibit unspecific binding of proteins. To prevent the synthesis of endogenous proteins 
during the adhesion experiment (Clark et al. 1986), the cells were preincubated with 
cycloheximide (10 g/ml; Sigma) at 37°C for 1 hour, after which the cells were 
trypsinized, treated with trypsin-neutralizing solution (Promocell) and collected by 
centrifugation. Altogether 20 000 43A, 43B and 43A-SNA cells in serum-free cell culture 
medium supplied with 10 g/ml cycloheximide were placed into each well, and the plates 
were incubated at 37°C for 1 hour. After careful washing in PBS to remove non-adherent 
cells, phosphatase substrate solution (6 mg/ml phosphatase substrate in 50 mM sodium 
acetate buffer, pH 5.0; Sigma, 1% Triton X-100) was added, and the plates were incubated 
at 37°C for 1 hour. The reaction was stopped with 1 M NaOH, and the absorbances were 
measured with a spectrophotometer at 405 nm. Wells that were coated with only BSA 
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were used as controls. The experiments were performed at least in triplicate, and 
absorbances were expressed as SD of three wells.  
6.16. Wound-healing assay in vitro (IV) 
The cells were grown to confluency on coverslips and wounded with a rubber policeman. 
After washing with PBS, non-viable cells were removed with careful suction and fresh cell 
culture medium was applied. The cells were allowed to grow and migrate at 37°C for 2-24 
hours, after which they were fixed in 4% paraformaldehyde at RT and labelled with 
appropriate antibodies. EGF (100 ng/ml, Sigma-Aldrich) was used in some experiments to 
induce cell migration in 43A cells. The images were acquired with a Leica TCS SP2 
AOBS confocal microscope with an HCX PL APO CS 40x/ 1.25 NA oil immersion 
objective as above. 
6.17. Random cell migration assay (IV) 
For random cell migration (Entschladen et al. 2005), the cells were labelled with 20 M 
CellTracker Orange (Molecular Probes/ Invitrogen) in serum-free RPMI culture medium 
at 37oC for 30 minutes. After trypsinization and treatment with trypsin-neutralizing 
solution, 100 000 43A and 43B cells were seeded on coverglass bottom dishes (coverglass 
thickness 1.5; MatTek, Ashland, MA, USA) in pre-warmed CO2-Independent Medium 
(Gibco/ Invitrogen) supplemented with 10% FCS and allowed to attach for 20 minutes. 
Cell migration was analysed using epifluorescence imaging at 37oC with an Olympus 
IX71 inverted microscope and a TILL Photonics imaging system (TILL Photonics/ 
Agilent Technologies, Munich, Germany) with UPlanFl 10x/ 0.30 NA dry objective, 
polychrome IV monochromator, and TILLvisION software v. 4.01. Cells were exposed to 
540 nm monochromatic light for 20 ms with 5-minute intervals for 10 hours, and emission 
was collected using a 605/55 nm bandpass filter. The trajectory length, distance between 
the start and end points and directionality of the trajectories were analysed with ImageJ 
version 1.41e software (Rasband WS: ImageJ, National Institutes of Health, Bethesda, 
MD, USA, http://rsb.info.nih.gov/ij/, 1997-2008) using an MTrackJ plugin (by Erik 
Meijering). The experiments were repeated at least three times.  
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6.18. Analysis of podosomes and invadopodia on different ECM 
substrata (IV) 
To analyse the effects of different ECM components on the number and morphology of 
podosomes and invadopodia, 43A and 43B cells were seeded on glass coverslips that were 
coated with 4 g/ml type I collagen, 4 g/ml plasma fibronectin, 2 g/ml laminin-332 or 2 
g/ml laminin-511. Type I collagen was obtained from rat tails (Sigma-Aldrich), and 
fibronectin was purified as above. For these experiments, purified human laminin-332 was 
obtained from Patricia Rousselle (Institut de Biologie et Chimie des Protéines, Unité 
Mixte de Recherche, Université Lyon, France), and purified human laminin-511 was from 
Kiyotoshi Sekiguchi (Institute for Protein Research, Osaka University, Japan). The cells 
were allowed to adhere and assemble podosomes or invadopodia for 48 hours at 37oC. The 
cells were fixed in 4% paraformaldehyde and labelled with rhodamine phalloidin. The 
percentage of cells that had organized at least two podosomes or invadopodia per cell were 
counted in 10 microscope fields (ca. 20-40 cells/ field) using an Olympus AX70 Provis 
microscope with a 40x/ 0.75 NA objective. The experiments were repeated at least three 
times.  
6.19. In situ zymography for ECM degradation (IV) 
To analyse the presence of podosomes and invadopodia and the ECM degradation 
capacities of 43A and 43B cells, we performed in situ zymography assays. Glass 
coverslips were coated with fluorescein-conjugated gelatin (0.2 mg/ml in 2% sucrose 
buffer; Molecular Probes/ Invitrogen) for 2 hours, crosslinked with 0.5% glutaraldehyde 
for 15 minutes and treated with NaBH4 (5 mg/ml) at RT for 3 minutes. Fluorescein-
conjugated gelatin was quenched with two washes of RPMI medium at 37oC for 30 
minutes and coated with 1 g/ml fibronectin at RT for 1 hour. Fibronectin was purified as 
above. 43A and 43B cells were seeded on coverslips, incubated at 37oC for 2-15 h, fixed 
with 4% paraformaldehyde and labelled with rhodamine phalloidin and TO-PRO-3. The 
degraded areas of the matrix were visible as dark foci devoid of fluorescence. Images were 
acquired with a Leica TCS SP2 AOBS confocal microscope with an HCX PL APO CS 
63x/ 1.40 NA oil immersion objective using sequential scanning and were deconvolved 
with Huygens Professional software as above. 3D reconstructions and relative volume 
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calculations (m3) of actin fluorescence intensity (n=5-9 cells per time point) were 
performed with Imaris software (Bitplane, Zurich, Switzerland). The results were 
normalized against a standard curve generated using 0.5, 1.0 and 2.0 m diameter 
carboxylate-modified polystyrene microspheres (FluoSpheres Size Kit, Molecular Probes/ 
Invitrogen). Degradation cavities produced by cells (n=33 for 43A; n=32 for 43B cells) 
were photographed with an Olympus AX70 Provis microscope with a 60x/ 1.40 NA oil 
objective, counted and analysed with ImageJ software. The resorption areas per cell (m2) 
were measured by thresholding (maximum entropy thresholding plugin by Jarek Sacha) 
after background subtraction (rolling ball background subtraction plugin by Michael 
Castle and Janice Keller).  
6.20. Field emission scanning electron microscopy (IV) 
43A and 43B cells were cultured on glass coverslips and fixed in 2.5% glutaraldehyde in 
0.1 M sodium cacodylate buffer (pH 7.2) at RT for 30 minutes. The samples were washed 
thrice with cacodylate buffer, dehydrated through a graded series of ethanol, and treated 
with hexamethyldisilazane. The samples were then coated with 20 M chromium with 
Emitech K575X sputter coater (Emitech, Kent, UK) and studied under a field emission 
scanning electron microscope (FESEM, JEOL JSM-6335F; JEOL, Tokyo, Japan) at 5–15 
kV operating voltage and 0-45° inclination.  
6.21. Live-cell imaging and total internal reflection fluorescence 
microscopy (IV) 
To analyse the functions of podosomes and invadopodia in live cells, 43A and 43B cells 
were transfected with EGFP-actin or EGFP-cortactin and seeded on coverglass bottom 
dishes in pre-warmed CO2-Independent Medium supplemented with 10% FCS. 
Epifluorescence images were acquired using an Olympus IX71 inverted microscope with a 
PlanAPO 60x/ 1.20 NA water immersion objective at 37oC and a TILL Photonics imaging 
system. Cells were exposed to 480 nm monochromatic light for 20-100 ms with 10-s 
intervals for 30 minutes or with 5-minute intervals for 15 hours, and emission was 
collected using a 520 nm longpass filter. The exposure times and acquisition intervals 
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were chosen to avoid phototoxicity caused by the excitation wavelength. 2D 
deconvolution was performed with Huygens Professional software, and the images were 
further analysed and movies compiled with ImageJ followed by QuickTime Pro version 
7.4 and H.264 codec (Apple Inc., Cupertino, CA, USA) softwares. In some experiments, 
the cells were treated with cycloheximide, cytochalasin B, demecolcine (10 g/ml; Sigma-
Aldrich) or their combination.  
 
Total internal reflection fluorescence (TIRF) microscopy was used to assess the events at 
the narrow cell-ECM surface interface. TIRF images were acquired with an Olympus 
IX71 inverted microscope equipped with a CellR imaging system, a 476 nm solid state 20 
mW laser, a PLAPON 60x/ 1.45 NA TIRF objective and a Hamamatsu Orca ER CCD 
camera. To ensure evanescent field detection, a mixture of carboxylate-modified 
fluorescent 20 nm and 200 nm polystyrene beads (Molecular Probes/ Invitrogen) was 
immobilized onto the surface of coverglass bottom dishes, and the laser angle was 
optimized for TIRF detection of the 20 nm particles. For prolonged TIRF imaging, a 
motorized Nikon Eclipse Ti-E TIRF system was used with a TI-ND6-Perfect Focus Unit, 
NIS-Elements AR software, a Coherent Sapphire 488 nm solid state 20 mW laser, a CFI 
APO 100x/ 1.49 NA TIRF objective and a Nikon DS-Qi1MC camera (Nikon Instruments, 
Melville, NY, USA). Images were acquired at 37oC with 10-s intervals for 30-60 minutes 
or with 30-s intervals for 6-12 hours.  
6.22. Fluorescence recovery after photobleaching (IV) 
The exchange and kinetics of fluorescent molecules in live cells were studied with 
fluorescence recovery after photobleaching (FRAP) experiments. 43A and 43B cells were 
transfected with EGFP-actin, EGFP-cortactin or EGFP-filamin A and seeded on 
coverglass bottom dishes in CO2-Independent Medium. FRAP was performed at 37oC 
with a Leica TCS SP2 AOBS confocal microscope with an argon excitation line of 488 
nm and an HCX PL APO LU-V-I 63x/ 0.9 NA water immersion objective, using a 200 m 
pinhole (1.12 Airy) and a zoom factor of 4. With 512x512 pixel image format and 1000 
Hz scanning speed, prebleaching was carried out with 10 pulses at low-intensity 
illumination and bleaching with 5 high intensity short pulses (3.3 s total). Zoom-in 
function for the region of interest was used to increase the bleaching power. Fluorescence 
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recovery was monitored by time-lapse imaging for a total duration of 135 s under low 
intensity illumination. After raw data measurement, the background was subtracted, and 
the data was corrected and normalized taking into account laser intensity fluctuations and 
loss of fluorescence during recording (Rabut and Ellenberg 2005). Half-time of recovery, 
plateau of recovery and mobile and immobile fractions were calculated with Prism 4.0 
software using non-linear regression (GraphPad Software, La Jolla, CA, USA). For each 
FRAP experiment, an area of 10 m2 was bleached and the fluorescence recovery was 
measured from a 1.35 m2 region of interest surrounding podosomes (n=25), invadopodia 
(n=25) or cell extensions (n=9). When cell extensions were imaged, the average distance 
between the extension and cell surface was ca. 3 m.  
6.23. Statistical analysis (II-IV) 
Statistical analyses were performed using a two-tailed, unpaired t-test, or the analysis of 
one-way variance (ANOVA) followed by Bonferroni´s post hoc test, and non-linear 
regression analysis (Prism 4.0 software). P<0.05 was regarded as statistically significant. 
The results are expressed as ± SD or SEM.  
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7 RESULTS 
7.1. Characterization of EMT in oral SCC cells (I) 
7.1.1. Endogenous EMT in oral SCC cells (I) 
43A cells were obtained from a primary squamous cell carcinoma of the oral cavity and 
43B cells from its recurrent tumour after irradiation therapy and surgery. Our first aim was 
to study how these two cell lines differ from each other in vitro. In cell culture, 43A cells 
grew as islands and showed a typical epithelial, cobblestone morphology, whereas 43B 
cells showed a more fibroblastoid morphology and retained only a few cell-cell contacts. 
When the cells were grown in KGM-1 cell culture medium, which is used to promote the 
growth of epithelial cells over non-epithelial cells, 43A cells thrived and proliferated, 
whereas 43B cells were unable to survive. Immunolabelling with rhodamine phalloidin 
revealed that actin filament bundles encircled 43A cells, while 43B cells harboured actin 
stress fibres. Concerning intermediate filaments, immunolabelling and Western blots with 
MAbs KA1 and 2A4 detected Cks typical for simple epithelia (Cks 8, 18 and 19) and for 
stratified epithelia (Cks 5 and 14) (Bragulla and Homberger 2009) in 43A cells. In 43B 
cells, only focal immunoreactivity for Cks 8, 18 and 19 was found, and no 
immunoreactivity for Cks 5 or 14. Western blots showed minor amounts of Cks 8 18, and 
19 in 43B cells. In addition, 43A cells showed only irregular accumulations of vimentin 
with MAb 65EE3 near the cell nuclei, in contrast to 43B cells, which showed strong, 
fibrillar vimentin arrays that appeared to be concentrated in one or two polar clusters at the 
cell periphery. These observations were supported by Western blots, revealing a strong Mr 
54 000 band corresponding to vimentin.  
 
As these results suggested several mesenchymal characteristics in 43B cells, we further 
analysed the expression of adherens junction proteins E-cadherin and N-cadherin. Loss of 
E-cadherin and emergence of N-cadherin have been reported in vivo and in vitro in 
progression of oral SCC (Islam et al. 1996; Chen et al. 2004), and their reciprocal 
expression may be linked to EMT (Tran et al. 1999; Vandewalle et al. 2005). MAb 
HECD-1 showed reactivity for E-cadherin at the cell-cell junctions of 43A cells, whereas 
43B cells were negative. In contrast, 43A cells did not react with MAb 13A9 against N-
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cadherin, but 43B cells showed strong, serrated immunoreactivity at the cell-cell junctions. 
In Western blots, 43A cells revealed a Mr 120 000 band of E-cadherin and a faint Mr 
127 000 band of N-cadherin, whereas 43B cells showed no reaction against E-cadherin, 
but strong bands corresponding to N-cadherin. These results, including the E-cadherin to 
N-cadherin switch, indicated that 43B cells had undergone an endogenous EMT.  
7.1.2. Induction of EMT by overexpression of Snail in oral SCC cells (I) 
To further investigate the events of EMT in oral SCC cells, we transfected 43A cells with 
haemagglutinin-tagged cDNA of Snail, a transcription factor that has gained increasing 
evidence as a major inducer of EMT (Batlle et al. 2000; Cano et al. 2000). Stable Snail 
transfectants were rather difficult to establish, as the transfected cells seemed to engage 
apoptosis. This may be due to the finding that downregulation of E-cadherin via the Akt 
pathway can lead to apoptosis (Kurrey et al. 2005). Transfection efficiency was controlled 
with immunolabellings and Western blots with MAb to haemagglutinin as well as with 
newly established MAbs to Snail (Section 7.2). Stable 43A-SNA transfectants were 
manually subcloned to gain cell lines with homogeneous and high ectopic expression of 
Snail. Subcloning was supported by the finding that in uncloned cultures the cells that do 
not express the Snail transgene overpopulate the stable transfectants (Ohkubo and Ozawa 
2004). The morphology of 43A-SNA cells resembled that of 43B cells; the cells failed to 
organize compact colonies in culture and represented an elongated, fibroblastoid 
phenotype with sparse cell-cell contacts. 43A-SNA cells showed similar actin stress fibres 
as 43B cells, and immunolabellings and Western blots revealed no evidence of Cks 5 or 
14, and only traces of Cks 8, 18 and 19. Instead, 43A-SNA cells synthesized prominent 
vimentin filaments, and production of mesenchymal N-cadherin substituted that of E-
cadherin. These findings suggested that 43A-SNA cells had undergone a full EMT as a 
result of expression of Snail.  
7.1.3. Expression of E-cadherin repressors in oral SCC cells (I) 
In order to characterize which of the several possible E-cadherin repressors were present 
in 43A, 43B and 43A-SNA cells, we performed Northern blots with cDNA probes. 43A 
cells expressed a faint 5.7 kb transcript of ZEB-1 and a prominent 2.1 kb transcript of 
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Slug, but not ZEB-2 or Snail. 43B cells showed a stronger band for ZEB-1, prominent 
double bands of ca. 5.6 kb corresponding to ZEB-2, and a weaker band for Slug compared 
with 43A cells. 43B cells showed no expression of Snail. 43A-SNA cells, however, 
showed a potent 1.0 kb transcript of Snail as expected, but also bands corresponding to 
ZEB-1, ZEB-2 and Slug. These studies suggested that 43A cells expressed only a minor 
amount of ZEB-1 and a high amount of Slug mRNA, but Snail transfection in 43A-SNA 
cells augmented the expression of ZEB-1 and induced expression of ZEB-2 mRNA. 
Expression of Slug was diminished in 43B and 43A-SNA cells relative to 43A cells. As 
both ZEB-1 and ZEB-2 mRNAs were present in 43B and 43A-SNA cells, they may be 
important in EMT of oral SCC cells.  
7.2. Production and specificity of monoclonal antibodies 
against Snail (I, II) 
Next, we aimed to generate a MAb that would detect Snail protein in human cell lines and 
tissues. The hybridomas producing MAbs were created by immunizing mice with GST-
Snail fusion protein (Batlle et al. 2000) (Section 6.6). The initial screening of the 
hybridomas was performed with immunofluorescence labellings using 43A-SNA cells, 
and the hybridomas potentially producing MAbs specific to Snail were cloned. The 
specificity of the MAbs was further analysed with immunofluorescence labellings, ELISA 
and Western blots. In immunolabellings with 43A-SNA cells, MAbs 173CE2 (IgG2a) and 
173EC3 (IgG1) as well as their subclones showed strong Snail immunoreactivity in the 
nuclei, excluding the nucleoli. Only occasionally was immunoreactivity detected in the 
cytoplasm. This finding is in accordance with the previous findings of GFP-Snail 
transfected HEK293 cells (Zhou et al. 2004). No immunoreaction occurred when the 
purified MAbs were preabsorbed with GST-tagged Snail protein. Furthermore, the MAbs 
did not crossreact with Slug in immunolabellings with GFP-Slug-transfected RWP-1 
pancreatic carcinoma cells. In ELISA, the MAbs reacted only with Snail protein, and not 
with GST protein or negative controls. ELISA showed high affinity for both human and 
murine Snail proteins, and mapping of the epitope indicated that MAb 173EC3 reacted 
strongest to the 1-82 amino acid sequence of murine Snail. In Western blots of 43A, 43B 
and 43A-SNA whole-cell lysates, MAbs to Snail detected a Mr 32 000 polypeptide 
corresponding to Snail (Batlle et al. 2000) only in 43A-SNA cells. These results indicated 
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that MAbs 173CE2 and 173EC3 specifically recognize Snail protein in 
immunofluorescence labellings and Western blots of Snail-overexpressing cells.  
7.3. Localization of Snail in human and mouse cell lines and 
tissues (I, II) 
7.3.1. Localization and kinetics of Snail in cell lines (I, II) 
To determine whether Snail antibody can detect endogenous Snail in human cell lines and 
the localization of endogenous Snail in cells, we labelled several pancreatic carcinoma 
cells, i.e., AsPC-1, BxPC-3, HPAC and PANC-1, with MAb 173CE2. Among these cell 
lines, previous studies have shown that apart from PANC-1 cells, all cells synthesize and 
secrete chains of laminin-332 and express hemidesmosomal proteins (Tani et al. 1997; 
Katayama et al. 2003). On the other hand, PANC-1 cells showed only low levels of 
integrin 4 subunit and were strongly immunoreactive for N-cadherin, suggesting for an 
EMT profile (Section 7.4.1). PANC-1 cells showed heterogeneous immunoreactivity for 
Snail, whereas other pancreatic carcinoma cell lines were not reactive. The reactivity was 
strictly nuclear and excluded the nucleoli. For Western blots, we used nuclear extraction 
or pre-exposure of the cells to 10 M proteasome inhibitor MG132, which represses the 
proteasomal degradation of, e.g., transcription factors (Zhou et al. 2004). Western blots of 
PANC-1 nuclear extracts showed a Mr 32 000 polypeptide, corresponding to Snail, and 
proteasome inhibitor treatment of cell lysates for 0-5 hours revealed increased levels of the 
polypeptide. Snail protein was found also in immunolabellings and Western blots of 
proteasome inhibitor-treated human embryonal, gingival and murine NIH-3T3 fibroblasts, 
as well as in SW-620 and HT-29 M6 colon carcinoma cell lines, the latter of which 
contained an inducible Snail cDNA. These results indicated that MAbs 173EC2 and 
173CE3 are able to detect endogenous Snail in immunolabelling studies and Western 
blots.  
 
As addition of serum has been shown to induce EMT in some cell lines, e.g., in rat bladder 
carcinoma cells NBR-II (Boyer et al. 1989), we were also interested in the effect of serum 
on the levels of Snail. When gingival fibroblasts were grown in serum-depleted cell 
culture medium for 24 hours, Snail immunoreactivity was lost. Next, the levels of Snail in 
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NIH-3T3 cells were analysed with a kinetic study. After 24 hours of starvation, serum was 
re-introduced to the cells, and the amounts of Snail mRNA and protein were analysed by 
Western blots and quantitative RT-PCR at different time points (0-24 hours). At three 
hours, the levels of both Snail mRNA and protein peaked. At 24 hours, the levels of Snail 
mRNA had declined back to the initial stage, but the protein levels exceeded the control. 
These results indicated that expression of Snail is not constitutive in fibroblasts, but is 
dependent on the presence of serum.  
7.3.2. Localization of Snail in normal and malignant tissues (II) 
Because the localization of Snail protein in human and mouse tissues has remained 
obscure due to the lack of specific antibodies, MAb 173EC3 was used to analyse the 
expression of Snail by immunohistochemistry, first in mouse embryonal tissues. At E7.5, 
Snail immunoreactivity was confined mainly to the mesoderm, but also to extraembryonic 
tissues, namely, the parietal endoderm, which is derived from the primitive endoderm, and 
the ectoplacental cone, derived from the trophectoderm. At E9.5, reactivity for Snail was 
detected in the branchial arches. At E15.5, Snail immunoreactivity was strong in the cells 
of developing cartilage, as well as in the lung mesenchyme. Snail reactivity was less 
intense in the lungs of two-day-old mice. In skin, Snail reactivity was detected only in the 
mesenchymal cells of the upper layers of the dermis at E15.5, and in two-day-old mice, it 
was found around the mesenchymal cells near the hair follicle at the dermal condensate.  
 
As Snail has been suggested to induce EMT and a migratory phenotype in epithelial cells 
(Cano et al. 2000; Nieto 2002; Peinado et al. 2007), the expression of Snail was analysed 
in wound-healing of mouse skin. The wounded areas were collected from the mice 2, 3, 5 
or 7 days after wounding, and MAb 173EC3 and haematoxylin were used in 
immunohistochemical labellings of the paraffin sections. Snail immunoreactivity was 
found especially in the migrating fibroblasts infiltrating the granulation tissue. These 
activated fibroblasts (Martin 1997) showed strong nuclear immunoreactivity for Snail 
already at day 2 post-wounding, but the levels of Snail fell on day 7, when the epidermis 
had recovered. To further investigate the role of Snail in activated fibroblasts, samples 
from fibromatotic patients were studied. Fibromatosis is a condition characterized by 
lesions of proliferating and locally-infiltrating fibroblastoid cells. Heterogeneous 
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immunoreactivity for Snail was found in fibroblastoid cells throughout the lesions. 
Fibrosarcoma and sarcoma, malignant tumours of mesenchymal origin, showed strong 
nuclear Snail immunoreactivity localizing to cells with the fibroblastoid phenotype.  
 
Next, the expression of Snail was analysed in carcinoma samples, taking into account the 
results of Snail reactivity in fibroblastoid cells. In colon adenocarcinoma, Snail protein 
reactivity was detected mainly in the stroma and the bordering cells of tumour islets. 
Although the majority of Snail-positive cells showed an elongated phenotype, some cells 
located in the invasive fronts had epithelial characteristics. Samples from cervical SCC 
showed a similar finding; i.e., cells at the periphery of the tumour islands were reactive for 
Snail. Finally, colon carcinoma and laryngeal SCC sections were labelled with MAb 
173EC3 against Snail and MAb clone 36 against E-cadherin. Snail reactivity was most 
commonly found at the edges of tumour cell islands and adjacent to the stroma in both 
carcinomas. Furthermore, E-cadherin was absent from these cells, although in some single 
cells, both proteins were expressed. In these carcinomas, Snail-positive elongated cells 
were also detected in the centre of the tumours. These results indicated that MAbs 173CE2 
and 17EC3 are able to detect Snail in paraffin sections, and that Snail immunoreactivity is 
frequent in elongated, fibroblastoid cells, e.g., at the edges of skin wound, in cancers of 
mesenchymal origin and at the tumour-stroma interface of carcinomas.  
7.4. Effect of EMT on expression and production of laminins (I, 
III) 
7.4.1. Laminin-332 (I) 
Laminin-332 is synthesized by most epithelial cells and is present in BMs of many 
carcinomas (Galliano et al. 1995; Aumailley et al. 2003; Miyazaki 2006). Laminin-332 or 
its chains have been suggested to contribute to invasion of carcinoma cells; however, the 
presence of laminin-332 has usually been studied only with antibodies against laminin 2 
chain (Ziober et al. 2006). We set out to investigate the effects of EMT on the synthesis 
and secretion of laminin-332 and laminin 3, 3 and 2 chains in oral SCC 43A, 43B and 
43A-SNA cells. Synthesis of laminin-332 was first studied with polyclonal antiserum to 
laminin-332. 43A cells showed prominent cell substratum-confined immunoreactivity to 
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laminin-332, whereas early passages (p3-6) of 43B cells revealed only cytoplasmic 
reactivity. Next, we analysed more thoroughly the synthesis and deposition of laminin-332 
chains. MAb D4B5 against laminin 2 chain showed a strong cell substratum-confined 
reactivity in 43A cells and a cytoplasmic reactivity in 43B cells. When we used MAb 
GB3, which recognizes laminin 2 chain only when it is associated with laminin-332, a 
similar result was obtained in 43A cells. However, in 43B cells, no reactivity was detected 
with this MAb, suggesting that the cytoplasmic laminin 2 chain was not affiliated with 
laminin 3 and 3 chains. Next, the synthesis and secretion of laminin-332 chains were 
studied with immunoprecipitations of 43A and 43B culture media and cell lysates. 
Polyclonal antiserum against laminin-332, as well as MAbs BM2 and D4B5 against 
laminin 3 and 2 chains, all detected Mr 165 000 processed form of 3 chain, Mr 145 000 
3 chain, and Mr 155 000 unprocessed form as well as Mr 105 000 processed forms of 2 
chain in the 43A cell culture medium. MAb 12C4, which detects the unprocessed form of 
laminin 3 chain, precipitated the corresponding, unprocessed Mr 190 000 form of laminin 
3 chain together with 3 chain, and the processed and unprocessed forms of 2 chain 
only in the ECM-enriched material, but not in the cell culture medium of 43A cells. In 
immunoprecipitations of the culture medium obtained from early passages of 43B cells, 
polyclonal laminin-332 antiserum precipitated only 3 chain and the unprocessed form of 
2 chain. MAb against laminin 3 chain did not precipitate any polypeptides in the 43B 
cell culture medium. MAb against laminin 2 chain showed 3 chain and the processed 
and unprocessed forms of 2 chain. When we immunoprecipitated the cell culture medium 
from late passages of 43B cells with polyclonal antiserum to laminin-332, and MAbs to 
laminin 3 or 2 chains, as well as with polyclonal antiserum to 2 chain, no proteins were 
found. However, polyclonal 2 chain antiserum precipitated the unprocessed form of 2 
chain in 43B cell lysates. Next, we evaluated the production of mRNA in 43A and late-
passage 43B cells. Northern blots with cDNA probes showed 5.5 kb and 5.0 kb transcripts 
of laminin 3 and 2 chains only in 43A cells. After prolonged exposure, a faint transcript 
of laminin 2 chain was detected in late passages of 43B cells.  
 
These results suggested that 43A cells synthesize and secrete processed and unprocessed 
forms of laminin 3 chain, 3 chain and processed and unprocessed forms of 2 chain. 
The unprocessed 3 chain is deposited only to the ECM. Early passages of 43B cells do 
not synthesize or secrete 3 chain, but secrete 32 chain dimer. Late passages of 43B 
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cells synthesize only the unprocessed form of laminin 2 chain, which is retained in the 
cytoplasm. We also studied the synthesis of laminin-332 in 43A-SNA cells. Western blots 
detected no chains of laminin-332 in 43A-SNA cell lysates, and no immunoreactivity for 
laminin 2 chain was seen. Taken together, EMT in oral SCC cells attenuates or ceases the 
synthesis and deposition of laminin-332.  
7.4.2. Laminin-511 (III) 
As we had found that EMT had an effect on the synthesis and secretion of laminin-332, 
we hypothesized that EMT could affect the expression of other laminin chains as well. 
Next, we studied the synthesis of laminin-511, which is ubiquitously expressed in 
epithelial BMs as well as by many carcinoma cells (Miner et al. 1997; Patarroyo et al. 
2002). In Northern blots with cRNA probe, 43A cells expressed a strong 12.0 kb transcript 
of laminin 5 chain mRNA, and 43B cells expressed a slightly weaker transcript. In 43A-
SNA cells, laminin 5 chain mRNA was absent. To investigate the synthesis of 5 chain 
protein, we exposed the cells to monensin, which inhibits the intracellular protein 
transport and thus their secretion outside the cell. MAb 4C7 against laminin 5 chain 
showed a strong vesicular cytoplasmic reactivity for laminin 5 chain in 43A cells, and a 
highly reduced reactivity in 43B cells. 43A-SNA cells were negative for laminin 5 chain. 
Immunoprecipitations of cell culture media obtained from radioactively labelled cells with 
MAb against laminin 5 chain showed prominent Mr 380 000 and 390 000 bands, 
corresponding to the sizes of laminin 5 chain (Champliaud et al. 2000), together with Mr 
ca. 220 000 1 and 1 chains in 43A cells. Similar, although distinctly weaker bands of 
laminin 5, 1 and 1 chains were precipitated from 43B cell culture medium. In 43A-
SNA cells, no polypeptides were found. Secretion of laminin 2 chain was studied with 
MAb SF11 against laminin 2 chain. No laminin 2 chain was observed in 43A, 43B or 
43A-SNA cell culture media, suggesting that neither laminin-521 nor laminin-421 was 
produced. These results showed that 43A cells express laminin 5 mRNA and synthesize 
and secrete laminin-511, 43B cells secrete markedly reduced amounts of laminin-511 and 
43A-SNA cells do not synthesize or secrete laminin-511. EMT appears to downregulate 
the synthesis and secretion of laminin-511. 
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7.4.3. Laminin-411 (III) 
Next, we turned to laminin-411, which is produced mainly by cells of mesenchymal origin 
(Lefebvre et al. 1999; Petäjäniemi et al. 2002). Northern blots with cRNA probe against 
laminin 4 chain showed a 6.5 kb transcript of laminin 4 chain mRNA in 43B and 43A-
SNA cells, but not in 43A cells. Immunolabellings with MAb 168FC10 against laminin-
411 preceded by monensin treatment revealed vesicular accumulation of laminin-411 only 
in 43B and 43A-SNA cells. Immunoprecipitations of cell culture media with MAb 3H2 
against laminin-411 did not detect any polypeptides in 43A cells, but found strong Mr 
180 000 and 220 000 bands, corresponding to the sizes of 1 and 1 chains (Champliaud 
et al. 2000), in 43B and 43A-SNA cells. As the precipitates of 1 and 1 chains are of 
similar size to laminin 4 chain, we performed further studies to corroborate the presence 
of 4 chain. In immunoprecipitation of cell culture medium with MAb 113BC7 to laminin 
1 chain, followed by Western blot of the precipitated samples with polyclonal antiserum 
against laminin 4 chain, 43A cells were again negative for laminin 4 chain. However, 
prominent bands of Mr 180 000-220 000 laminin 4 chain were found in 43B and 43A-
SNA cells. The slight size variation between the bands in 43B and 43A-SNA cells was 
possibly due to different glycosylation or glycosaminoglycan modification of the 4 chain, 
as previously detected, for instance, in human endothelial, rat Schwannoma and human 
embryonal kidney cells (Talts et al. 2000; Kortesmaa et al. 2002). Thus, laminin-411 
transcription, synthesis and secretion are induced in EMT.  
 
To extend our findings of laminin 5 chain downregulation and laminin 4 chain 
upregulation by EMT, we used chromatin immunoprecipitations to evaluate whether Snail 
binds directly to the gene promoter sites of laminin 5 and 4 chains in 43A-SNA cells. 
However, because the promoter sites of laminin 5 and 4 chains are unknown (Aberdam 
et al. 2000), we first designed primers to cover areas 3000 bp upstream of their gene 
transcription start sites. Immunoprecipitation of 43A-SNA cells with MAb 173EC3 to 
Snail and PCR amplification of the precipitated chromatin showed two regions (-1890/-
1535; -1016/-572) upstream of laminin 5 chain gene and three regions (-2059/-1732; -
1339/-1007; -873/-533) upstream of laminin 4 chain gene transcription start sites that 
could potentially function as binding sites for Snail. Lastly, we screened these regions for 
E-box motifs (5´-CANNTG-3´), which are the recognized binding sequences for Snail 
(Mauhin et al. 1993). Laminin 5 chain promoter region precipitate -1890/-1535 contained 
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one CAGGTG E-box, and the -1016/-572 precipitate contained two CAGGTG and two 
CAGCTG E-boxes. Laminin 4 chain promoter region precipitate -1339/-1007 contained 
one CAGGTG E-box, and the -873/-533 precipitate contained one CAGCTG E-box. The -
2059/-1732 precipitate contained one CAGGTA Z-box, but no E-boxes; however, this 
sequence with only a single nucleotide deviation from E-box, CAGGTGCAGGTA, has 
been shown to bind other Snail- and EMT-related transcription factors (Spaderna et al. 
2006). Taken together, these results suggested that Snail binds to specific regions 
upstream of both laminin 5 and 4 chain genes and may directly control their expression.  
7.5. Expression and distribution of cell surface receptors in 
EMT (I, III) 
7.5.1. Integrin 64 (I, III) 
Integrin 64 is an important part of the hemidesmosomal complex and connects the 
intermediate filaments to the BM and laminin-332 (Nievers et al. 1999; Kikkawa et al. 
2000). It has also been reported to bind laminin-511 outside hemidesmosomes (Kikkawa 
et al. 2000; Pouliot et al. 2001). Owing to these qualities, integrin 64 is considered a 
hallmark of the epithelial phenotype. 43A cells showed strong cell surface-confined 
immunoreactivity for both integrin 6 and 4 subunits. However, the reactivity was 
excluded from certain spot-like areas, a hemidesmosomal pattern described as “Swiss 
cheese” immunoreactivity (Spinardi et al. 1995). In 43B and 43A-SNA cells, cell surface 
reactivity for integrin 6 subunit was irregular and did not organize in a hemidesmosome-
like pattern. MAb AA3 to integrin 4 subunit showed scattered reactivity in 43B cells, 
which was absent in 43A-SNA cells. Concerning other hemidesmosomal proteins (Litjens 
et al. 2006), MAb HD-121 against HD1/ plectin showed hemidesmosomal reactivity in 
43A cells, whereas the protein had redistributed adjacent to cytoplasmic fibrils in 43B 
cells. In addition, MAb 233 against BP180 showed reactivity for hemidesmosomes only in 
43A cells. These results suggested that 43A cells synthesize laminin-332 and laminin-511 
and produce their receptor integrin 64. In EMT-experienced 43B cells, the production of 
laminin-332 and -511 is diminished, and in 43A-SNA cells, the production has ceased 
together with their corresponding integrin receptors.  
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7.5.2. Integrin 61 (III) 
As our immunolocalization studies suggested that hemidesmosomal complexes were 
disintegrated in EMT-experienced 43B and 43A-SNA cells, and that immunoreactivity for 
integrin 4 subunit was decreased, we searched for the integrin subunit that could bind the 
still present integrin 6 subunit. Immunoprecipitation studies with MAb GoH3 against 6 
showed Mr 140 000 and 210 000 bands in 43A cells, which corresponded to integrin 6 
and 4 subunits. 43B cells showed similar, although fainter bands, suggesting that some 
integrin 6 subunit was still dimerized with integrin 4 subunit in these cells. In 43A-SNA 
cells, however, MAb against 6 precipitated a Mr 110 000 band, corresponding to integrin 
1 subunit, suggesting a switch from 64 to 61 in EMT. In line with their laminin 
synthesis profile, 43A-SNA cells hence produce integrin 61, which is one of the few 
established receptors for laminin-411 (Kortesmaa et al. 2000; Fujiwara et al. 2001).  
7.5.3. Integrin 11 (III) 
As the results showed that one mesenchymal integrin, 61, was present in 43A-SNA cells, 
we also searched for other candidates, namely integrin 11. This integrin is considered 
mainly a collagen-binding integrin detected primarily in mesenchymal cells and tissues 
such as smooth muscle cells, kidney mesangial cells and fibroblasts (Hemler et al. 1984). 
Immunoprecipitations with MAb 102DF5 against integrin 1 subunit revealed a strong Mr 
110 000 band, corresponding to integrin 1 subunit, in 43A, 43B, and 43A-SNA cells. 
Several  subunits were precipitated with the 1 subunit in all cells. Immunoprecipitation 
of 43A, 43B and 43A-SNA cells with MAb TS2/7 against integrin 1 subunit showed Mr 
200 000 and 110 000 bands, corresponding to integrin 1 and 1 subunits, only in 43A-
SNA cells.  
7.5.4. Integrin-linked kinase (III) 
ILK functions as an adaptor between 1, 2 and 3 integrin subunits and the actin 
cytoskeleton (Hannigan et al. 1996; Li et al. 1999; Guo and Giancotti 2004). ILK is a 
component of focal adhesion plaques and its activity is modulated by cell-ECM 
interactions (Hannigan et al. 1996; Li et al. 1999; Mulrooney et al. 2000). MAb against 
ILK showed no immunoreactivity in 43A cells. In 43B and 43A-SNA cells, strong ILK 
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reactivity was found at streak-like structures resembling focal adhesions. In Western blots, 
ILK was absent in 43A cells, but prominent Mr 59 000 bands, corresponding to ILK 
(Somasiri et al. 2001), were detected in 43B and 43A-SNA cell lysates.  
7.5.5. Lutheran glycoprotein (III) 
To further study the EMT-induced downregulation of laminin-511, we examined the 
presence of Lutheran, which is a specific receptor for laminin 5 chain (Kikkawa and 
Miner 2005). MAb BRIC221 to Lutheran showed strong immunoreactivity in 43A cells at 
the cell surface. However, 43B cells showed a markedly weaker and irregular 
immunoreactivity for Lutheran. 43A-SNA cells were completely devoid of Lutheran 
reactivity. These results were confirmed with immunoprecipitations using polyclonal 
antiserum against Lutheran. Strong levels of Mr 85 000 isoform of Lutheran (Parsons et al. 
2001) were present in 43A cells, whereas low levels were found in 43B cell lysates, and 
no Lutheran was present in 43A-SNA cells. These results suggested that in conjunction 
with the decreasing levels of laminin-511, its receptor Lutheran is also lost in EMT.  
7.6. Adhesion of oral SCC cells to different ECM substrata (III) 
To address the potential functional role of laminins in the adhesion of oral SCC cells, we 
measured the adhesion efficiencies of 43A, 43B and 43A-SNA cells to fibronectin, 
laminin-511 and laminin-411. Wells of 96-well plates were coated with these proteins and 
the cells were allowed to adhere in the presence of cycloheximide, which prevents 
synthesis of endogenous proteins. In quantitative cell adhesion assays, 43A, 43B and 43A-
SNA cells adhered strongly to 5 g/ml fibronectin and 4 g/ml laminin-511, as expected. 
However, adhesion of the cells to 4 g/ml laminin-411 was minimal and significantly 
lower than to fibronectin or laminin-511 (P<0.001). As the cells encounter laminin-411 in 
combination with other ECM molecules in vivo, we investigated whether laminin-411 
would be anti-adhesive when the cells are allowed to attach to an otherwise adhesive ECM 
component. We coated the wells with increasing amounts of laminin-411 (1-20 g/ml) 
together with 5 g/ml fibronectin or 4 g/ml laminin-511. Laminin-411 significantly 
decreased the adhesion efficiency of 43A, 43B and 43A-SNA cells to fibronectin already 
at the concentration of 5 g/ml (P<0.001). Laminin-411 concentration of 20 g/ml 
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inhibited the adhesion of 43A and 43B cells to fibronectin totally and the adhesion of 
43A-SNA cells by 60%. Laminin-411 concentration of 20 g/ml inhibited the adhesion of 
43A cells to laminin-511 slightly (P=0.06) and the adhesion of 43B and 43A-SNA cells 
significantly (P<0.001 for both). To address the possibility that laminin-411 would 
interfere with the adhesion to other proteins by binding to them, we performed 
immunoprecipitations. Immunoprecipitation of cell culture medium of 43B cells with 
MAb to laminin-411, followed by Western blot with polyclonal antiserum against 
fibronectin precipitated a Mr 220 000 band, corresponding to the size of fibronectin. These 
findings suggested that laminin-411 may interact with fibronectin by direct binding, thus 
compromising cell adhesion to it.  
7.7. Effect of EMT on cell invasion, migration and wound-
healing (III, IV) 
To assess the changes induced by EMT in cell invasion, we seeded the cells on Matrigel-
coated Boyden chambers and let the cells grow and invade for 24 hours. 43A cells grew in 
Matrigel as epithelioid cell islands with close cell-cell contacts, whereas 43B cells and 
especially 43A-SNA cells showed only small amounts of cell-cell contacts. Invasion of 
43B and 43A-SNA cells was significantly increased relative to 43A cells (P<0.001 for 
both). 43B cells invaded to the lower Boyden chamber in amounts that were fivefold 
greater than those of 43A cells, whereas 43A cells were practically non-invasive. The 
invasion ability of 43A-SNA cells, on the other hand, was fiftyfold greater than that of 
43A cells. When we examined the cytoskeletal structures of the cells with rhodamine 
phalloidin labelling, 43A and 43B cells, but not 43A-SNA cells, showed dot- or string-like 
actin-based accumulations on their ventral cell membranes that resembled podosomes and 
invadopodia, respectively (Lehto et al. 1982; Chen et al. 1994).  
 
Next, we focused our interest on the actin-based structures in 43A and 43B cells. We then 
studied the migration of 43A and 43B cells and the presence of actin-based accumulations, 
first with in vitro wound-healing experiments. At two hours after wounding, stationary 
43A cells were tightly attached to each other and showed a purse-string morphology, with 
actin filament cables extending from cell to cell at the wound margin, a situation detected 
previously in closure of corneal wounds (Danjo and Gipson 1998). After 24 hours, 43A 
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cells migrated as a common sheet of cells, maintaining close contacts at the leading edge 
and showing lamellipodial extensions. Rhodamine phalloidin labelling showed actin as 
podosome-like structures in 43A cells both at the wound border and in adjacent cells in the 
following cell rows. In 43B cells, ventral actin accumulations were present at all time 
points, although their appearance differed from those in 43A cells. 43B cells showed cell 
protrusions already after two hours of wounding. After 24 hours, 43B cells migrated as 
individual, elongated cells and showed actin-rich cell extensions with clubbed tips at their 
leading and trailing edges. When 100 ng/ml EGF was applied to induce cell migration, 
43A cells again assembled similar actin-based accumulations. Only a few cells escaped 
the cell front and migrated as single cells. Migration ability of 43A cells did not transform 
the actin structures to resemble those in 43B cells.  
 
To study the effects of EMT and the actin-based structures on random cell migration, the 
cells were followed with fluorescence time-lapse imaging for 10 hours. The mean 
trajectory length of 43A cells was 66±9.0 m, whereas in 43B cells it was 339±23.7 m. 
Thus, the trajectories of 43B cells were significantly longer than those of 43A cells 
(P<0.0001). The migration distance of both cells increased linearly with time. However, 
when we calculated the ratio of the total trajectory length and the distance between the end 
and start points of the trajectory, we found that the mean ratio of 43A cells was 54±14.7, 
whereas in 43B cells it was 12±1.8. This result indicated that the trajectories of 43A cells 
were highly convoluted relative to 43B cells (P=0.0050), revealing a rotatory movement in 
which 43A cells remained virtually stationary. On the other hand, the small ratio of 43B 
cells suggested that the cells migrated in a more directed fashion (Figure 9).  
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Figure 9. The trajectories of 43A and 43B cells in a 10-hour follow-up. Random cell migration of 
43A and 43B cells was examined with epifluorescence wide-field time-lapse 
microscopy. The trajectories of 43A cells were short and the cells remained immobile. 
The trajectories of 43B cells were fivefold longer than those of 43A cells. The mean 
velocity of 43A cells was 5.5±1.2 m/h and of 43B cells 19.5±2.7 m/h. Scale bar, 20 
m.  
We then analysed the number of actin-based structures in 43A and 43B cells. In a 48-hour 
assay, the majority of both cells (43A 86±1.9% and 43B 98±1.8%, P<0.001) formed actin 
accumulations on a glass matrix. To address the question of whether the ECM substrate 
has an effect on the formation of actin structures (Moreau et al. 2006), the cells were 
seeded on glass coverslips coated with type I collagen, fibronectin, laminin-332 or 
laminin-511. We detected no significant change in the morphology of actin accumulations 
in 43A or 43B cells as a function of ECM substrates. However, 43B cells formed less 
actin accumulations on fibronectin than on a plain glass matrix (90.2±2.5% vs. 97.9±1.8%, 
P<0.05).  
7.8. Effect of EMT on structural proteins of podosomes and 
invadopodia (IV) 
As cytoskeletal F-actin had a diverse distribution in 43A and 43B cells, we next studied 
whether the cytoplasmic actin accumulations were indeed podosomes and/or invadopodia. 
Podosomes and invadopodia are columnar actin-based cell adhesion structures that also 
elicit ECM degradation (Tarone et al. 1985; Chen et al. 1994). We seeded the cells on 
fluorescently labelled gelatin and studied the spatial and temporal organization of actin 
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and proteolysis of gelatin. After two hours of seeding, 43A cells showed actin in 
rhodamine phalloidin labellings as dot-like accumulations at the ventral cell membrane. 
The accumulations colocalized with proteolytic areas in the fluorescently labelled gelatin. 
In contrast, 43B cells showed actin in a more irregular manner, and the accumulations 
were more numerous and seemed smaller. 43B cells also showed membrane extensions 
that colocalized with the degradation cavities in gelatin. After five hours of seeding, the 
actin-based cell extensions in 43B cells had changed in shape. Now, the membrane 
extensions had gained club-like endings, which also localized at the gelatin cavities. In 
EGFP-actin-transfected 43B cells, we detected multiple narrow, tail-like projections of 
actin both inside and outside the cell. These structures could be seen in phase-contrast 
microscopy as dark dots and filaments near the basal cell surface. The morphology of 43A 
and 43B cells was further studied with FESEM. Broad lamellipodia and membrane-
bulging nuclei were characteristic of epithelioid 43A cells. 43B cells, on the other hand, 
were covered with small round membrane buds and slender cell extensions that showed 
enlargement at the tips.  
 
Taken together, the actin accumulations showed colocalization with degradation cavities 
in both cells, although their mutual morphology was diverse. The actin structures in 43A 
cells were similar to dot-like podosomes detected in, e.g., rat bladder carcinoma cells 
(Spinardi et al. 2004; Spinardi and Marchisio 2006), whereas the cytoplasmic organization 
of actin in EMT-experienced 43B cells showed twisted, tail-like structures that resembled 
those of invadopodia in melanoma cells (Baldassarre et al. 2006). The club-ended cell 
extensions in 43B cells differed from filopodia or other previously described cell 
structures.  
 
Next, we studied which structural proteins would localize to podosomes, invadopodia and 
cell extensions in 43A and 43B cells. Podosomes usually consist of an inner actin core 
surrounded by a peripheral ring with adhesion and linker proteins, although the molecular 
interrelationship between the core and ring is controversial (Linder and Aepfelbacher 
2003). Invadopodia do not have such a well-defined organization, and there is no clear 
division of core and ring (Weaver 2006). We used EGFP-actin-transfected cells or double-
labellings with previously characterized podosome-related proteins (Arp 2/3, cortactin) to 
assure the localization to podosomes or invadopodia. HD1/ plectin immunoreactivity, 
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detected with MAb HD-121, was confined to hemidesmosomes as well as to podosome 
rings of EGFP-actin-transfected 43A cells. In 43B cells, reactivity was not found at the 
invadopodia, but localized to cytoplasmic fibrils. II-spectrin localized to podosome rings 
in 43A cells, whereas in 43B cells only a diffuse, cytoplasmic reactivity was detected with 
MAb 101AA6 that did not localize to invadopodia. Arp 2/3 localized to podosome cores 
and covered the heads and tails of invadopodia. In double-labellings with polyclonal Arp 
2/3 antiserum, talin was found only in the podosome rings of 43A cells. MAb MCA725S 
showed talin in focal adhesions in both cell types. Cortactin immunoreactivity was 
confined to podosome cores in 43A cells, the heads and tails of invadopodia and to the 
club-ended cell extensions in 43B cells. In double-labellings with MAb 4F11 to cortactin, 
vinculin was found at the podosome rings in 43A cells as well as in the invadopodia and 
cell extensions in 43B cells. Furthermore, polyclonal vinculin antiserum showed 
immunoreactivity in focal adhesions in 43B cells. As talin is considered a major 
intracellular adaptor mediating adhesion between the cell membrane and the cytoskeleton 
(Critchley 2004; Le Clainche and Carlier 2008), we next studied which other proteins 
could take its place in 43B cells. We turned to tensin, which has been implicated in 
capping the barbed ends of actin filaments (Le Clainche and Carlier 2008; Legate and 
Fässler 2009). Tensin immunoreactivity, detected with MAb Clone 5, was distributed 
diffusely in the cytoplasm of 43A cells, but did not localize to podosomes. In 43B cells, 
however, tensin was detected in invadopodia and cell extensions. MAb 2A7 to focal 
adhesion kinase (FAK) showed immunoreactivity in focal adhesions and podosome rings 
in 43A cells, whereas it was found only in focal adhesions in 43B cells. In Western blots 
of 43A and 43B cells, equal amounts of Mr 500 000 plectin, Mr 240 000 II-spectrin, Mr 
225 000 talin and Mr 117 000 vinculin were detected. Double bands of Mr 80 000 and 
85 000, corresponding to cortactin, and Mr 200 000 band of tensin were found in both 43A 
and 43B cell lysates. Immunoprecipitation of FAK, followed by Western blot with MAb 
PY20 to phosphotyrosine, detected a strong Mr 125 000 band in 43A cells and a lighter 
band in 43B cells.  
 
As podosomes and invadopodia have been reported to contain integrins that may have a 
role in adhesion or in gathering other proteins to the cell membrane (Marchisio et al. 1988; 
Mueller et al. 1999; Deryugina et al. 2001; Pfaff and Jurdic 2001; Weaver 2006), we set 
out to study which integrin subunits localize to these structures in 43A and 43B cells. To 
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ensure the localization to podosomes or invadopodia, the cells were transfected with 
EGFP-actin and labelled with appropriate antibodies. Integrin 3 subunit immunoreactivity 
was enriched in 43A cells around the actin cores of podosomes. In 43B cells, integrin 3 
subunit localized at the cell membrane surrounding the invadopodia as well as at the cell 
extensions. A highly similar reactivity was found when the cells were labelled with MAb 
102DF5 against integrin 1 subunit. Immunoprecipitation experiments with MAb J143 
against integrin 3 subunit detected strong bands of Mr 150 000 and 110 000, 
corresponding to the sizes of integrin 3 and 1 subunits, in both cells. The same result was 
obtained with immunoprecipitations with MAb against 1 subunit, suggesting the presence 
of integrin 31 heterodimer in 43A and 43B cells. Integrin v5 is linked to cell migration, 
for instance, in wound-healing (Gailit et al. 1994). Integrin v subunit immunoreactivity 
localized only to focal adhesions in 43A cells. In 43B cells transfected with EGFP-actin, 
integrin v subunit was found at the focal adhesions, but also at the heads of actin-based 
invadopodia. Integrin 5 subunit immunoreactivity was faint in 43A cells and was not 
detected in podosomes. In contrast, integrin 5 subunit localized to the heads of 
invadopodia in 43B cells, as well as to point and focal adhesions. Immunoprecipitation of 
surface-labelled cells with MAb LM 142.69 against integrin v subunit showed a faint, Mr 
150 000 band in 43A cells, corresponding to integrin v subunit, and MAb 1A9 against 
integrin 5 subunit showed again a faint Mr 100 000 band, corresponding to integrin 5 
subunit. In contrast, both MAbs against integrin v and 5 subunits precipitated two strong 
bands in 43B cells, being congruent with the immunolocalization studies, and suggesting 
that v and 5 are binding partners.  
 
Cell adhesion, migration and invasion mediated by podosomes and invadopodia are 
suggested to occur through formation of membrane protrusions (Chen et al. 1994; Linder 
and Aepfelbacher 2003). Therefore, we studied the localization of pacsin 2, which through 
its F-BAR domain has been implicated in inducing tubulation of cell membranes 
(Qualmann and Kelly 2000; Heath and Insall 2008). Pacsin 2 was detected at the 
peripheral rings surrounding 43A cell podosomes. It was not detected in 43B cells. 
Furthermore, we studied the expression of filamin A, which is a potential binding partner 
for pacsin 2 in focal adhesions (Nikki et al. 2002). Strong immunoreactivity for filamin A 
was found at the podosome cores in 43A cells. In 43B cells, we found a temporal shift in 
filamin A protein expression. 43B cells organize invadopodia and produce ECM 
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degradation on fluorescently labelled gelatin matrix in two hours. During this time filamin 
A did not accumulate in invadopodia. Only after 15 hours could filamin A be detected in 
some cells harbouring invadopodia. Next, we transfected the cells with EGFP-filamin A in 
order to study whether or not the overexpression of filamin A had an effect on the 
localization of pacsin 2. EGFP-filamin A did not induce accumulation of pacsin 2 in 
invadopodia. In Western blots, the protein levels of Mr 56 000 pacsin 2 and Mr 280 000 
filamin A, detected with polyclonal pacsin 2 antiserum and MAb PM6/317 to filamin A, 
were equal in both cell lines.  
 
As one of the major functions of podosomes and invadopodia is suggested to be ECM 
degradation (Weaver 2006; Clark et al. 2007; Linder 2007; Weaver 2008), we studied 
which proteases would localize to podosomes and invadopodia. When the cells were 
seeded on fluorescently labelled gelatin, MT1-MMP expression was found in podosomes, 
invadopodia and cell extensions. MT1-MMP also localized to the degradation cavities in 
gelatin. Western blots with MAb LEM-2/15 confirmed the expression of Mr 50 000 MT1-
MMP in both cell lines. MMP-2 and MMP-9 antisera showed vesicular immunoreactivity 
in both cells, but no specific localization to podosomes or invadopodia. The results of 
immunolocalization studies are summarized in Study IV, Table 2.  
7.8.1. Morphologic and proteolytic differences between podosomes and 
invadopodia (IV) 
To characterize the differences between podosomes and invadopodia further, we used 3D 
confocal imaging combined with in situ zymography assays. The cells were seeded on 
fluorescently labelled gelatin and allowed to adhere and organize podosomes and 
invadopodia for 2-6 hours. These time points were chosen to ensure that the cells had 
properly adhered and to prevent excess cell migration and cell division. Actin filaments 
were visualized with rhodamine phalloidin and the nuclei with TO-PRO-3. At four hours, 
43A cells formed significantly less (P<0.001) podosomes per cell than 43B cells formed 
invadopodia (12.3±0.7 vs. 32.4±1.6). The vertical actin columns were wide in 43A cells, 
whereas they were narrow and tail-like in 43B cells. The columns in both cells protruded 
into the gelatin matrix. The relative volumes of podosomes, measured from 3D rendered 
confocal images, increased significantly in 2-6 hours (from 0.37±0.09 m3 to 1.05±0.14 
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m3, P<0.05), whereas the sizes of invadopodia increased only slightly (from 0.17±0.03 
m3 to 0.40±0.03 m3, P>0.05). The volumes of podosomes were significantly larger than 
the volumes of invadopodia at 4-6 hours (P<0.01 for both). We also analysed in more 
depth the amount of gelatin degradation produced by the cells. 43A cells produced 
resorption areas that corresponded to the shapes of the round actin cores of podosomes. 
43B cells, however, produced cavities of various shapes and sizes. 43B cells produced a 
significantly greater number of cavities per cell than 43A cells (126±13.6 vs. 70±12.1, 
P<0.01). Furthermore, the degradation area per cell was significantly larger under 43B 
cells than under 43A cells (231±36.1 m2 vs. 118±18.1 m2, P<0.01).  
7.8.2. Dynamic differences between podosomes and invadopodia (IV) 
The dynamics of podosomes and invadopodia in EGFP-actin-transfected cells was first 
studied with wide-field epifluorescence microscopy. In 30-minute time-lapse imaging, 
43A cells showed dot-like podosomes that were immobile and highly stabile structures. 
43B cells, on the other hand, showed numerous tail-like actin arrays that moved in a 
circular manner around their attachment sites at the basal cell membrane. Although 
vigorous rotation was detected at these invadopodia tails, the life-span of the whole 
invadopodia complex seemed long. Similar findings were obtained with EGFP-cortactin 
transfections. “Externalized invadopodia” could be detected in the retracting sides of cells 
as well as at the boundaries between two cells. Furthermore, we observed events in which 
the heads of invadopodia were released from their attachment to the basal cell membrane 
and the tails moved across the cytoplasm and eventually disappeared. When the migration 
of 43A cells was induced with EGF treatment, the podosomes were quickly assembled and 
disassembled as the cells moved. However, their morphology remained the same, 
indicating that the transformation from podosomes to invadopodia was not due to 
augmented migration activity. Next, we used TIRF microscopy to more accurately follow 
the events at the narrow, 100-200 nm evanescent field of the basal cell membrane. In 12-
hour time-lapse TIRF imaging, 43A cell podosomes were again long-lived. A halo of 
EGFP-actin was found around podosomes, possibly consisting of actin monomers. When 
podosomes were left outside the cell membrane as a result of cell migration, they were 
quickly disassembled. In 43B cells, TIRF microscopy showed that the heads of 
invadopodia were attached to the basal cell membrane. The tails, however, were only 
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partially visible due to the narrow imaging plane. The cell extensions showed constant 
movement of EGFP-actin molecules. The invadopodia in 43B cells were not surrounded 
by actin halos similar to those seen in 43A cells.  
 
The assembly of podosomes has been suggested to rely on an intact actin network, but 
also microtubules are required in some cells (Linder et al. 2000b; Evans et al. 2003). We 
treated the cells with cytochalasin B, which inhibits actin polymerization, and followed the 
events with wide-field time-lapse imaging for 30 minutes. The actin cytoskeleton of both 
cells disrupted rapidly and resulted in cytoplasmic aggregates. The podosomes, 
invadopodia, or cell extensions remained in place (Lehto et al. 1982; Akisaka et al. 2001; 
Spinardi et al. 2004), and no new podosomes or invadopodia developed during this time. 
When we treated the cells with demecolcine to depolymerize the microtubule system, the 
effects were even less pronounced, and podosomes, invadopodia, and cell extensions 
remained. A combination treatment with cytochalasin B and demecolcine resulted in the 
same outcome as cytochalasin B treatment alone. As organization of podosomes and 
invadopodia has been suggested to occur without new protein synthesis (Tarone et al. 
1985; Linder and Aepfelbacher 2003), we applied cycloheximide to block the synthesis of 
new proteins. No new podosomes or invadopodia emerged in the 60-minute follow-up. 
These results suggested that microtubules, actin filaments and de novo synthesis of 
proteins are needed in these cells for successful podosome assembly.  
 
Finally, to obtain information about the turnover of structural proteins in podosomes, 
invadopodia and cell extensions, we used FRAP experiments and transfections with 
EGFP-actin, EGFP-cortactin or EGFP-filamin A. After photobleaching (n=25), the plateau 
of fluorescence recovery for EGFP-actin was reached in podosomes in 64.4±5.2 s and in 
invadopodia after a significantly longer time (80.6±5.5 s; P<0.05). Half-time of recovery 
for EGFP-actin was 8.0±0.6 s in 43A podosomes, whereas it was significantly longer in 
43B invadopodia (10.5±1.0 s; P<0.05). The mobile fraction of EGFP-actin in invadopodia 
was significantly smaller (92%, P<0.001) than the total recovery in podosomes. We also 
analysed the turnover of EGFP-actin in 43B club-ended cell extensions (n=9). After 
photobleaching, the recovery was slower in the cell extensions than in the cytoplasmic 
invadopodia; the plateau of recovery was reached in 74.4±16.5 s, the half-time of recovery 
was 11.9±3.2 s and the mobile fraction was 63%. Next, we measured the turnover of 
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EGFP-cortactin (n=25). The plateau of recovery was reached in 22.0±4.7 s in 43A cells 
and significantly slower in 43B cells (103.1±6.2 s; P<0.0001). The half-time of recovery 
for cortactin was 2.4±0.5 s in 43A podosomes, whereas it was 8.4-fold slower in 43B 
invadopodia (20.1±2.3 s; P<0.0001). The mobile fractions were 100% and 95%, 
respectively. After photobleaching of EGFP-filamin A (n=25), the plateau of recovery was 
reached rapidly in both cells (43A 35.2±3.0 s vs. 43B 44.2±4.1 s). The half-time of 
recovery was again significantly faster in podosomes than in invadopodia (3.8±0.2 s vs. 
5.1±0.5 s; P<0.05), and the mobile fractions were 100% and 98%, respectively. Taken 
together, photobleaching experiments showed faster reorganization of EGFP-actin, EGFP-
cortactin and EGFP-filamin A in podosomes than in invadopodia. Furthermore, the cell 
extensions in 43B cells were also replenished with new molecules, which may, at least in 
part, indicate their active involvement in cell migration and invasion in EMT-experienced 
43B cells.  
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8 DISCUSSION 
8.1. Snail-dependent and -independent EMT in oral SCC cells  
Oral SCC is a highly invasive cancer with a poor prognosis (Greer 2006; Ziober et al. 
2006). The mechanisms of oral SCC progression are known only partially, and due to the 
malignant nature of oral SCC, research focusing on its detection and molecular 
characteristics is required. One of the culprits of progression of carcinomas may be EMT 
(Guarino et al. 2007; Peinado et al. 2007; Yang et al. 2007; Yanjia and Xinchun 2007). 
The first aim of this study was to analyse the characteristics of cell lines obtained from the 
oral SCC primary tumour and from its recurrence. 43A cells showed an epithelial 
phenotype, i.e., round, flattened morphology, close contact with neighbouring cells and 
circumferential actin filaments. 43B cells were more fibroblastoid-like cells with less 
prominent cell-cell adhesions complexes and strong actin stress fibres. The majority of 
intermediate filaments in 43A cells were cytokeratins. Only in 43B cells did we detect 
prominent fibrillar arrays of vimentin filaments, which have previously been connected to 
a malignant phenotype of oral SCC (de Araujo et al. 1993; Islam et al. 2000). Since the 
intermediate filaments express distinct mechanical properties, these switches may affect 
the overall ability of the cells to change shape, migrate and establish cell-cell contacts 
(Savagner 2001).  
 
The adherens junctions of 43A cells were enriched with E-cadherin, which is one of the 
classic epithelial hallmarks and is considered to be one of the tumour-suppressor genes 
(Vleminckx et al. 1991; Perl et al. 1998; Semb and Christofori 1998; Van Aken et al. 
2001). Loss of E-cadherin is an indicator of poor prognosis in several cancers, including 
oral SCC (Schipper et al. 1991; Chow et al. 2001; Lim et al. 2004; Diniz-Freitas et al. 
2006). 43B cells were devoid of E-cadherin, but showed N-cadherin immunoreactivity, 
suggestive of an E-cadherin/ N-cadherin switch (Islam et al. 1996; Cavallaro et al. 2002; 
Cavallaro and Christofori 2004; Maeda et al. 2005b). Furthermore, loss of E-cadherin and 
acquisition of fibroblastoid morphology indicated that 43B cells had experienced EMT. 
By failing to maintain the stable connections to other epithelial cells via E-cadherin, the 
EMT-driven cells may be released from their positions (Thiery 2002; Thiery 2003). 
Ectopic expression of Snail in 43A-SNA cells resulted in a highly similar, but even more 
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pronounced EMT relative to 43B cells. Immunolabellings and Western blots showed 
cadherin switching in conjunction with a morphological change to strictly fibroblastoid 
phenotype, drastic reduction of cytokeratins and accumulation of vimentin (Boyer et al. 
1989). With these cell lines, we further studied the role of EMT in oral SCC.  
 
E-cadherin is mainly downregulated in EMT through transcriptional repression (Van Aken 
et al. 2001; Christofori 2003). Northern blots showed that 43A cells expressed transcripts 
for ZEB-1 and Slug, whereas 43B cells expressed prominently ZEB-1, ZEB-2 and Slug. 
The transcription factors present in 43A-SNA cells, in addition to Snail, were similar to 
the EMT-driven 43B cells. These results suggested, first, that the faint expression of ZEB-
1 or the strong expression of Slug was not sufficient to repress E-cadherin and induce 
EMT in 43A cells, second, that ZEB-1 and ZEB-2 were most probably responsible for the 
endogenous EMT in 43B cells, and third, that ectopic Snail could upregulate the levels of 
transcription factors ZEB-1 and ZEB-2 in 43A-SNA cells. Considering 43B cells, ZEB-2 
is linked to lower survival rates in oral SCC (Maeda et al. 2005a). In other cell systems, 
Snail has been shown to stimulate expression of other transcription factors such as ZEB-1 
or Ets-1 (Guaita et al. 2002; Taki et al. 2006). ZEB-2 is unable to induce the levels of 
ZEB-1 or Snail (Taki et al. 2006), suggesting that Snail is a stronger trigger for EMT. Slug 
has been considered a weaker repressor of E-cadherin than Snail (Bolós et al. 2003), a 
conclusion supported by our studies.  
 
Next, we used the epithelial 43A and fibroblastoid 43B and 43A-SNA SCC cells 
expressing endogenous or exogenous EMT in search of new, potential signs of EMT. Loss 
of BM components is considered an important step towards tumour malignancy (Bosman 
et al. 1992; Ingber 2002; Kalluri 2003). Immunoprecipitations and immunofluorescence 
labellings showed that 43A cells prominently synthesized and secreted all chains of 
laminin-332 into the culture medium and ECM. In EMT-experienced 43B cells, synthesis 
of laminin 3 chain mRNA and protein ceased in early-passage cells, and the cells 
secreted laminin 32 chains to the culture medium. Only unprocessed laminin 2 chain 
was finally synthesized in late-passage 43B cells, but was not secreted. In 43A-SNA cells, 
we found neither synthesis nor secretion of laminin-332 chains. The polymerization of 
laminin chains is guided primarily by the  chain (Matsui et al. 1995b; Yurchenco et al. 
1997). Apart from the  chain, it seems that  and  chains may play roles in cancer. For 
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instance, in colorectal carcinoma, the budding cells in the invasive fronts have been shown 
to have immunoreactivity for laminin 32 chains (Sordat et al. 1998). In their study, 
laminin 3 chain was only weakly present in fragmented BMs of poorly differentiated 
carcinomas and metastases. It was concluded that laminin 32 chains could mark the 
transition from a stationary to an invading phenotype (Sordat et al. 1998). On the other 
hand, presence of laminin 2 fragments in circulation of pancreatic carcinoma patients has 
been suggested to predict malignant tendency (Katayama et al. 2003; Miyazaki 2006). It 
seems that the expression of laminin 2 chain could be regulated by -catenin signalling, 
which represents one of the EMT pathways (Hlubek et al. 2001). However, it remains 
unclear how intracellular laminin chains affect cell functions. For instance, laminin 2 
chain harbours binding sites for EGF, through which it has been proposed to promote 
invasion and migration (Katoh et al. 2002). Our results showed that in EMT of oral SCC 
cells, the synthesis, secretion and deposition of laminin-332 chains were progressively 
downregulated. Furthermore, pancreatic carcinoma cells with endogenous Snail reactivity 
did not synthesize laminin-332, although this laminin was ubiquitously expressed in Snail-
negative pancreatic carcinoma cells. Corroborating our findings concerning the effects of 
EMT on laminins, later studies have implicated ZEB-1 in downregulating the expression 
of laminin-332 in colorectal carcinoma (Spaderna et al. 2006).  
 
Our results showed that the distribution and amount of integrin 64, a receptor for 
laminin-332, were affected in EMT. Integrin 64 is a part of the hemidesmosomal 
complex and is essential for a polarized phenotype and for organization and maintenance 
of the normal epithelial structure (Tamura et al. 1990; Litjens et al. 2006). 43A cells 
organized hemidesmosomal complexes with reactivity for integrin 4 subunit and linker 
proteins HD1/ plectin and BP180 antigen. However, the amount of integrin 4 subunit was 
highly reduced in 43B cells, and it was found only sparsely at the cell membrane in a 
streak-like distribution. HD1/ plectin had changed its normal localization and was now 
attached to other cytoplasmic fibres, probably vimentin, and BP180 was lost. In 43A-SNA 
cells, integrin 64 was not detected at all. In the epidermis, integrin 64 has been 
suggested to mediate mainly pro-adhesive signals. The cytoplasmic tail of integrin 4 
subunit enables the connection between Ck filaments and laminin-332 (Tamura et al. 
1990; Nievers et al. 1999). The proteolytic cleavage of laminin 3 chain appears to induce 
a change towards a form that actively binds integrin 64 and enables stable adhesion 
  94
(Goldfinger et al. 1999; Miyazaki 2006). Although some cancers have upregulated 
integrin 64 levels, disappearance of integrin 64 in conjunction with loss of BM 
components have been reported in invasive margins of oral SCC (Downer et al. 1993; 
Jones et al. 1993; Tani et al. 1996). Marked integrin 64 loss or change in localization is 
more common in poorly differentiated tumours. For instance, in undifferentiated SCC of a 
mouse skin carcinogenesis model, integrin 64 levels are highly reduced and the 
remaining protein dimer is aberrantly distributed, suggesting an altered function 
(Witkowski et al. 2000). Loss of integrin 64 may also enhance the survival of colon and 
breast carcinoma cells when they have lost anchorage to laminin-332 (Bachelder et al. 
1999; Guo and Giancotti 2004). Our findings suggested that as a result of EMT 
hemidesmosomal complexes are disintegrated in oral SCC cells. A recent study supports 
our results concerning the downregulation of integrin 4 subunit in EMT (Yang et al. 
2009). Thus, EMT affects the expression of both cytoplasmic and ECM proteins.  
8.2. Expression of Snail protein in the tumour-stroma interface  
Snail mRNA has been studied in cells and tumour samples via Northern blots, RT-PCR, in 
situ hybridization and microarray analysis. We produced two MAbs, 173CE2 and 
173EC3, against Snail protein. In ELISA and Western blots of 43A-SNA cells, the MAbs 
specifically recognized a Mr 32 000 polypeptide, corresponding to the previously reported 
size of Snail protein (Batlle et al. 2000). The short, ca. 25-minute half-life of Snail protein 
sets a challenge for its detection. Furthermore, GSK3-dependent phosphorylation 
influences the subcellular localization of Snail, and Snail is considered inactive in the 
cytoplasm (Domínguez et al. 2003; Zhou et al. 2004; Yang et al. 2005; Yook et al. 2005). 
We have also shown that Snail may control its own expression by binding to E-box motifs 
in its promoter (Peiró et al. 2006). Immunofluorescence analysis demonstrated a strong 
nuclear localization of Snail in 43A-SNA cells and a heterogeneous, yet nuclear 
localization in pancreatic carcinoma cells. Endogenous Snail immunoreactivity was 
detected, for instance, in human and mouse fibroblasts and in colon carcinoma cell lines.  
 
During early-mid gastrulation of mouse development at E7.5, Snail protein localized to 
the mesoderm, parietal endoderm and ectoplacental cone. At E9.5, reactivity for Snail was 
detected in the neural crest cells migrating to branchial arches. During late embryogenesis 
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at E15.5, Snail reactivity was strong in the cartilage, lung mesenchyme and the upper 
layers of the dermis. After birth, the levels of Snail immunoreactivity were less intense, 
but still detectable in the lung and skin, where it was found around the mesenchymal cells 
near the hair follicle. These results are congruent with those gained from mRNA 
localization studies in the mouse (Nieto et al. 1992; Sefton et al. 1998). Our findings 
partly agree with others concerning the expression of Snail during hair follicle 
development. Mesenchymal cells required for hair growth reside at the dermal papilla 
(Jahoda et al. 1984). Mice overexpressing Snail transgene develop a thickened, 
hyperproliferative epidermis, suggesting that Snail plays a role in hair follicle 
morphogenesis (Jamora et al. 2005). However, by in situ hybridization, Snail was not 
detected in the cells of the epidermal-dermal interface as in our studies, but was located 
only transiently in the developing hair bud (Jamora et al. 2005).  
 
To gain more information on the roles of Snail in skin and especially cell migration, we 
performed in vivo wound-healing assays. Cutaneous wound-healing requires rapid and 
transient events to restore the integrity of the skin. The migration of keratinocytes during 
re-epithelization involves morphological and functional changes that resemble EMT. 
Previously, expression of transcription factor Slug mRNA has been associated with 
wound-healing (Savagner et al. 2005). In their study, Slug induced cohesive cell 
migration, which could be interpreted as a partial EMT. Expression of Slug rose at wound 
margins after one day and fell after four days (Savagner et al. 2005). We found Snail 
protein at the margins of mouse skin wounds on days 2-7. Thereafter, the levels of Snail 
declined as the proliferation period was accomplished. The fibroblast-like cells that were 
infiltrating the granulation tissue showed prominent Snail reactivity. Therefore, both Snail 
and Slug seem to operate in wound-healing, although their reciprocal functions remain to 
be evaluated. To study the role of activated fibroblasts further, we analysed the expression 
of Snail in fibromatosis, fibrosarcoma and sarcoma samples; large numbers of Snail-
positive cells were found throughout the lesions.  
 
An inverse correlation between Snail and E-cadherin mRNA has been reported in vivo and 
in vitro in oral SCC, diffuse gastric, colorectal, hepatocellular and breast carcinomas 
(Yokoyama et al. 2001; Rosivatz et al. 2002; Fujita et al. 2003; Sugimachi et al. 2003; 
Pálmer et al. 2004; Moody et al. 2005; Peña et al. 2005). In invasive ductal breast 
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carcinoma, Snail mRNA expression is inversely correlated with the grade of 
differentiation and predicts the presence of lymph node metastasis (Blanco et al. 2002). In 
breast and ovarian carcinoma effusions, Snail mRNA corresponds to a shorter disease-free 
period and also shorter overall survival (Elloul et al. 2005). Furthermore, in chemically-
induced mouse skin SCCs, Snail mRNA has been detected at the invasive fronts of the 
tumours (Cano et al. 2000). As stated above, Snail mRNA and protein levels do not 
always correlate since the protein is rather unstable and its localization and activity depend 
on its status of phosphorylation (Domínguez et al. 2003; Zhou et al. 2004). We also found 
that the levels of Snail mRNA and protein are dependent on the presence of serum. 
Furthermore, the mRNA from Snail retrogene may also interfere with PCR analyses 
(Locascio et al. 2002). In our study, colon carcinoma and cervical SCC specimens showed 
Snail immunoreactivity mainly at the invasive fronts of the tumours as well as in the 
stromal cells close to the tumour islets. Although the majority of Snail-positive cells 
showed an elongated phenotype, some cells demonstrated epithelioid characteristics, 
suggesting that they could be entering EMT. To analyse the relationship between Snail 
and E-cadherin, laryngeal SCC and colon adenocarcinoma sections were labelled with 
MAbs to Snail and E-cadherin. Snail reactivity was most commonly found at the edges of 
tumour cell islands and adjacent to the stroma, whereas E-cadherin in these cells was 
typically missing. Snail-positive, elongated cells were also detected in the centre of these 
tumours. Considering the findings of Snail immunoreactivity in stromal cells, the 
progression of a carcinoma lesion has been suggested to depend on the engagement of a 
reactive stroma that provides structural and vascular support for tumour growth and 
invasion (Liotta and Kohn 2001; Tlsty and Coussens 2006). The microenvironment of the 
tumour-host margin may even represent an active participant in the progression of a 
carcinoma (Moinfar et al. 2000; Liotta and Kohn 2001; Orimo et al. 2005). In addition to 
the carcinoma cells, many molecules and enzymes operating at the invasive front can also 
arise from the stroma (Stuelten et al. 2005). For instance, carcinoma-associated fibroblasts 
from a prostate tumour enhance the progression and growth of prostate carcinoma cells 
(Olumi et al. 1999), and stromal cells of breast carcinoma secrete MMP-2 and MMP-9 in 
response to stimuli from the tumour (Shekhar et al. 2001; Petersen et al. 2003; Stuelten et 
al. 2005). Importantly, oral SCCs and breast carcinomas could develop carcinoma-
associated fibroblasts from their primary tumours through EMT (Petersen et al. 2003; 
Vered et al. 2010). These EMT-derived stromal cells can augment the growth and size of 
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the tumour or be highly tumourigenic and invasive themselves (Petersen et al. 2003; Galiè 
et al. 2005). It is therefore possible that the Snail-positive stromal cells in our studies, 
which most likely originated through EMT from the primary tumour, could represent cells 
migrating away from the tumour as well as contributing to the stromal reaction. The MAbs 
developed here have been used since to verify the role of Snail in other carcinomas. In oral 
SCC and colon adenocarcinoma (Francí et al. 2009; Franz et al. 2009), Snail was mainly 
located in the stroma of the invasive fronts, thus supporting our findings. In addition, a 
polyclonal antibody showed a correlation between high amounts of Snail-positive 
carcinoma cells, lymph node metastasis and poor prognosis in oral SCC (Schwock et al. 
2010). The roles of Snail in other carcinomas remain to be established.  
 
During this thesis project another group described a rat monoclonal antibody against 
human Snail (Rosivatz et al. 2006). In adenocarcinomas of the upper gastrointestinal tract, 
expression of Snail protein was limited (in 27/340; 7.9%). Tissue microarray samples 
showed a significantly more frequent expression of Snail in oesophageal carcinomas than 
in cardiac or gastric carcinomas (Rosivatz et al. 2006). Endogenous Snail localized to the 
cell nuclei, as in our studies. They reported Snail expression also in a subset of stromal 
cells, in which it was potentially connected to areas of mucosal erosion. Possibly related to 
the limits of using tissue microarrays, they did not report the presence or absence of Snail 
at the invasive fronts of these carcinomas.  
8.3. EMT downregulates laminin 5 chain and upregulates 
laminin 4 chain in oral SCC cells  
The results that showed downregulation of laminin-332 and its receptor integrin 64 in 
EMT raised the question of whether other laminins could also be targeted by EMT. The 
oral epithelium has been shown to synthesize laminin chains 3, 5, 1, 2, 3, 1 and 2 
(Kosmehl et al. 1999; Pakkala et al. 2002). We evaluated the effect of EMT on laminin-
511 and laminin-411. Laminin 5 chain guides epithelial morphogenesis during 
development and is crucial, for instance, in the MET of kidney (Miner and Li 2000; 
Rebustini et al. 2007). Laminin-511 is ubiquitously expressed in normal epithelial BMs, 
but is lost in some carcinomas, including oral SCC and invasive colorectal carcinoma 
(Miner et al. 1995; Lohi et al. 1996; Miner et al. 1997; Kosmehl et al. 1999; Lohi et al. 
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2000; Brar et al. 2003). Laminin-411, on the other hand, is considered a mainly 
mesenchymal laminin and is suggested to participate in the progression of malignancy of 
breast cancer and glioma (Ljubimova et al. 2001; Ljubimova et al. 2004; Fujita et al. 
2005). In Northern blots, the expression of laminin 5 chain mRNA was strong in 43A 
cells, but in EMT-experienced 43B cells the expression was less prominent and in 43A-
SNA cells was absent altogether. Immunofluorescence studies and immunoprecipitations 
corroborated the findings, as laminin 5 was found together with laminin 1 and 1 chains 
in 43A cell culture medium, whereas the secretion of laminin-511 chains was diminished 
in 43B cells and absent in 43A-SNA cells.  
 
In contrast to laminin 5 chain, Northern blots did not detect any laminin 4 chain 
transcripts in 43A cells, whereas they were clearly present in 43B and 43A-SNA cells. 
Immunofluorescence labellings, immunoprecipitations and Western blots showed 
polypeptides corresponding to laminin-411 chains, but not laminin-421 chains, only in 
43B and 43A-SNA cells. To further evaluate the role of EMT and especially Snail in the 
control of laminin chain expression, we used chromatin immunoprecipitations of 43A-
SNA cells. As the transcriptional control of laminins is generally poorly known and the 
promoter sites not established (Aberdam et al. 2000; Virolle et al. 2002), we screened 
genomic regions 3000 bp upstream of both laminin 5 and 4 chain transcription start 
sites. MAb 173EC3 against Snail detected two regions upstream of laminin 5 chain gene 
and three regions upstream of laminin 4 chain gene that bound Snail. These regions 
contained E-box or Z-box motifs, which are the specific sequences bound by Snail and 
ZEB transcription factors (Mauhin et al. 1993; Postigo and Dean 1997; Verschueren et al. 
1999). Thus, Snail may directly control the transcription of laminin 5 and 4 chains.  
 
To assess the effects of EMT on different laminin receptors, we first turned to Lutheran. 
Lutheran is a specific receptor for α5 chain-containing laminins (Moulson et al. 2001; 
Parsons et al. 2001; Kikkawa et al. 2002), and in parallel studies we have shown their co-
existence in normal oral BM (Willberg et al. 2007). Recently, we further demonstrated 
that human embryonic stem cells use Lutheran and integrin α3β1 as receptors for laminin-
511, and integrin α6β1 as a receptor for laminin-411 (Vuoristo et al. 2009). 43A cells 
showed a strong expression of Lutheran in immunofluorescence labellings and 
immunoprecipitation, whereas 43B cells revealed a reduced, diffuse immunolabelling and 
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43A-SNA cells had no expression of Lutheran. Lutheran expression seems to follow 
laminin α5 chain levels, as in laminin α5 chain knock-out mice Lutheran expression is 
decreased and the cell surface distribution is non-polarized, whereas in laminin α5 chain 
overexpressing mice, also Lutheran levels are increased (Moulson et al. 2001). In skin 
tumours, Lutheran/ B-CAM expression has been found in SCC and basal cell carcinoma, 
but not in melanomas (Schön et al. 2000), suggesting an epithelial origin for Lutheran. 
Our results are in line with these findings, providing further evidence that also Lutheran is 
under the control of EMT.  
 
Having observed that integrin α6β4 complex is reduced in EMT, we investigated which 
other integrins could mediate adhesion to ECM. In immunohistochemical studies of oral 
SCC, loss of integrin 64 has been connected to persisting expression of integrin 6 
subunit (Garzino-Demo et al. 1998). This could imply that upon dissociation of 64 
complex, integrin 6 subunit recruits another  subunit. Immunolabellings and 
immunoprecipitations showed that the levels of integrin 64 were strong in 43A cells, less 
intense in 43B cells, indicating some complex formation, and absent in 43A-SNA cells. 
Instead, 43A-SNA cells assembled integrin α6β1, which is one of the few recognized 
receptors for laminin-411 (Kortesmaa et al. 2000; Fujiwara et al. 2001). Cancer cells have 
been shown to switch to expression of integrins favouring their survival and migration 
(Guo and Giancotti 2004). In agreement with our findings, integrin 64 is replaced by 
61 in progression of prostate carcinoma (Cress et al. 1995). In addition, integrin 61 is 
connected to an invasive phenotype, as it promotes survival and growth of metastatic 
breast carcinoma cells (Wewer et al. 1997a). In an EMT cell model of Ha-Ras-
transformed mammary epithelial cells, expression of integrins 51 and 61 is upregulated 
(Maschler et al. 2005). The localization of 5 and 6 subunits, however, is depolarized and 
distributed at the entire cell surface as opposed to focal adhesions, questioning whether 
they are functional. Our results further showed that 43A-SNA cells upregulated the levels 
of integrin α1β1, which is mainly a collagen-binding integrin and also related to a 
migratory phenotype (Hemler et al. 1984; Gardner et al. 1996). The levels of integrin α1β1 
rise in some malignancies such as invasive bladder carcinomas and mesenchymal tumours, 
fibrosarcoma and leiomyosarcoma (Miettinen et al. 1993; Liebert et al. 1994). We also 
detected neoexpression of ILK in focal adhesions of 43B and 43A-SNA cells. Ectopic ILK 
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induces cell invasion and tumourigenesis in nude mice (Novak et al. 1998; Janji et al. 
1999). ILK may also initiate EMT and augment the levels of Snail through the GSK3 
pathway (Somasiri et al. 2001; Tan et al. 2001). Our results suggest a feedback loop in 
which EMT upregulates ILK. This could be achieved, for instance, through EMT-induced 
engagement of potentially ILK-binding integrins 61 and α1β1, leading to activation of 
the TGF-β pathway and upregulation of ILK (Nieto 2002; Oloumi et al. 2004).  
 
Laminin-411 and laminin-511 may have opposing effects on cell migration, as laminin-
411 seems to promote monocyte migration through blood vessel walls into tissues and 
laminin-511 may determine their arrest (Pedraza et al. 2000). In our functional cell 
adhesion experiments, oral SCC cells adhered strongly to fibronectin and laminin-511, 
whereas adhesion to laminin-411 was minimal. Laminin-411 has previously been 
implicated in the detachment, migration and invasion of cancer cells, and suggested to 
belong to matricellular proteins that participate in modulation of anti-adhesive properties 
(Fujiwara et al. 2001; Murphy-Ullrich 2001; Bornstein and Sage 2002; Khazenzon et al. 
2003; Vainionpää et al. 2007). There is also evidence that matricellular protein SPARC 
enables local tumour cell colonization and induces EMT in progression of melanoma 
(Bornstein and Sage 2002; Robert et al. 2006). When we used fibronectin or laminin-511 
as adhesion substrates with increasing concentrations of laminin-411, laminin-411 
significantly compromised the adhesion of 43A, 43B and 43A-SNA cells. Interference of 
laminin-411 or tenascin-C with adhesion to fibronectin has previously been detected with 
glioblastoma, breast and renal cell carcinoma cells (Huang et al. 2001; Vainionpää et al. 
2007). Western blots and immunoprecipitations of 43B cells further showed co-
precipitation of laminin-411 and fibronectin, indicating that they bind to each other. These 
results suggested that laminin-411 may modulate cell adhesion as an intermediary with 
other ECM proteins. The EMT-experienced oral SCC cells may control their 
microenvironment and gain access to distant sites by regulating the synthesis of ECM 
proteins that enhance their migration abilities.  
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8.4. Podosome-like structures of non-invasive oral SCC cells 
are replaced in EMT by actin comet-based invadopodia  
Our observations suggest that 43A cells organize prominent hemidesmosomes and focal 
adhesions, whereas 43B and 43A-SNA cells organize mainly focal and fibrillar adhesions. 
We further found that EMT strongly potentiates the invasion abilities of oral SCC cells. 
Wound-healing and invasion assays combined with rhodamine phalloidin labellings 
revealed that 43A and mesenchymally transformed 43B cells assembled actin-based 
structures that resembled podosomes and invadopodia (Lehto et al. 1982; Linder and 
Aepfelbacher 2003; Weaver 2006; Linder 2007; Yilmaz and Christofori 2009). 
Podosomes of 43A cells were punctate structures, whereas 43B cell invadopodia had tail-
like, curling actin assemblies. In wound-healing experiments and FESEM, 43B cells 
developed similar actin-rich protrusions from their cell membranes. 43A-SNA cells lacked 
such actin accumulations, although their invasion and migration competence was 
significantly higher than that of 43A or 43B cells. This could indicate that 43A-SNA cells 
employ an ameboid-type of movement, which has been detected during migration of 
highly malignant cancer cells (Friedl and Bröcker 2000; Wolf et al. 2003; Carragher et al. 
2006). In such situation, the cells do not degrade their surrounding extracellular matrix 
substantially, but squeeze through the collagen networks.  
 
To attain more knowledge about podosome-like structures and invadopodia in 43A and 
43B cells, we first followed random cell migration with epifluorescence wide-field live-
cell imaging. Confirming the results obtained with wound-healing experiments, 43A cells 
migrated in ten hours only marginally, whereas 43B cells had significantly longer 
migration trajectories and greater velocity. In contrast to many other cell models (Tarone 
et al. 1985; Hai et al. 2002; Moreau et al. 2003; Furmaniak-Kazmierczak et al. 2007), 43A 
and 43B cells assembled podosomes and invadopodia constitutively under normal cell 
culture conditions, without any need for stimulation with growth factors or tyrosine 
kinases. These structures organized independently of the ECM substrate coating and their 
morphology did not change when cell migration was stimulated with EGF. When the cells 
were seeded on fluorescently labelled gelatin, 43A and 43B cells formed the podosomes 
and invadopodia rapidly, in two hours, and degraded the underlying matrix possibly via 
MT1-MMP (Sato et al. 1997). 43B cells further formed actin-based, club-ended cell 
extensions in five hours, which also degraded the ECM. FESEM indicated 43A cells as 
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flat epithelioid cells with prominent lamellae, whereas 43B cells were covered with club-
ended cell extensions that seemed to originate from the dorsal cell surfaces. These 
extensions were distinct from filopodia, which do not have such large endings (Faix and 
Rottner 2006; Yamaguchi and Condeelis 2007). 3D confocal microscopy and in situ 
gelatin zymography disclosed 43A podosomes as relatively large, ECM-protruding 
structures, whose volumes increased over time. 43B cells assembled greater numbers of 
invadopodia that were narrow tail-like structures with no specific tendency to increase in 
volume over time. With regard to their invasion capacities, 43B invadopodia degraded 
significantly larger areas of ECM per cell than 43A podosomes.  
 
To gain more information about the structural proteins in podosomes and invadopodia, we 
used EGFP-actin transfections together with immunofluorescence labellings, 
immunoprecipitations and Western blots. In addition to hemidesmosomes in 43A cells, 
HD1/ plectin was found at the peripheral ring of 43A podosomes, but not in 43B 
invadopodia. HD1/ plectin is a linker protein that regulates also microtubule and actin 
dynamics through its different domains (Niessen et al. 1997; Sonnenberg and Liem 2007). 
As the binding sites of integrin β4 subunit and actin seem to overlap, HD1/ plectin cannot 
bind both of these molecules simultaneously (Sonnenberg and Liem 2007). This could be 
the reason why HD1/ plectin localized with actin filaments in podosomes, but with Ck 
filaments in hemidesmosomes of 43A cells. HD1/ plectin and II-spectrin belong to the 
spectraplakin superfamily and function as membrane anchoring and scaffolding molecules 
that crosslink actin to the cell membrane (Röper et al. 2002; Sonnenberg and Liem 2007). 
Similarly to HD1/ plectin, we detected II-spectrin reactivity only at the podosome rings 
of 43A cells, not in 43B invadopodia. These proteins may be used to mediate protein 
recruitment and membrane scaffolding in 43A podosomes. 
 
Other proteins that localized to 43A podosome rings, but not to 43B invadopodia were 
talin, FAK and pacsin 2. Talin is an important adaptor between integrins, mediators such 
as FAK, and the cytoskeleton, and it regulates actin assembly by capping the barbed 
filament ends (Critchley 2004; Le Clainche and Carlier 2008). Our results suggested that 
talin was replaced by tensin in 43B cell invadopodia and cell extensions. Previously, the 
talin-tensin switch has been found in maturing focal adhesions (McCleverty et al. 2007; 
Legate and Fässler 2009), in which they both bind integrin 1 and 5 subunits and mediate 
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adhesion to actin filaments. The talin-tensin switch has been suggested to transform a 
structural adhesion to an actively signalling one (Legate and Fässler 2009), which could be 
advantageous to rapidly migrating EMT-experienced 43B cells.  
 
The results also showed pacsin 2 immunoreactivity together with its binding partner 
filamin A only in the 43A podosome ring and core, respectively, not in invadopodia. 
Filamin A, an actin crosslinking protein (van der Flier and Sonnenberg 2001b; Nikki et al. 
2002), did not accumulate to 43B invadopodia until 15 hours after seeding, i.e., after the 
functional invadopodia had formed. This suggested that invadopodia can mature into 
actively degrading structures independent of filamin A. Filamin A overexpression did not 
recruit pacsin 2 to 43B invadopodia. As pacsin 2 has been implicated as a membrane-
bending protein with a role in mediating endocytosis (Modregger et al. 2000; Qualmann 
and Kelly 2000; Halbach et al. 2007; Heath and Insall 2008), it may participate in the 
formation of podosome 3D structure and gather proteins for cytoplasmic import. 
Furthermore, by binding to filamin A, it may contribute to stabilization of the podosome 
in a time-dependent manner.  
 
Integrin v5 localized only to the sharp interface between the invadopodia head and the 
cell membrane. Integrin v5, a vitronectin receptor, is linked to a mesenchymal 
phenotype, has been reported in EMT in normal tooth development and is required for 
invasion of human embryonal kidney cells undergoing EMT (Salmivirta et al. 1996; Yan 
and Shao 2006). In addition, integrin v5 may have a role in endocytosis, as it mediates 
degradation and internalization of vitronectin in fibroblasts (Panetti and McKeown-Longo 
1993). Integrin 31, on the other hand, is able to bind multiple ligands, including 
fibronectin, type IV collagen and laminins (Belkin and Stepp 2000). We found integrin 
31 at the podosome rings of 43A cells. In 43B cells, the distribution of integrin 31 was 
restricted to cover the cell membrane around the invadopodia and the cell extensions 
protruding from the cells. Although this integrin has been detected previously in 
invadopodia, a similar distribution has not been reported (Mueller et al. 1999). The 
localization of integrin 31 in 43B cells could be explained partly by the fact that the 
morphology of 43B invadopodia is rather unique, as only one study has previously 
reported actin tails in invadopodia (Baldassarre et al. 2006). If this integrin is used in 43B 
cells in the docking of proteolytic enzymes to invadopodia (Mueller et al. 1999), its wide 
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distribution around the actin tails could explain the greater degrading activity of the 
invadopodia. However, it remains to be shown whether integrins de facto mediate 
invadopodia adhesion to ECM or function primarily as guiding or tethering proteins.  
 
Time-lapse epifluorescence and TIRF microscopy with EGFP-actin and EGFP-cortactin-
transfected cells disclosed 43A podosomes as highly stable structures with long life-spans. 
In contrast, 43B invadopodia had long, vigorously propelling tails that were attached by 
their heads to the basal cell membrane. Although predominantly long-lived, the actin tails 
were occasionally released from their attachment site and shuttled through the cytoplasm 
and new invadopodia developed. Migrating 43B cells showed club-ended extensions at the 
retracting cells as well as between the cell borders, suggesting that they are involved in 
maintenance of contacts between the cells and the ECM. Prolonged TIRF microscopy 
revealed halos of EGFP-actin in the immediate basal cell surface focal plane, correlating 
to a pool of monomeric actin (Destaing et al. 2003) surrounding 43A podosomes, but not 
in the vicinity of 43B invadopodia. In contrast to suggestions by Yamaguchi et al. (2005a), 
we could not detect migration of single podosomes or invadopodia, nor did we witness 
their fission from existing podosomes, thus concluding that they are formed de novo in 
43A and 43B cells. Furthermore, when the actin filaments or microtubules were disrupted 
with cytochalasin B or demecolcine (Linder et al. 2000b), respectively, no new podosomes 
or invadopodia developed, suggesting that both networks are needed for their 
organization. As the growing heads of actin filaments in podosomes reach towards the 
membrane (Akisaka et al. 2008), they presumably provide the tension to create membrane 
protrusions. If implemented to cover the functions of actin comets in 43B invadopodia, 
they may be related to invasive abilities. In congruence, actin comets have been first 
discovered in intracellular bacteria, where they gather an actin polymerization machinery 
to produce movement (Gouin et al. 2005). These results are supported by our findings of 
several members of the actin treadmilling machinery, e.g., Arp 2/3, cortactin and vinculin, 
in both 43A podosomes and 43B invadopodia.  
 
The formation and maintenance of function of both podosomes and invadopodia depend 
on continuous actin assembly (Linder et al. 2000a; Linder et al. 2000b; Yamaguchi et al. 
2005a; Weaver 2006). FRAP experiments with EGFP-transfected cells showed significant 
differences between the turnover of fluorescent proteins in 43A podosomes and 43B 
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invadopodia. Actin, cortactin and filamin A were all rapidly organized to both podosomes 
and invadopodia, but the recovery times were always shorter in podosomes. Also the 43B 
cell extensions showed shuffling of actin molecules, indicating that they are actively 
regulated cell organs. FRAP experiments of osteoclast podosomes have shown that the 
recovery of actin to plateau is ca. 1-2 minutes (Ochoa et al. 2000; Destaing et al. 2003). As 
opposed to our study, osteoclast podosomes were photobleached in colonies of tens to 
hundreds of podosomes, and their results may be compromised by the diffusion distance 
of actin molecules being longer in such a setting. When bleaching is directed to a broader 
area, the phototoxicity also affects a larger cytoplasmic environment. Congruent with the 
slower recovery of 43B invadopodia compared with 43A podosomes, photobleaching of 
melanoma cell invadopodia have shown actin recovery of 3 minutes (Baldassarre et al. 
2006). The life-spans of osteoclast podosomes have been reported to be 2-12 minutes, 
although they depend on the stage of podosome differentiation, i.e., whether the 
osteoclasts form podosome clusters, belts or rings (Kanehisa et al. 1990; Akisaka et al. 
2001; Destaing et al. 2003). In this respect, the several-hour-long life-spans of oral SCC 
podosomes and invadopodia resemble characteristics reported for invadopodia 
(Yamaguchi et al. 2005a; Baldassarre et al. 2006). Taken together, 43A podosomes are 
complex structures with typical organization with a ring and core. Actin, cortactin and 
filamin A molecules present high turnover in these structures, indicating a strict regulation 
of podosome dynamics. The actin tail-embedded invadopodia in 43B cells are long-lived, 
but the reorganization of structural proteins is slower than in podosomes, possibly 
reflecting a more labile phenotype. As the 3D structure of invadopodia remains the same 
during their life-span, and regardless of their small size, invadopodia being able to degrade 
ECM in high amounts, it can be suggested that they may be used in invasion of oral SCC 
cells. The cell extensions in 43B cells harboured the same proteins as invadopodia and 
showed dynamic shuffling of actin molecules, suggesting that they also participate in the 
migration and invasion of EMT-experienced cells.  
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9 CONCLUSIONS 
Invasion and metastasis of epithelial tumours remains the primary cause of treatment failure 
and death of cancer patients. Further insights into the mechanisms leading to malignancy are a 
prerequisite for identifying new, clinically valuable prognostic markers and developing new 
therapies. Emerging interest has focused on the involvement of EMT in pathological 
conditions, including cancer progression. The primary focus of this thesis was to study the role 
of EMT in oral SCC cell lines and in tumour samples.  
 
As the role and localization of transcription factor Snail in cancer have remained 
undetermined due to lack of proper antibodies, we created two MAbs specific for Snail. The 
MAbs showed endogenous and exogenous Snail in the nuclei of murine and human fibroblasts 
and in many human carcinoma cells. Snail was detected at the stroma and invasive margins of 
colon adenocarcinoma and cervical and laryngeal SCC. It also localized to activated 
fibroblastoid cells in wound borders and was found in fibromatosis, fibrosarcoma and sarcoma 
samples.  
 
In oral SCC cells, EMT not only downregulated E-cadherin at the adherens junction, but 
upregulated N-cadherin and induced a vast cytoskeletal change by downregulating cytokeratin 
expression profile, upregulating vimentin intermediate filaments and dissociating 
hemidesmosomal complexes. E-cadherin repressors ZEB-1 and ZEB-2 were most likely 
responsible for the endogenous EMT, and Snail was further found to induce these 
transcription factors in the exogenous EMT. In addition, EMT affected the expression and 
distribution of a variety of integrins, namely 11, 31, 61, 64 and v5, which operate in 
the adhesion, proliferation and migration of normal and malignant cells. EMT also 
progressively downregulated the expression of epithelial BM components laminin-332 and 
laminin-511 and upregulated the expression of mesenchymal laminin-411. The results showed 
that Snail can directly bind the promoter sites of laminin 5 and 4 chains and control their 
transcription. Laminin-411 may hinder the binding of cells to other ECM components and thus 
elicit migration of cancer cells. EMT gave rise to a highly migratory and invasive phenotype 
in oral SCC cells. EMT induced a switch in the adhesion and invasion machinery, changing 
from assembly of podosome-like structures to actin comet-embedded invadopodia. Previously 
unidentified structural proteins, e.g., HD1/ plectin, II-spectrin, pacsin 2 and filamin A, that 
were detected in podosomes or invadopodia depict and emphasize their differences as 
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mediators of cancer development. Compared with podosomes, invadopodia had a less 
regulated and less stable appearance. Invadopodia were more numerous, degraded greater 
amounts of ECM and, through cellular extensions, probed their immediate environment, thus 
presenting qualities that EMT-experienced carcinoma cells could exploit in migration and 
invasion.  
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Figure 10. A schematic model of EMT in oral SCC cells. Further details are described in the text.  
The principal findings of this study suggest that EMT affects the transcription, synthesis and 
secretion of laminins-332, -411 and -511 in addition to the levels and distribution of their 
specific receptors. The oral SCC cell lines can be used in the future to further evaluate the 
roles of EMT in the progression of malignancy, as well as in studies of the function of 
podosomes and invadopodia in cell migration and invasion. The MAbs created in this study 
revealed Snail protein in invasive fronts of carcinomas and in the tumour-stroma 
compartment. They can thus be used to detect Snail and to predict the presence of EMT and 
malignant phenotype in cell lines and patient samples. More thorough understanding of the 
pathomechanisms of cancer will pave the way for novel, effective cancer treatment modalities.  
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